<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>PharmaSalts India 2026 â€“ Top 400 API Explorer</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
<style>
  body { font-family: 'Inter', sans-serif; background-color: #F1F5F9; color: #1E293B; }
  .chart-container { position:relative; width:100%; max-width:520px; margin:auto; height:280px; }
  @media(min-width:768px){ .chart-container{ height:320px; } }
  .custom-scrollbar::-webkit-scrollbar{width:5px}
  .custom-scrollbar::-webkit-scrollbar-track{background:#F1F5F9}
  .custom-scrollbar::-webkit-scrollbar-thumb{background:#CBD5E1;border-radius:4px}
  .card-hover{transition:all .2s ease}
  .card-hover:hover{transform:translateY(-3px);box-shadow:0 12px 24px -6px rgba(0,0,0,.12)}
  /* Schedule badge colours */
  .sch-OTC{background:#E2E8F0;color:#475569}
  .sch-C  {background:#CCFBF1;color:#0F766E}
  .sch-H  {background:#DBEAFE;color:#1D4ED8}
  .sch-H1 {background:#FED7AA;color:#C2410C}
  .sch-X  {background:#FEE2E2;color:#B91C1C}
  /* Section pill colours */
  .sec-1{background:#DBEAFE;color:#1D4ED8}
  .sec-2{background:#FEE2E2;color:#B91C1C}
  .sec-3{background:#DCFCE7;color:#15803D}
  .sec-4{background:#F3E8FF;color:#7E22CE}
  .sec-5{background:#FEF3C7;color:#B45309}
  .sec-6{background:#E0E7FF;color:#3730A3}
  .sec-7{background:#FFE4E6;color:#9F1239}
  .sec-8{background:#FDF4FF;color:#86198F}
  .sec-9{background:#E0F2FE;color:#0369A1}
  .sec-10{background:#ECFDF5;color:#047857}
  .filter-active{ring:2px solid currentColor;font-weight:600}
  input[type=text]:focus{outline:none}
</style>
</head>
<body class="min-h-screen flex flex-col">

<!-- â”€â”€ HEADER â”€â”€ -->
<header class="bg-white border-b border-slate-200 sticky top-0 z-30 shadow-sm">
  <div class="max-w-7xl mx-auto px-4 sm:px-6 lg:px-8 py-3 flex flex-col md:flex-row md:items-center justify-between gap-3">
    <div>
      <h1 class="text-2xl font-bold text-teal-700 tracking-tight">
        Pharma Salts<span class="text-slate-500 font-light"> India 2026</span>
      </h1>
      <p class="text-xs text-slate-400 mt-0.5">Interactive Index Â· Top 400 Active Pharmaceutical Ingredients</p>
    </div>
    <div class="flex-1 max-w-xl w-full">
      <div class="relative">
        <span class="absolute inset-y-0 left-3 flex items-center text-slate-400 text-sm">ğŸ”</span>
        <input type="text" id="searchInput" placeholder="Search salt name, brand, uses, formationâ€¦"
          class="block w-full pl-9 pr-3 py-2 border border-slate-300 rounded-lg bg-slate-50 placeholder-slate-400
                 focus:bg-white focus:border-teal-500 focus:ring-1 focus:ring-teal-500 text-sm transition">
      </div>
    </div>
  </div>
</header>

<!-- â”€â”€ MAIN â”€â”€ -->
<main class="flex-grow max-w-7xl mx-auto px-4 sm:px-6 lg:px-8 py-6 w-full">

  <!-- Intro -->
  <section class="mb-6">
    <p class="text-slate-600 max-w-3xl leading-relaxed text-sm">
      Complete ranked analysis of 400 pharmaceutical salts dominating the Indian market in 2026.
      Data from <strong>IQVIA/PharmaTrac</strong>, <strong>NLEM 2022</strong>, and hospital formularies.
      Each card shows <strong>brand names</strong>, drug <strong>schedule</strong>, section, dosing, and contraindications.
    </p>
  </section>

  <!-- Dashboard row -->
  <div class="grid grid-cols-1 lg:grid-cols-3 gap-5 mb-6">

    <!-- Chart -->
    <div class="bg-white p-5 rounded-2xl border border-slate-200 shadow-sm flex flex-col items-center">
      <h3 class="text-xs font-bold text-slate-400 uppercase tracking-widest mb-3 w-full text-center">Therapeutic Category Mix</h3>
      <div class="chart-container"><canvas id="categoryChart"></canvas></div>
      <p class="text-xs text-slate-400 text-center mt-3">Based on 400 indexed salts</p>
    </div>

    <!-- Filters panel -->
    <div class="bg-white p-5 rounded-2xl border border-slate-200 shadow-sm lg:col-span-2 flex flex-col gap-4">

      <!-- Safety row -->
      <div class="grid grid-cols-1 sm:grid-cols-2 gap-3">
        <div class="p-3 bg-rose-50 rounded-xl border border-rose-100">
          <div class="flex items-center justify-between mb-1">
            <span class="text-rose-700 font-semibold text-sm">Liver Safety</span>
            <span>âš ï¸</span>
          </div>
          <p class="text-xs text-rose-500 mb-2">Exclude hepatotoxic agents</p>
          <button id="btn-liver"
            class="w-full py-1.5 bg-white border border-rose-200 text-rose-700 rounded-lg text-xs font-medium hover:bg-rose-100 transition">
            Hide Liver-Contraindicated
          </button>
        </div>
        <div class="p-3 bg-blue-50 rounded-xl border border-blue-100">
          <div class="flex items-center justify-between mb-1">
            <span class="text-blue-700 font-semibold text-sm">Pediatric Focus</span>
            <span>ğŸ‘¶</span>
          </div>
          <p class="text-xs text-blue-500 mb-2">Salts with defined child dosing</p>
          <button id="btn-pediatric"
            class="w-full py-1.5 bg-white border border-blue-200 text-blue-700 rounded-lg text-xs font-medium hover:bg-blue-100 transition">
            Pediatric Approved Only
          </button>
        </div>
      </div>

      <!-- Section pills -->
      <div>
        <p class="text-xs font-bold text-slate-400 uppercase tracking-widest mb-2">Book Section</p>
        <div class="flex flex-wrap gap-1.5" id="section-pills"></div>
      </div>

      <!-- Schedule pills -->
      <div>
        <p class="text-xs font-bold text-slate-400 uppercase tracking-widest mb-2">Drug Schedule (India)</p>
        <div class="flex flex-wrap gap-1.5" id="schedule-pills"></div>
      </div>

      <!-- Category pills -->
      <div>
        <p class="text-xs font-bold text-slate-400 uppercase tracking-widest mb-2">Therapeutic Category</p>
        <div class="flex flex-wrap gap-1.5" id="category-pills"></div>
      </div>

    </div>
  </div>

  <!-- Toolbar -->
  <div class="flex flex-col sm:flex-row justify-between items-center mb-4 border-b border-slate-200 pb-3 gap-3">
    <h2 class="text-base font-bold text-slate-800 flex items-center gap-2">
      Salt Index
      <span id="count-badge" class="px-2.5 py-0.5 rounded-full bg-slate-100 text-slate-600 text-xs font-medium border border-slate-200">â€”</span>
    </h2>
    <div class="flex items-center gap-2 text-sm">
      <span class="text-slate-500">Sort:</span>
      <select id="sortSelect" class="border border-slate-300 rounded-lg px-2 py-1 bg-white focus:border-teal-500 outline-none text-sm">
        <option value="rank">Market Rank (1â€“400)</option>
        <option value="alpha">Name (Aâ€“Z)</option>
      </select>
      <button onclick="resetFilters()" class="ml-2 px-3 py-1 rounded-lg bg-slate-100 hover:bg-slate-200 text-slate-600 text-xs font-medium transition">
        Reset Filters
      </button>
    </div>
  </div>

  <!-- Grid -->
  <div id="saltGrid" class="grid grid-cols-1 md:grid-cols-2 xl:grid-cols-3 gap-5"></div>

  <!-- Empty state -->
  <div id="emptyState" class="hidden text-center py-20">
    <div class="text-5xl mb-4">ğŸ§ª</div>
    <h3 class="text-lg font-medium text-slate-800">No salts match your filters</h3>
    <p class="text-slate-500 text-sm mt-1">Try adjusting your search or filter criteria.</p>
    <button onclick="resetFilters()" class="mt-4 text-teal-600 hover:text-teal-800 font-medium text-sm">Reset All Filters</button>
  </div>

</main>

<footer class="bg-white border-t border-slate-200 py-6 mt-auto">
  <div class="max-w-7xl mx-auto px-4 text-center">
    <p class="text-sm text-slate-500">Â© 2026 Pharmacological Inventory of India Â· Data from IQVIA/PharmaTrac, NLEM 2022, CDSCO & NPPA</p>
    <p class="text-xs text-slate-400 mt-1">For educational & reference use only. Consult CDSCO/NLEM guidelines before clinical decisions.</p>
  </div>
</footer>

<script>
// â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
//  DATA
// â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
const saltsData = [
  {
    "rank": 1,
    "name": "Amoxicillin + Potassium Clavulanate",
    "section": "Section 1: Foundational Molecules",
    "category": "Antibiotics",
    "schedule": "H",
    "brand": "Augmentin / Clavam / Moxikind-CV",
    "formation": "Penicillin derivative + beta-lactamase inhibitor",
    "uses": "Community-acquired pneumonia, sinusitis, soft tissue infections",
    "adult": "625 mg TID or 1 g Duo BID (based on severity)",
    "child": "25â€“45 mg/kg/day in divided doses",
    "avoid": "Penicillin hypersensitivity, history of cholestatic jaundice"
  },
  {
    "rank": 2,
    "name": "Metformin + Glimepiride",
    "section": "Section 1: Foundational Molecules",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Glycomet-GP / Glimestar-M",
    "formation": "Biguanide + third-generation sulfonylurea",
    "uses": "First-line management of Type 2 Diabetes Mellitus",
    "adult": "500 mg/1 mg to 1000 mg/2 mg BID (with meals)",
    "child": "Not recommended for standard diabetic use",
    "avoid": "Renal failure (eGFR < 30 mL/min), metabolic acidosis"
  },
  {
    "rank": 3,
    "name": "Pantoprazole Sodium",
    "section": "Section 1: Foundational Molecules",
    "category": "Gastrointestinal",
    "schedule": "H",
    "brand": "Pan / Pantodac / Pantop",
    "formation": "Substituted benzimidazole (Proton Pump Inhibitor)",
    "uses": "GERD, peptic ulcers, NSAID-induced ulcer prophylaxis",
    "adult": "40 mg OD, 30â€“60 minutes before breakfast",
    "child": "1 mg/kg/day (usage restricted under 5 years)",
    "avoid": "Hypersensitivity to benzimidazoles, severe hepatic impairment"
  },
  {
    "rank": 4,
    "name": "Telmisartan",
    "section": "Section 1: Foundational Molecules",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Telma / Telmikind",
    "formation": "Non-peptide angiotensin II receptor antagonist",
    "uses": "Hypertension, cardiovascular risk reduction",
    "adult": "40â€“80 mg OD",
    "child": "Not recommended",
    "avoid": "Pregnancy (2nd/3rd trimester), bilateral renal artery stenosis"
  },
  {
    "rank": 5,
    "name": "Paracetamol (Acetaminophen)",
    "section": "Section 1: Foundational Molecules",
    "category": "Analgesics",
    "schedule": "OTC",
    "brand": "Dolo-650 / Calpol / Crocin",
    "formation": "p-aminophenol derivative",
    "uses": "Fever (antipyretic), mild-to-moderate pain (analgesic)",
    "adult": "500â€“1000 mg every 4â€“6 hrs (max 4 g/day)",
    "child": "10â€“15 mg/kg per dose (max 60 mg/kg/day)",
    "avoid": "Severe hepatic impairment, chronic heavy alcohol use"
  },
  {
    "rank": 6,
    "name": "Formoterol + Budesonide",
    "section": "Section 1: Foundational Molecules",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Foracort / Symbicort",
    "formation": "Long-acting beta2-agonist + inhaled corticosteroid",
    "uses": "Maintenance of Asthma and COPD symptoms",
    "adult": "12 mcg/400 mcg, 1â€“2 puffs BID",
    "child": "6/100 mcg or 6/200 mcg BID (Consult specialist)",
    "avoid": "Status asthmaticus, pulmonary tuberculosis"
  },
  {
    "rank": 7,
    "name": "Insulin Human (70/30)",
    "section": "Section 1: Foundational Molecules",
    "category": "Antidiabetic",
    "schedule": "C",
    "brand": "Mixtard / Huminsulin 30/70",
    "formation": "Biphasic mixture of Isophane (70%) and Soluble (30%) insulin",
    "uses": "Type 1 and Type 2 Diabetes Mellitus",
    "adult": "Individualized based on glucose (30 mins before meals)",
    "child": "Weight-based titration (0.5â€“1.0 units/kg/day)",
    "avoid": "During episodes of hypoglycemia"
  },
  {
    "rank": 8,
    "name": "Tirzepatide",
    "section": "Section 1: Foundational Molecules",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Mounjaro",
    "formation": "Dual GIP and GLP-1 receptor agonist (Synthetic peptide)",
    "uses": "Advanced Type 2 Diabetes, weight management",
    "adult": "2.5 mg/week initial, titrate to 5â€“15 mg/week",
    "child": "Not recommended",
    "avoid": "History of Medullary Thyroid Carcinoma, MEN 2 syndrome"
  },
  {
    "rank": 9,
    "name": "Pantoprazole + Domperidone",
    "section": "Section 1: Foundational Molecules",
    "category": "Gastrointestinal",
    "schedule": "H",
    "brand": "Pan-D / Pantodac-D / Razo-D",
    "formation": "PPI + dopamine-receptor antagonist",
    "uses": "GERD with dyspepsia, acidity with nausea/vomiting",
    "adult": "40 mg/30 mg OD (30 mins before breakfast)",
    "child": "Not recommended",
    "avoid": "Prolactinoma, GI hemorrhage, cardiac conduction delays"
  },
  {
    "rank": 10,
    "name": "Levothyroxine Sodium",
    "section": "Section 1: Foundational Molecules",
    "category": "Hormonal",
    "schedule": "H",
    "brand": "Thyronorm / Eltroxin",
    "formation": "Synthetic levo-isomer of thyroxine (T4)",
    "uses": "Primary, secondary, and tertiary hypothyroidism",
    "adult": "12.5â€“200 mcg OD (on empty stomach, 1 hr before breakfast)",
    "child": "10â€“15 mcg/kg OD (titrate to euthyroid)",
    "avoid": "Uncorrected adrenal insufficiency, acute myocardial infarction"
  },
  {
    "rank": 11,
    "name": "Cilnidipine",
    "section": "Section 1: Foundational Molecules",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Cilacar / Clinidipine",
    "formation": "L-type and N-type calcium channel blocker",
    "uses": "Essential hypertension, hypertensive nephropathy",
    "adult": "5â€“20 mg OD",
    "child": "Not recommended",
    "avoid": "Unstable angina, cardiogenic shock"
  },
  {
    "rank": 12,
    "name": "Azithromycin",
    "section": "Section 1: Foundational Molecules",
    "category": "Antibiotics",
    "schedule": "H",
    "brand": "Azithral / Azee / Zithromax",
    "formation": "Azalide subclass of macrolide antibiotics",
    "uses": "Upper/lower RTI, typhoid, skin infections",
    "adult": "500 mg OD for 3â€“5 days",
    "child": "10 mg/kg Day 1, then 5 mg/kg Day 2â€“5",
    "avoid": "History of cholestatic jaundice, QT prolongation"
  },
  {
    "rank": 13,
    "name": "Atorvastatin",
    "section": "Section 1: Foundational Molecules",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Atorva / Storvas / Lipitor",
    "formation": "Synthetic HMG-CoA reductase inhibitor",
    "uses": "Primary hypercholesterolemia, prevention of CVD",
    "adult": "10â€“80 mg OD",
    "child": "Not recommended",
    "avoid": "Active liver disease, pregnancy, breastfeeding"
  },
  {
    "rank": 14,
    "name": "Cefixime",
    "section": "Section 1: Foundational Molecules",
    "category": "Antibiotics",
    "schedule": "H1",
    "brand": "Taxim-O / Zifi / Cefix",
    "formation": "Third-generation cephalosporin",
    "uses": "Typhoid fever, urinary tract infections, otitis media",
    "adult": "200â€“400 mg daily or BID",
    "child": "8â€“12 mg/kg/day in 2 divided doses",
    "avoid": "Cephalosporin/penicillin hypersensitivity"
  },
  {
    "rank": 15,
    "name": "Metformin",
    "section": "Section 1: Foundational Molecules",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Glycomet / Cetapin / Glucophage",
    "formation": "Biguanide (dimethylbiguanide)",
    "uses": "First-line Type 2 DM, PCOS management",
    "adult": "500â€“1000 mg BID (max 2550 mg/day)",
    "child": "500 mg BID (approved >10y for T2DM)",
    "avoid": "Severe renal impairment (eGFR < 30), metabolic acidosis"
  },
  {
    "rank": 16,
    "name": "Ursodeoxycholic Acid",
    "section": "Section 1: Foundational Molecules",
    "category": "Gastrointestinal",
    "schedule": "H",
    "brand": "Udiliv / Ursocol",
    "formation": "Naturally occurring bile acid",
    "uses": "Dissolution of cholesterol gallstones, primary biliary cirrhosis",
    "adult": "300â€“600 mg daily in divided doses",
    "child": "10â€“15 mg/kg/day",
    "avoid": "Acute cholecystitis, complete biliary obstruction"
  },
  {
    "rank": 17,
    "name": "Rosuvastatin",
    "section": "Section 1: Foundational Molecules",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Rosuvas / Rozavel / Crestor",
    "formation": "Hydrophilic HMG-CoA reductase inhibitor",
    "uses": "Severe hyperlipidemia, atherosclerosis stabilization",
    "adult": "5â€“40 mg OD",
    "child": "Not recommended",
    "avoid": "Active liver disease, severe renal impairment"
  },
  {
    "rank": 18,
    "name": "Ceftriaxone",
    "section": "Section 1: Foundational Molecules",
    "category": "Antibiotics",
    "schedule": "H1",
    "brand": "Monocef / Ceftriax / Rocephin",
    "formation": "Parenteral third-generation cephalosporin",
    "uses": "Meningitis, sepsis, gonorrhea, surgical prophylaxis",
    "adult": "1â€“2 g IV/IM daily",
    "child": "50â€“100 mg/kg/day (max 4 g/day)",
    "avoid": "Hyperbilirubinemic neonates, concomitant IV calcium"
  },
  {
    "rank": 19,
    "name": "Amlodipine",
    "section": "Section 1: Foundational Molecules",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Amlodac / Stamlo / Norvasc",
    "formation": "Dihydropyridine calcium channel blocker",
    "uses": "Hypertension, chronic stable angina",
    "adult": "2.5â€“10 mg OD",
    "child": "0.1â€“0.6 mg/kg (usually 2.5 mg initial in teens)",
    "avoid": "Severe aortic stenosis, cardiogenic shock"
  },
  {
    "rank": 20,
    "name": "Aceclofenac + Paracetamol",
    "section": "Section 1: Foundational Molecules",
    "category": "Analgesics",
    "schedule": "H",
    "brand": "Zerodol-P / Aceclo-P",
    "formation": "Phenylacetic acid NSAID + p-aminophenol",
    "uses": "Acute musculoskeletal pain, osteoarthritis flares",
    "adult": "100 mg/325 mg BID",
    "child": "Not recommended (under 12 years)",
    "avoid": "Active GI ulcer, severe renal or cardiac failure"
  },
  {
    "rank": 21,
    "name": "Glimepiride",
    "section": "Section 1: Foundational Molecules",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Amaryl / Glimpid / Glimy",
    "formation": "Third-generation sulfonylurea",
    "uses": "Glycemic control in Type 2 Diabetes",
    "adult": "1â€“4 mg OD",
    "child": "Not recommended",
    "avoid": "Type 1 DM, diabetic ketoacidosis"
  },
  {
    "rank": 22,
    "name": "Vitamin D3 (Cholecalciferol)",
    "section": "Section 1: Foundational Molecules",
    "category": "Vitamins/Minerals",
    "schedule": "OTC",
    "brand": "Calcirol / D-3 60K / Uprise-D3",
    "formation": "Fat-soluble seco-steroid",
    "uses": "Vitamin D deficiency, osteoporosis, immune support",
    "adult": "60,000 IU once weekly for 8 weeks (deficiency)",
    "child": "400â€“1000 IU/day or 60,000 IU monthly",
    "avoid": "Hypercalcemia, hypervitaminosis D"
  },
  {
    "rank": 23,
    "name": "Diclofenac Sodium",
    "section": "Section 1: Foundational Molecules",
    "category": "Analgesics",
    "schedule": "H",
    "brand": "Voveran / Voltaren / Reactin",
    "formation": "Phenylacetic acid derivative",
    "uses": "Rheumatoid arthritis, acute trauma pain, spondylitis",
    "adult": "50â€“75 mg BID or 100 mg SR OD",
    "child": "1â€“3 mg/kg/day in divided doses",
    "avoid": "GI bleeding, aspirin-induced asthma, post-CABG pain"
  },
  {
    "rank": 24,
    "name": "Levocetirizine",
    "section": "Section 1: Foundational Molecules",
    "category": "Antiallergic",
    "schedule": "H",
    "brand": "L-Cetzine / Levorid / Xyzal",
    "formation": "Third-generation piperazine antihistamine",
    "uses": "Allergic rhinitis, chronic idiopathic urticaria",
    "adult": "5 mg OD (bedtime)",
    "child": "1.25â€“2.5 mg OD (6moâ€“12y)",
    "avoid": "End-stage renal disease (CrCl < 10 mL/min)"
  },
  {
    "rank": 25,
    "name": "Montelukast + Levocetirizine",
    "section": "Section 1: Foundational Molecules",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Montair-LC / Telekast-L",
    "formation": "CysLT1 antagonist + antihistamine",
    "uses": "Chronic allergic rhinitis with bronchial asthma",
    "adult": "10 mg/5 mg OD",
    "child": "4 mg/2.5 mg OD",
    "avoid": "Acute asthma attack, neuropsychiatric events history"
  },
  {
    "rank": 26,
    "name": "Rabeprazole + Domperidone",
    "section": "Section 1: Foundational Molecules",
    "category": "Gastrointestinal",
    "schedule": "H",
    "brand": "Cyra-D / Rabeloc-D / Razo-D",
    "formation": "PPI + prokinetic",
    "uses": "Dyspepsia, GERD with gastric stasis",
    "adult": "20 mg/30 mg OD (before breakfast)",
    "child": "Not recommended",
    "avoid": "Intestinal obstruction, cardiac arrhythmia history"
  },
  {
    "rank": 27,
    "name": "Sitagliptin + Metformin",
    "section": "Section 1: Foundational Molecules",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Janumet / Sitamet",
    "formation": "DPP-4 inhibitor + biguanide",
    "uses": "Type 2 DM uncontrolled on Metformin monotherapy",
    "adult": "50 mg/500 mg or 50 mg/1000 mg BID",
    "child": "Not recommended",
    "avoid": "Renal failure, risk of pancreatitis"
  },
  {
    "rank": 28,
    "name": "Teneligliptin",
    "section": "Section 1: Foundational Molecules",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Tenglyn / Tengli / Tenepure",
    "formation": "Synthetic DPP-4 inhibitor",
    "uses": "Glycemic management in Type 2 Diabetes",
    "adult": "20 mg OD",
    "child": "Not recommended",
    "avoid": "Patients with heart failure, severe ketoacidosis"
  },
  {
    "rank": 29,
    "name": "Salbutamol (Albuterol)",
    "section": "Section 1: Foundational Molecules",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Asthalin / Ventolin / Derihaler",
    "formation": "Selective beta2-adrenoceptor agonist",
    "uses": "Bronchospasm in asthma, COPD, and exercise-induced asthma",
    "adult": "200 mcg (2 puffs) every 4â€“6 hrs PRN",
    "child": "0.1â€“0.15 mg/kg per dose or 1â€“2 puffs",
    "avoid": "Severe cardiac disease, tachyarrhythmias"
  },
  {
    "rank": 30,
    "name": "Itraconazole",
    "section": "Section 1: Foundational Molecules",
    "category": "Antifungal",
    "schedule": "H",
    "brand": "Canditral / Sporanox / Itaspor",
    "formation": "Triazole antifungal",
    "uses": "Tinea infections, vulvovaginal candidiasis, blastomycosis",
    "adult": "100â€“200 mg OD or BID",
    "child": "3â€“5 mg/kg/day (under specialist guidance)",
    "avoid": "Congestive heart failure, drug-drug interactions with statins"
  },
  {
    "rank": 31,
    "name": "Iron + Folic Acid",
    "section": "Section 1: Foundational Molecules",
    "category": "Vitamins/Minerals",
    "schedule": "H",
    "brand": "Livogen / Fefol / Feronia-XT",
    "formation": "Ferrous salt + Vitamin B9",
    "uses": "Prevention and treatment of iron-deficiency anemia",
    "adult": "100 mg Fe/500 mcg FA OD",
    "child": "20 mg Fe/100 mcg FA (peds tablets/syrup)",
    "avoid": "Hemosiderosis, hemochromatosis"
  },
  {
    "rank": 32,
    "name": "Dapagliflozin",
    "section": "Section 1: Foundational Molecules",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Forxiga / Dapaglit",
    "formation": "SGLT2 inhibitor (glycoside)",
    "uses": "T2DM, heart failure (HFrEF/HFpEF), chronic kidney disease",
    "adult": "5â€“10 mg OD",
    "child": "Not recommended",
    "avoid": "Dialysis patients, history of ketoacidosis"
  },
  {
    "rank": 33,
    "name": "Vildagliptin + Metformin",
    "section": "Section 1: Foundational Molecules",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Galvus Met / Vildamet",
    "formation": "DPP-4 inhibitor + biguanide",
    "uses": "Combination therapy for Type 2 Diabetes",
    "adult": "50 mg/500 mg or 50 mg/1000 mg BID",
    "child": "Not recommended",
    "avoid": "Hepatic impairment, severe renal failure"
  },
  {
    "rank": 34,
    "name": "Sildenafil",
    "section": "Section 1: Foundational Molecules",
    "category": "Urology",
    "schedule": "H",
    "brand": "Manforce / Penegra / Viagra",
    "formation": "Phosphodiesterase-5 (PDE5) inhibitor",
    "uses": "Erectile dysfunction, pulmonary arterial hypertension",
    "adult": "25â€“100 mg (ED) or 20 mg TID (PAH)",
    "child": "0.5â€“2 mg/kg/dose (PAH use only)",
    "avoid": "Nitrate use, severe hypotension, retinitis pigmentosa"
  },
  {
    "rank": 35,
    "name": "Calcium + Vitamin D3",
    "section": "Section 1: Foundational Molecules",
    "category": "Vitamins/Minerals",
    "schedule": "OTC",
    "brand": "Shelcal / Calcimax / Calcitas",
    "formation": "Calcium carbonate + Cholecalciferol",
    "uses": "Hypocalcemia, osteoporosis, post-menopausal health",
    "adult": "500 mg/250 IU BID",
    "child": "250â€“500 mg daily",
    "avoid": "Nephrolithiasis (kidney stones), hypercalcemia"
  },
  {
    "rank": 36,
    "name": "Gabapentin + Nortriptyline",
    "section": "Section 1: Foundational Molecules",
    "category": "CNS",
    "schedule": "H1",
    "brand": "Gabapin-NT / Gabantin-NT",
    "formation": "GABA analog + tricyclic antidepressant",
    "uses": "Diabetic neuropathic pain, post-herpetic neuralgia",
    "adult": "300 mg/10 mg BID or TID",
    "child": "Not recommended",
    "avoid": "Recent MI, glaucoma, urinary retention"
  },
  {
    "rank": 37,
    "name": "Clopidogrel",
    "section": "Section 1: Foundational Molecules",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Clopilet / Plavix / Deplatt",
    "formation": "P2Y12 platelet inhibitor",
    "uses": "Post-stent antiplatelet therapy, stroke prevention",
    "adult": "75 mg OD",
    "child": "0.2â€“1.0 mg/kg OD (Consult specialist)",
    "avoid": "Active pathological bleeding (e.g., peptic ulcer)"
  },
  {
    "rank": 38,
    "name": "Empagliflozin",
    "section": "Section 1: Foundational Molecules",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Jardiance / Empa",
    "formation": "SGLT2 inhibitor",
    "uses": "T2DM, reduction of CV death risk",
    "adult": "10â€“25 mg OD",
    "child": "Not recommended",
    "avoid": "eGFR < 30 mL/min, during pregnancy"
  },
  {
    "rank": 39,
    "name": "Telmisartan + Amlodipine",
    "section": "Section 1: Foundational Molecules",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Telma-AM / Telmikind-AM",
    "formation": "ARB + Calcium channel blocker",
    "uses": "Moderate-to-severe hypertension",
    "adult": "40 mg/5 mg or 80 mg/5 mg OD",
    "child": "Not recommended",
    "avoid": "Cardiogenic shock, biliary obstruction"
  },
  {
    "rank": 40,
    "name": "Ofloxacin",
    "section": "Section 1: Foundational Molecules",
    "category": "Antibiotics",
    "schedule": "H",
    "brand": "Oflox / Zanocin / Oflomac",
    "formation": "Second-generation fluoroquinolone",
    "uses": "Typhoid, chronic bronchitis flares, UTI",
    "adult": "200â€“400 mg BID",
    "child": "7.5â€“15 mg/kg/day (Restrict use <18y)",
    "avoid": "Tendinitis history, pregnancy, epilepsy"
  },
  {
    "rank": 41,
    "name": "Povidone-Iodine",
    "section": "Section 1: Foundational Molecules",
    "category": "Topical",
    "schedule": "OTC",
    "brand": "Betadine / Wokadine",
    "formation": "Iodophor complex",
    "uses": "Topical antiseptic for wounds/surgery",
    "adult": "5â€“10% solution/ointment PRN",
    "child": "5% (Same as adult)",
    "avoid": "Iodine allergy, thyroid disease (extensive use)"
  },
  {
    "rank": 42,
    "name": "Pregabalin",
    "section": "Section 1: Foundational Molecules",
    "category": "CNS",
    "schedule": "H1",
    "brand": "Maxgalin / Lyrica / Pregaba",
    "formation": "Gabapentinoid (GABA analog)",
    "uses": "Neuropathic pain, generalized anxiety disorder",
    "adult": "50â€“150 mg BID or TID (max 600 mg/day)",
    "child": "Not recommended (under 18 years)",
    "avoid": "Renal impairment (reduce dose), severe angioedema"
  },
  {
    "rank": 43,
    "name": "Human Albumin",
    "section": "Section 1: Foundational Molecules",
    "category": "Biologicals",
    "schedule": "C",
    "brand": "Alburel / Albunorm",
    "formation": "Purified blood protein",
    "uses": "Hypovolemic shock, hypoalbuminemia",
    "adult": "20% solution, dose based on clinical response",
    "child": "0.5â€“1 g/kg (as 5% or 20% solution)",
    "avoid": "Severe anemia, congestive heart failure"
  },
  {
    "rank": 44,
    "name": "Cefuroxime Axetil",
    "section": "Section 1: Foundational Molecules",
    "category": "Antibiotics",
    "schedule": "H",
    "brand": "Pulmocef / Ceftin / Zinnat",
    "formation": "Second-generation cephalosporin ester",
    "uses": "Tonsillitis, skin infections, pneumonia",
    "adult": "250â€“500 mg BID",
    "child": "20â€“30 mg/kg/day in 2 divided doses",
    "avoid": "Cephalosporin allergy, phenylketonuria"
  },
  {
    "rank": 45,
    "name": "Alpha Ketoanalogue",
    "section": "Section 1: Foundational Molecules",
    "category": "Nephrology",
    "schedule": "H",
    "brand": "Nefrosave / Ketosave",
    "formation": "Essential amino acid precursors",
    "uses": "Chronic Kidney Disease (with low protein diet)",
    "adult": "1 tablet per 5 kg body weight/day",
    "child": "Weight-adjusted (Consult nephrologist)",
    "avoid": "Hypercalcemia, disturbed amino acid metabolism"
  },
  {
    "rank": 46,
    "name": "Ipratropium + Salbutamol",
    "section": "Section 1: Foundational Molecules",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Duolin / Combivent",
    "formation": "Anticholinergic + SABA",
    "uses": "Acute bronchospasm in COPD and asthma",
    "adult": "250 mcg/100 mcg (Respules) every 6 hrs",
    "child": "0.15 mg/kg (Salbutamol) via nebulizer",
    "avoid": "Glaucoma, bladder neck obstruction"
  },
  {
    "rank": 47,
    "name": "Ciprofloxacin",
    "section": "Section 1: Foundational Molecules",
    "category": "Antibiotics",
    "schedule": "H",
    "brand": "Ciplox / Ciprobid / Cifran",
    "formation": "Fluoroquinolone derivative",
    "uses": "UTI, gastroenteritis, bone/joint infections",
    "adult": "250â€“750 mg BID",
    "child": "10â€“20 mg/kg per dose (Restrict use)",
    "avoid": "Tendon disorders, concomitant tizanidine"
  },
  {
    "rank": 48,
    "name": "Semaglutide",
    "section": "Section 1: Foundational Molecules",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Rybelsus / Ozempic",
    "formation": "Human GLP-1 receptor agonist",
    "uses": "Type 2 Diabetes, chronic weight management",
    "adult": "3â€“14 mg OD (Oral) or 0.25â€“2.4 mg weekly (SC)",
    "child": "Not recommended",
    "avoid": "Family history of MTC, MEN 2 syndrome"
  },
  {
    "rank": 49,
    "name": "B-Complex + Vitamin C",
    "section": "Section 1: Foundational Molecules",
    "category": "Vitamins/Minerals",
    "schedule": "OTC",
    "brand": "Becosules / Polybion",
    "formation": "Water-soluble vitamin combination",
    "uses": "Vitamin deficiency, post-viral recovery",
    "adult": "1 capsule OD",
    "child": "2.5â€“5 ml OD (syrup form)",
    "avoid": "Megaloblastic anemia (with uncorrected B12)"
  },
  {
    "rank": 50,
    "name": "Omeprazole",
    "section": "Section 1: Foundational Molecules",
    "category": "Gastrointestinal",
    "schedule": "H",
    "brand": "Omez / Ocid / Prilosec",
    "formation": "Substituted benzimidazole (PPI)",
    "uses": "GERD, gastric ulcers, Zollinger-Ellison syndrome",
    "adult": "20â€“40 mg OD (30 mins before breakfast)",
    "child": "0.7â€“3 mg/kg/day",
    "avoid": "Concomitant use with nelfinavir"
  },
  {
    "rank": 51,
    "name": "Losartan Potassium",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Losar / Cozaar / Losartan",
    "formation": "Biphenyl tetrazole derivative (ARB)",
    "uses": "Hypertension, diabetic nephropathy",
    "adult": "25â€“100 mg OD or BID",
    "child": "0.7 mg/kg initial (max 50 mg OD)",
    "avoid": "Pregnancy, severe hepatic impairment"
  },
  {
    "rank": 52,
    "name": "Metoprolol Succinate",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Metolar XL / Lopressor / Metpure XL",
    "formation": "Selective beta1-blocker (Extended-release)",
    "uses": "Hypertension, chronic heart failure, angina",
    "adult": "25â€“100 mg OD",
    "child": "1â€“2 mg/kg OD (Consult cardiology)",
    "avoid": "Severe bradycardia, second/third-degree AV block"
  },
  {
    "rank": 53,
    "name": "Ramipril",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Cardace / Ramace / Altace",
    "formation": "ACE inhibitor (Pro-drug)",
    "uses": "Hypertension, heart failure post-MI",
    "adult": "2.5â€“10 mg OD",
    "child": "Not recommended",
    "avoid": "History of angioedema, pregnancy"
  },
  {
    "rank": 54,
    "name": "Olmesartan Medoxomil",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Olsar / Olmy / Benicar",
    "formation": "Angiotensin II receptor antagonist",
    "uses": "Hypertension management",
    "adult": "20â€“40 mg OD",
    "child": "Not recommended",
    "avoid": "Biliary obstruction, severe renal failure"
  },
  {
    "rank": 55,
    "name": "Bisoprolol Fumarate",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Concor / Biselect / Bisocor",
    "formation": "Beta1-selective adrenoceptor blocker",
    "uses": "Hypertension, stable chronic heart failure",
    "adult": "2.5â€“10 mg OD",
    "child": "Not recommended",
    "avoid": "Acute heart failure, bronchospastic diseases"
  },
  {
    "rank": 56,
    "name": "Furosemide",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Lasix / Frusemide",
    "formation": "Anthranilic acid derivative (Loop diuretic)",
    "uses": "Edema in CHF, renal disease, liver cirrhosis",
    "adult": "20â€“80 mg OD or BID",
    "child": "1â€“2 mg/kg per dose (max 6 mg/kg)",
    "avoid": "Anuria, hepatic coma, severe dehydration"
  },
  {
    "rank": 57,
    "name": "Spironolactone",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Aldactone / Spiromide",
    "formation": "Synthetic steroid (Aldosterone antagonist)",
    "uses": "Edema, primary hyperaldosteronism, CHF",
    "adult": "25â€“100 mg daily",
    "child": "1â€“3.3 mg/kg/day",
    "avoid": "Hyperkalemia, Addison's disease, acute renal failure"
  },
  {
    "rank": 58,
    "name": "Atorvastatin + Clopidogrel",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Deplatt-A / Atorva-CV",
    "formation": "Statin + P2Y12 inhibitor",
    "uses": "Secondary prevention of ischemic events",
    "adult": "10/75 mg or 20/75 mg OD",
    "child": "Not recommended",
    "avoid": "Active GI bleed, severe liver disease"
  },
  {
    "rank": 59,
    "name": "Rosuvastatin + Fenofibrate",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Rosufeno / Rosuvas-F",
    "formation": "Statin + fibric acid derivative",
    "uses": "Mixed dyslipidemia (elevated LDL and TG)",
    "adult": "10 mg/160 mg OD",
    "child": "Not recommended",
    "avoid": "Severe renal impairment, gallbladder disease"
  },
  {
    "rank": 60,
    "name": "Sacubitril + Valsartan",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Vymada / Entresto",
    "formation": "Neprilysin inhibitor + ARB (Crystal complex)",
    "uses": "Chronic heart failure (NYHA Class II-IV)",
    "adult": "50â€“200 mg BID (Individualized)",
    "child": "Consult specialist (Weight-based)",
    "avoid": "Concomitant ACE inhibitor use, history of angioedema"
  },
  {
    "rank": 61,
    "name": "Chlorthalidone",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Hygroton / Thalitone",
    "formation": "Monosulfonamyl diuretic",
    "uses": "Hypertension, edema",
    "adult": "12.5â€“25 mg OD",
    "child": "2 mg/kg 3 times/week",
    "avoid": "Anuria, hypersensitivity to sulfonamides"
  },
  {
    "rank": 62,
    "name": "Nebivolol",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Nebicard / Bystolic / Nebitop",
    "formation": "Beta1-selective blocker with vasodilatory effects",
    "uses": "Hypertension, chronic heart failure",
    "adult": "5 mg OD",
    "child": "Not recommended",
    "avoid": "Liver impairment, severe circulatory disorders"
  },
  {
    "rank": 63,
    "name": "Atenolol",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Aten / Tenormin / Betacard",
    "formation": "Synthetic beta1-selective blocker",
    "uses": "Hypertension, angina pectoris, arrhythmias",
    "adult": "25â€“100 mg OD",
    "child": "0.5â€“1 mg/kg/dose BID",
    "avoid": "Sinus bradycardia, pulmonary hypertension"
  },
  {
    "rank": 64,
    "name": "Nifedipine (SR)",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Adalat Retard / Depin-E",
    "formation": "Dihydropyridine calcium channel blocker",
    "uses": "Angina, hypertension, preterm labor (off-label)",
    "adult": "30â€“60 mg OD (Extended-release)",
    "child": "0.25â€“0.5 mg/kg/dose",
    "avoid": "Cardiogenic shock, recent MI"
  },
  {
    "rank": 65,
    "name": "Valsartan",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Valzaar / Diovan",
    "formation": "Non-peptide tetrazole derivative (ARB)",
    "uses": "Hypertension, heart failure, post-MI",
    "adult": "80â€“160 mg OD",
    "child": "1.3 mg/kg OD (max 40 mg)",
    "avoid": "Pregnancy, concomitant use with Aliskiren"
  },
  {
    "rank": 66,
    "name": "Carvedilol",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "C-Vadin / Coreg / Carca",
    "formation": "Non-selective beta and alpha-1 blocker",
    "uses": "Congestive heart failure, post-MI",
    "adult": "3.125â€“25 mg BID",
    "child": "0.05â€“0.4 mg/kg BID",
    "avoid": "Bronchial asthma, severe hepatic failure"
  },
  {
    "rank": 67,
    "name": "Hydrochlorothiazide",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Esidrex / Aquazide",
    "formation": "Benzothiadiazine (Thiazide diuretic)",
    "uses": "Hypertension, edema",
    "adult": "12.5â€“25 mg OD",
    "child": "1â€“2 mg/kg/day",
    "avoid": "Sulfa allergy, anuria"
  },
  {
    "rank": 68,
    "name": "Clonidine HCl",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Arkamin / Catapres",
    "formation": "Imidazoline derivative (Alpha-2 agonist)",
    "uses": "Hypertension, ADHD (extended-release), pain",
    "adult": "0.1 mg BID (titrate based on response)",
    "child": "0.05â€“0.4 mg/day (ADHD use)",
    "avoid": "Severe bradyarrhythmia"
  },
  {
    "rank": 69,
    "name": "Enoxaparin Sodium",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "C",
    "brand": "Clexane / Lovenox",
    "formation": "Low molecular weight heparin (LMWH)",
    "uses": "DVT prophylaxis, unstable angina, MI",
    "adult": "40 mg SC OD or 1 mg/kg SC BID",
    "child": "1 mg/kg SC BID",
    "avoid": "Major active bleeding, heparin-induced thrombocytopenia"
  },
  {
    "rank": 70,
    "name": "Rivaroxaban",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Xarelto / Relvus",
    "formation": "Factor Xa inhibitor",
    "uses": "Stroke prevention in AF, treatment of DVT/PE",
    "adult": "10â€“20 mg OD",
    "child": "Weight-adjusted (Consult pediatric hematology)",
    "avoid": "Active bleeding, severe renal/hepatic impairment"
  },
  {
    "rank": 71,
    "name": "Apixaban",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Eliquis",
    "formation": "Selective Factor Xa inhibitor",
    "uses": "Prophylaxis of stroke and systemic embolism in AF",
    "adult": "2.5â€“5 mg BID",
    "child": "Not recommended",
    "avoid": "Severe hepatic impairment, significant bleeding risk"
  },
  {
    "rank": 72,
    "name": "Dabigatran Etexilate",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Pradaxa",
    "formation": "Direct thrombin inhibitor",
    "uses": "AF stroke prevention, post-orthopedic DVT prophylaxis",
    "adult": "110â€“150 mg BID",
    "child": "Weight-based pellets (Consult specialist)",
    "avoid": "Mechanical prosthetic heart valve, active bleeding"
  },
  {
    "rank": 73,
    "name": "Aspirin (Enteric Coated)",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "OTC",
    "brand": "Ecosprin / Aspirin / Disprin",
    "formation": "Salicylic acid derivative",
    "uses": "ACS prevention, analgesic, anti-inflammatory",
    "adult": "75â€“150 mg OD (Antiplatelet)",
    "child": "10â€“15 mg/kg (Analgesic)",
    "avoid": "Viral infection in kids (Reyeâ€™s), GI ulcer"
  },
  {
    "rank": 74,
    "name": "Propranolol HCl",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Inderal / Betacap / Ciplar",
    "formation": "Non-selective beta-adrenergic blocker",
    "uses": "Migraine prophylaxis, portal hypertension, anxiety",
    "adult": "20â€“40 mg BID or TID",
    "child": "0.5â€“1 mg/kg/day in divided doses",
    "avoid": "Bronchial asthma, cardiogenic shock"
  },
  {
    "rank": 75,
    "name": "Ezetimibe",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Ezetrol / Ezentia",
    "formation": "Cholesterol absorption inhibitor",
    "uses": "Primary hyperlipidemia (adjunct to statins)",
    "adult": "10 mg OD",
    "child": "10 mg OD (approved for >10y)",
    "avoid": "Moderate-to-severe hepatic impairment"
  },
  {
    "rank": 76,
    "name": "Fenofibrate",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Tricor / Lipanthyl / Fenolip",
    "formation": "Fibric acid derivative",
    "uses": "Hypertriglyceridemia, mixed dyslipidemia",
    "adult": "145â€“160 mg OD",
    "child": "Not recommended",
    "avoid": "Severe renal disease, gallbladder disease"
  },
  {
    "rank": 77,
    "name": "Nicorandil",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Nicoril / Ikorel / Nicoloc",
    "formation": "Potassium channel opener + nitrate moiety",
    "uses": "Angina pectoris prophylaxis",
    "adult": "5â€“20 mg BID",
    "child": "Not recommended",
    "avoid": "Cardiogenic shock, severe hypotension"
  },
  {
    "rank": 78,
    "name": "Ivabradine",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Ivabrad / Corlanor / Bradia",
    "formation": "Hyperpolarization-activated cyclic nucleotide-gated inhibitor",
    "uses": "Chronic heart failure (to reduce hospitalizations)",
    "adult": "5â€“7.5 mg BID",
    "child": "Not recommended",
    "avoid": "Bradycardia (HR < 60), pacemaker dependence"
  },
  {
    "rank": 79,
    "name": "Digoxin",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Lanoxin / Digoxin",
    "formation": "Cardiac glycoside",
    "uses": "Atrial fibrillation rate control, heart failure",
    "adult": "0.125â€“0.25 mg OD",
    "child": "5â€“10 mcg/kg/day (titrate carefully)",
    "avoid": "Ventricular fibrillation, hypokalemia"
  },
  {
    "rank": 80,
    "name": "Hydralazine",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Nepresol / Apresoline",
    "formation": "Phthalazine derivative (Vasodilator)",
    "uses": "Essential hypertension, hypertensive crisis in pregnancy",
    "adult": "10â€“50 mg TID or QID",
    "child": "0.75 mg/kg/day (Consult specialist)",
    "avoid": "Idiopathic Systemic Lupus Erythematosus"
  },
  {
    "rank": 81,
    "name": "Diltiazem HCl",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Dilzem / Cardizem / Dilcontin",
    "formation": "Benzothiazepine calcium channel blocker",
    "uses": "Angina, hypertension, AF rate control",
    "adult": "30â€“120 mg TID or 120â€“360 mg OD (SR)",
    "child": "1.5â€“2 mg/kg/day (Consult specialist)",
    "avoid": "Sick sinus syndrome, acute MI with lung congestion"
  },
  {
    "rank": 82,
    "name": "Verapamil HCl",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Calaptin / Isoptin / Verapress",
    "formation": "Phenylalkylamine calcium channel blocker",
    "uses": "Supraventricular tachycardia, hypertension, migraine prophy",
    "adult": "40â€“120 mg TID or 120â€“240 mg OD (SR)",
    "child": "4â€“8 mg/kg/day (Consult cardiology)",
    "avoid": "Heart block, severe left ventricular dysfunction"
  },
  {
    "rank": 83,
    "name": "Torsemide",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Dytor / Torasemide / Demadex",
    "formation": "Pyridine-sulfonylurea loop diuretic",
    "uses": "Edema associated with CHF or renal disease",
    "adult": "10â€“20 mg OD",
    "child": "Not recommended",
    "avoid": "Anuria, hypersensitivity to sulfonylureas"
  },
  {
    "rank": 84,
    "name": "Indapamide",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Natrilix / Lorvas",
    "formation": "Non-thiazide chlorobenzamide diuretic",
    "uses": "Essential hypertension",
    "adult": "1.5 mg OD (SR) or 2.5 mg OD",
    "child": "Not recommended",
    "avoid": "Severe renal failure, hepatic encephalopathy"
  },
  {
    "rank": 85,
    "name": "Perindopril Erbumine",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Coversyl / Acertil / Prexum",
    "formation": "ACE inhibitor (Long-acting)",
    "uses": "Hypertension, coronary artery disease",
    "adult": "4â€“8 mg OD",
    "child": "Not recommended",
    "avoid": "Bilateral renal artery stenosis, pregnancy"
  },
  {
    "rank": 86,
    "name": "Enalapril Maleate",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Enam / Vasotec / Envas",
    "formation": "ACE inhibitor pro-drug",
    "uses": "Hypertension, heart failure management",
    "adult": "5â€“40 mg OD or BID",
    "child": "0.08 mg/kg OD (max 5 mg)",
    "avoid": "Pregnancy, history of angioedema"
  },
  {
    "rank": 87,
    "name": "Lisinopril",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Listril / Zestril / Cipril",
    "formation": "Lysine analog of enalaprilat (ACEI)",
    "uses": "Hypertension, heart failure, post-MI",
    "adult": "10â€“40 mg OD",
    "child": "0.07 mg/kg OD (max 5 mg)",
    "avoid": "Hereditary or idiopathic angioedema"
  },
  {
    "rank": 88,
    "name": "Labetalol HCl",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Normodyne / Trandate / Labetalol",
    "formation": "Combined alpha and beta blocker",
    "uses": "Hypertension in pregnancy, hypertensive emergency",
    "adult": "100â€“400 mg BID (Oral)",
    "child": "1â€“3 mg/kg/day",
    "avoid": "Bronchial asthma, heart block"
  },
  {
    "rank": 89,
    "name": "Isosorbide Mononitrate",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Imdur / Monotrate / Ismo",
    "formation": "Organic nitrate",
    "uses": "Prophylaxis of angina pectoris",
    "adult": "20 mg BID or 60 mg OD (SR)",
    "child": "Not recommended",
    "avoid": "Hypertrophic obstructive cardiomyopathy, nitrate allergy"
  },
  {
    "rank": 90,
    "name": "Nitroglycerin",
    "section": "Section 2: Cardiovascular",
    "category": "Cardiovascular",
    "schedule": "H",
    "brand": "Nitrostat / Sorbitrate / GTN",
    "formation": "Organic nitrate vasodilator",
    "uses": "Acute angina pectoris, heart failure in MI",
    "adult": "0.5 mg sublingual PRN",
    "child": "Not recommended for routine use",
    "avoid": "Severe anemia, increased intracranial pressure"
  },
  {
    "rank": 91,
    "name": "Vildagliptin",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Galvus / Jalra / Zomelis",
    "formation": "Synthetic DPP-4 inhibitor",
    "uses": "Type 2 Diabetes management",
    "adult": "50 mg OD or BID",
    "child": "Not recommended",
    "avoid": "Moderate-to-severe renal failure (dose adjustment)"
  },
  {
    "rank": 92,
    "name": "Sitagliptin",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Januvia / Istamet",
    "formation": "Selective DPP-4 inhibitor",
    "uses": "Type 2 Diabetes",
    "adult": "100 mg OD",
    "child": "Not recommended",
    "avoid": "History of pancreatitis, renal failure (titrate)"
  },
  {
    "rank": 93,
    "name": "Linagliptin",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Trajenta / Glyxambi",
    "formation": "Xanthine-based DPP-4 inhibitor",
    "uses": "Type 2 Diabetes (preferred in renal impairment)",
    "adult": "5 mg OD",
    "child": "Not recommended",
    "avoid": "Acute pancreatitis history"
  },
  {
    "rank": 94,
    "name": "Saxagliptin",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Onglyza",
    "formation": "Cyclopropylglycine DPP-4 inhibitor",
    "uses": "Glycemic control in T2DM",
    "adult": "2.5â€“5 mg OD",
    "child": "Not recommended",
    "avoid": "Heart failure history (caution)"
  },
  {
    "rank": 95,
    "name": "Pioglitazone",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Pioz / Actos / Piosafe",
    "formation": "Thiazolidinedione (PPAR-gamma agonist)",
    "uses": "T2DM (specifically insulin resistance)",
    "adult": "15â€“45 mg OD",
    "child": "Not recommended",
    "avoid": "Bladder cancer, active heart failure"
  },
  {
    "rank": 96,
    "name": "Voglibose",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Volix / Vocarb / Volibo",
    "formation": "Alpha-glucosidase inhibitor",
    "uses": "Postprandial hyperglycemia in T2DM",
    "adult": "0.2â€“0.3 mg TID (at start of meal)",
    "child": "Not recommended",
    "avoid": "Chronic intestinal disease, hernia"
  },
  {
    "rank": 97,
    "name": "Insulin Glargine",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Antidiabetic",
    "schedule": "C",
    "brand": "Lantus / Basalog / Glaritus",
    "formation": "Long-acting analog insulin (rDNA origin)",
    "uses": "Basal glycemic control in Type 1 and Type 2 DM",
    "adult": "Individualized (SC OD at bedtime)",
    "child": "Consult specialist (approved for >2y)",
    "avoid": "Acute hypoglycemia"
  },
  {
    "rank": 98,
    "name": "Insulin Aspart",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Antidiabetic",
    "schedule": "C",
    "brand": "NovoRapid / NovoLog",
    "formation": "Rapid-acting analog insulin",
    "uses": "Prandial glycemic control",
    "adult": "Individualized (SC 5â€“10 mins before meals)",
    "child": "Weight-based titration",
    "avoid": "Hypoglycemia, severe insulin allergy"
  },
  {
    "rank": 99,
    "name": "Insulin Lispro",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Antidiabetic",
    "schedule": "C",
    "brand": "Humalog / Rosulin-R",
    "formation": "Rapid-acting analog insulin",
    "uses": "Type 1 and Type 2 Diabetes",
    "adult": "Individualized based on carbohydrate intake",
    "child": "Weight-based",
    "avoid": "During hypoglycemic episodes"
  },
  {
    "rank": 100,
    "name": "Dulaglutide",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Antidiabetic",
    "schedule": "C",
    "brand": "Trulicity",
    "formation": "GLP-1 receptor agonist (Injectable)",
    "uses": "T2DM management, CV risk reduction",
    "adult": "0.75â€“1.5 mg once weekly SC",
    "child": "Not recommended",
    "avoid": "Medullary thyroid carcinoma, MEN 2"
  },
  {
    "rank": 101,
    "name": "Metformin + Sitagliptin + Dapagliflozin",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Tribet / Janumet-S",
    "formation": "Biguanide + DPP-4i + SGLT2i",
    "uses": "Triple therapy for refractory T2DM",
    "adult": "500/50/5 mg to 1000/50/10 mg OD/BID",
    "child": "Not recommended",
    "avoid": "Renal failure (CrCl < 30), metabolic acidosis"
  },
  {
    "rank": 102,
    "name": "Metformin + Vildagliptin",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Vildamet / Galvus Met",
    "formation": "Biguanide + DPP-4 inhibitor",
    "uses": "Combination management for Type 2 Diabetes",
    "adult": "500/50 mg to 1000/50 mg BID",
    "child": "Not recommended",
    "avoid": "Hepatic impairment, severe ketoacidosis"
  },
  {
    "rank": 103,
    "name": "Gliclazide",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Diamicron / Glizid MR",
    "formation": "Second-generation sulfonylurea",
    "uses": "Type 2 Diabetes",
    "adult": "30â€“120 mg OD (Modified release)",
    "child": "Not recommended",
    "avoid": "Type 1 DM, pregnancy, liver failure"
  },
  {
    "rank": 104,
    "name": "Remogliflozin",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Remozen / Remo (Zydus)",
    "formation": "Selective SGLT2 inhibitor",
    "uses": "Glycemic control in T2DM",
    "adult": "100 mg BID",
    "child": "Not recommended",
    "avoid": "Dialysis, severe renal impairment"
  },
  {
    "rank": 105,
    "name": "Canagliflozin",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Invokana",
    "formation": "SGLT2 inhibitor",
    "uses": "T2DM, diabetic nephropathy",
    "adult": "100â€“300 mg OD",
    "child": "Not recommended",
    "avoid": "eGFR < 30, prone to genital mycotic infections"
  },
  {
    "rank": 106,
    "name": "Teneligliptin + Metformin",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Tengli-M / Zita-Met",
    "formation": "DPP-4i + Biguanide",
    "uses": "Type 2 Diabetes",
    "adult": "20 mg/500 mg OD or BID",
    "child": "Not recommended",
    "avoid": "Heart failure, renal acidosis"
  },
  {
    "rank": 107,
    "name": "Glibenclamide (Glyburide)",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Daonil / Euglucon / Gliben",
    "formation": "Sulfonylurea derivative",
    "uses": "Type 2 Diabetes",
    "adult": "2.5â€“10 mg OD or BID",
    "child": "Not recommended",
    "avoid": "Severe elderly frailty (hypoglycemia risk)"
  },
  {
    "rank": 108,
    "name": "Repaglinide",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Antidiabetic",
    "schedule": "H",
    "brand": "Novonorm / Repag",
    "formation": "Meglitinide derivative",
    "uses": "Type 2 Diabetes (post-prandial control)",
    "adult": "0.5â€“4 mg (15 mins before each meal)",
    "child": "Not recommended",
    "avoid": "Concomitant gemfibrozil use"
  },
  {
    "rank": 109,
    "name": "Alpha Lipoic Acid",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Vitamins/Minerals",
    "schedule": "OTC",
    "brand": "Thiocid / ALA-300 / Alphalipoic",
    "formation": "Naturally occurring antioxidant",
    "uses": "Diabetic neuropathy, cellular protection",
    "adult": "300â€“600 mg daily",
    "child": "Consult specialist",
    "avoid": "Hypoglycemia (additive effect with OADs)"
  },
  {
    "rank": 110,
    "name": "Myo-inositol",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Vitamins/Minerals",
    "schedule": "OTC",
    "brand": "Inofolic / Ovabless / Myo-Inositol",
    "formation": "Carbocyclic sugar (Vitamin-like)",
    "uses": "PCOD/PCOS, metabolic support",
    "adult": "2 g BID",
    "child": "Not recommended",
    "avoid": "Bipolar disorder (may trigger mania)"
  },
  {
    "rank": 111,
    "name": "Progesterone (Micronized)",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Hormonal",
    "schedule": "H",
    "brand": "Susten / Lutinus / Duphaston",
    "formation": "Natural steroid hormone",
    "uses": "Luteal phase support, prevention of preterm birth",
    "adult": "200â€“400 mg daily (Vaginal or Oral)",
    "child": "Not recommended",
    "avoid": "Undiagnosed vaginal bleeding, active liver disease"
  },
  {
    "rank": 112,
    "name": "Estradiol",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Hormonal",
    "schedule": "H",
    "brand": "Progynova / Estradot / Estradiol",
    "formation": "Principal endogenous human estrogen",
    "uses": "Menopause hormone replacement therapy (HRT)",
    "adult": "1â€“2 mg daily or 50 mcg/day (patch)",
    "child": "Titrate based on puberty induction needs",
    "avoid": "Estrogen-dependent tumors, history of DVT"
  },
  {
    "rank": 113,
    "name": "Norethisterone",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Hormonal",
    "schedule": "H",
    "brand": "Primolut-N / Regestrone",
    "formation": "Synthetic progestational hormone",
    "uses": "Dysmenorrhea, heavy menstrual bleeding",
    "adult": "5 mg TID (for 10 days) or 10â€“20 mg/day",
    "child": "Not recommended",
    "avoid": "Porphyria, active thrombophlebitis"
  },
  {
    "rank": 114,
    "name": "Levonorgestrel",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Hormonal",
    "schedule": "H",
    "brand": "i-Pill / Unwanted-72 / Eziday",
    "formation": "Second-generation synthetic progestogen",
    "uses": "Emergency contraception, long-term contraception",
    "adult": "1.5 mg single dose (within 72 hrs)",
    "child": "Same as adult post-menarche",
    "avoid": "Suspected pregnancy, severe hepatic disease"
  },
  {
    "rank": 115,
    "name": "Finasteride",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Urology",
    "schedule": "H",
    "brand": "Finpecia / Propecia / Finast",
    "formation": "Type II 5-alpha-reductase inhibitor",
    "uses": "Benign Prostatic Hyperplasia (BPH), androgenic alopecia",
    "adult": "5 mg daily (BPH) or 1 mg daily (Alopecia)",
    "child": "Not recommended",
    "avoid": "Women of childbearing age, pediatric patients"
  },
  {
    "rank": 116,
    "name": "Dutasteride",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Urology",
    "schedule": "H",
    "brand": "Dutas / Avodart",
    "formation": "Dual 5-alpha-reductase inhibitor",
    "uses": "Symptomatic BPH management",
    "adult": "0.5 mg OD",
    "child": "Not recommended",
    "avoid": "Hypersensitivity, severe hepatic impairment"
  },
  {
    "rank": 117,
    "name": "Cabergoline",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Hormonal",
    "schedule": "H",
    "brand": "Caberlin / Dostinex",
    "formation": "Ergot-derived dopamine receptor agonist",
    "uses": "Hyperprolactinemia, Parkinsonâ€™s disease adjunct",
    "adult": "0.25â€“0.5 mg twice weekly",
    "child": "Consult specialist",
    "avoid": "Uncontrolled hypertension, history of valvular heart disease"
  },
  {
    "rank": 118,
    "name": "Bromocriptine",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Hormonal",
    "schedule": "H",
    "brand": "Parlodel / Sicriptin",
    "formation": "Semisynthetic ergot alkaloid",
    "uses": "Hyperprolactinemia, acromegaly, T2DM (off-label)",
    "adult": "1.25â€“2.5 mg daily (titrate up)",
    "child": "Consult pediatric endocrinology",
    "avoid": "Preeclampsia, severe coronary artery disease"
  },
  {
    "rank": 119,
    "name": "Testosterone (Gel/Inj)",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Hormonal",
    "schedule": "H",
    "brand": "Androgel / Cernos / Testogel",
    "formation": "Principal male sex hormone",
    "uses": "Male hypogonadism, delayed puberty",
    "adult": "50 mg OD (Gel) or 250 mg every 3 weeks (IM)",
    "child": "Consult pediatric endocrinology",
    "avoid": "Prostate or breast cancer in males"
  },
  {
    "rank": 120,
    "name": "Clomifene Citrate",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Hormonal",
    "schedule": "H",
    "brand": "Siphene / Clomid / Fertomid",
    "formation": "Selective estrogen receptor modulator (SERM)",
    "uses": "Ovulation induction in infertile women",
    "adult": "50 mg daily for 5 days (starting day 3â€“5 of cycle)",
    "child": "Not recommended",
    "avoid": "Liver disease, ovarian cysts, pregnancy"
  },
  {
    "rank": 121,
    "name": "Letrozole",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Hormonal",
    "schedule": "H",
    "brand": "Letoval / Femara / Letroz",
    "formation": "Nonsteroidal aromatase inhibitor",
    "uses": "Breast cancer, infertility (off-label ovulation induction)",
    "adult": "2.5 mg daily",
    "child": "Not recommended",
    "avoid": "Pre-menopausal status (unless for fertility), pregnancy"
  },
  {
    "rank": 122,
    "name": "Human Growth Hormone (Somatropin)",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Biologicals",
    "schedule": "C",
    "brand": "Norditropin / Humatrope / Omnitrope",
    "formation": "rDNA-derived human growth hormone",
    "uses": "Growth failure in children, GHD in adults",
    "adult": "Individualized (usually 0.005â€“0.01 mg/kg SC)",
    "child": "0.16â€“0.24 mg/kg/week (divided daily doses)",
    "avoid": "Active malignancy, acute critical illness"
  },
  {
    "rank": 123,
    "name": "Desmopressin",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Hormonal",
    "schedule": "H",
    "brand": "Minirin / Desmospray",
    "formation": "Synthetic analog of vasopressin",
    "uses": "Diabetes insipidus, primary nocturnal enuresis",
    "adult": "0.1â€“0.4 mg/day in divided doses",
    "child": "0.2 mg at bedtime (Enuresis)",
    "avoid": "Hyponatremia, moderate-to-severe renal failure"
  },
  {
    "rank": 124,
    "name": "Hydrocortisone",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Hormonal",
    "schedule": "H",
    "brand": "Cortef / Solu-Cortef / Efcortesol",
    "formation": "Synthetic glucocorticoid steroid",
    "uses": "Adrenal insufficiency, severe allergies, inflammation",
    "adult": "20â€“30 mg daily (divided) or 100 mg IV TID",
    "child": "0.5â€“2 mg/kg/dose (IV emergency)",
    "avoid": "Systemic fungal infections, live virus vaccines"
  },
  {
    "rank": 125,
    "name": "Dexamethasone",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Hormonal",
    "schedule": "H",
    "brand": "Dexona / Decadron / Solurex",
    "formation": "High-potency synthetic glucocorticoid",
    "uses": "Cerebral edema, severe allergic states, COVID-19",
    "adult": "0.5â€“8 mg/day",
    "child": "0.02â€“0.3 mg/kg/day",
    "avoid": "Systemic fungal infections, active TB"
  },
  {
    "rank": 126,
    "name": "Betamethasone",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Hormonal",
    "schedule": "H",
    "brand": "Betnesol / Celestone",
    "formation": "Synthetic fluorinated glucocorticoid",
    "uses": "Skin inflammation, fetal lung maturity (prenatal)",
    "adult": "12 mg IM (two doses 24 hrs apart for fetal lung)",
    "child": "Not recommended for systemic use",
    "avoid": "Hypersensitivity, idiopathic thrombocytopenic purpura"
  },
  {
    "rank": 127,
    "name": "Methylprednisolone",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Hormonal",
    "schedule": "H",
    "brand": "Solu-Medrol / Medrol / Methpred",
    "formation": "Synthetic glucocorticoid",
    "uses": "Severe acute exacerbations of asthma/RA, organ transplant",
    "adult": "4â€“48 mg/day or high-dose pulse IV therapy",
    "child": "0.5â€“2 mg/kg/day",
    "avoid": "Intrathecal administration, systemic fungal infection"
  },
  {
    "rank": 128,
    "name": "Prednisolone",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Hormonal",
    "schedule": "H",
    "brand": "Wysolone / Omnacortil / Deltacortril",
    "formation": "Synthetic glucocorticoid derivative",
    "uses": "Bronchial asthma, nephrotic syndrome, RA",
    "adult": "5â€“60 mg/day",
    "child": "1â€“2 mg/kg/day",
    "avoid": "Active TB, chickenpox/measles exposure"
  },
  {
    "rank": 129,
    "name": "Deflazacort",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Hormonal",
    "schedule": "H",
    "brand": "Defcort / Calcort / Dezflam",
    "formation": "Oxazoline derivative of prednisolone",
    "uses": "Duchenne Muscular Dystrophy, RA, asthma",
    "adult": "6â€“90 mg/day",
    "child": "0.25â€“1.5 mg/kg/day",
    "avoid": "Hypersensitivity, live vaccine administration"
  },
  {
    "rank": 130,
    "name": "Triamcinolone",
    "section": "Section 3: Metabolic & Endocrine",
    "category": "Hormonal",
    "schedule": "H",
    "brand": "Kenacort / Tricort",
    "formation": "Synthetic corticosteroid",
    "uses": "Oral ulcers, joint inflammation, skin conditions",
    "adult": "4 mg OD or intra-articular injection (40 mg)",
    "child": "0.1â€“0.5 mg/kg/day (systemic use restricted)",
    "avoid": "Extensive plaque psoriasis, systemic fungal infection"
  },
  {
    "rank": 131,
    "name": "Cefpodoxime Proxetil",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H1",
    "brand": "Cepodem / Cefoprox / Vantin",
    "formation": "Oral third-generation cephalosporin ester",
    "uses": "Acute bronchitis, skin infections, tonsillitis",
    "adult": "200 mg BID",
    "child": "10 mg/kg/day in 2 divided doses",
    "avoid": "Hypersensitivity to beta-lactams"
  },
  {
    "rank": 132,
    "name": "Levofloxacin",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H1",
    "brand": "Levomac / Levoflox / Tavanic",
    "formation": "S-enantiomer of ofloxacin (Fluoroquinolone)",
    "uses": "Community-acquired pneumonia, acute pyelonephritis",
    "adult": "500 mg OD or BID",
    "child": "10â€“20 mg/kg/day (Restrict under 18y)",
    "avoid": "History of tendon rupture, myasthenia gravis"
  },
  {
    "rank": 133,
    "name": "Metronidazole",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H",
    "brand": "Flagyl / Metrogyl",
    "formation": "Nitroimidazole antibiotic/antiprotozoal",
    "uses": "Amoebiasis, giardiasis, anaerobic infections",
    "adult": "400 mg TID",
    "child": "30â€“50 mg/kg/day in 3 divided doses",
    "avoid": "First trimester of pregnancy, alcohol consumption"
  },
  {
    "rank": 134,
    "name": "Clindamycin HCl",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H",
    "brand": "Dalacin-C / Clincin / Cleocin",
    "formation": "Lincosamide antibiotic",
    "uses": "Skin and soft tissue infections, MRSA, dental abscess",
    "adult": "150â€“450 mg TID or QID",
    "child": "10â€“30 mg/kg/day in 3â€“4 divided doses",
    "avoid": "History of Pseudomembranous colitis"
  },
  {
    "rank": 135,
    "name": "Meropenem",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H1",
    "brand": "Meronem / Meromer / Merrem",
    "formation": "Parenteral carbapenem",
    "uses": "Complicated intra-abdominal infections, meningitis, sepsis",
    "adult": "500 mg to 1 g IV every 8 hrs",
    "child": "60â€“120 mg/kg/day in 3 divided doses",
    "avoid": "Anaphylactic reactions to beta-lactams"
  },
  {
    "rank": 136,
    "name": "Piperacillin + Tazobactam",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H1",
    "brand": "Piptaz / Tazact / Zosyn",
    "formation": "Ureidopenicillin + beta-lactamase inhibitor",
    "uses": "Nosocomial pneumonia, neutropenic fever",
    "adult": "4.5 g IV every 6â€“8 hrs",
    "child": "240â€“300 mg/kg/day in divided doses",
    "avoid": "Hypersensitivity to penicillins"
  },
  {
    "rank": 137,
    "name": "Linezolid",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H1",
    "brand": "Linox / Zyvox / Lizolid",
    "formation": "Oxazolidinone subclass",
    "uses": "Vancomycin-resistant Enterococcus (VRE), pneumonia",
    "adult": "600 mg BID",
    "child": "10 mg/kg TID",
    "avoid": "Concomitant MAO inhibitor use"
  },
  {
    "rank": 138,
    "name": "Faropenem Sodium",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H1",
    "brand": "Farobact / Romenem",
    "formation": "Oral penem subclass",
    "uses": "RTI, UTI, gynecological infections",
    "adult": "200â€“300 mg TID",
    "child": "Not recommended",
    "avoid": "History of seizure disorders"
  },
  {
    "rank": 139,
    "name": "Nitrofurantoin",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H",
    "brand": "Macrobid / Furadantin / Niftran",
    "formation": "Nitrofuran derivative",
    "uses": "Uncomplicated urinary tract infections",
    "adult": "100 mg BID for 5 days",
    "child": "5â€“7 mg/kg/day in 4 divided doses",
    "avoid": "Renal impairment (CrCl < 30), near-term pregnancy"
  },
  {
    "rank": 140,
    "name": "Norfloxacin",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H",
    "brand": "Norflox / Uroflox",
    "formation": "Fluoroquinolone derivative",
    "uses": "UTI, bacterial prostatitis, gastroenteritis",
    "adult": "400 mg BID",
    "child": "Not recommended (under 18 years)",
    "avoid": "Pregnancy, myasthenia gravis"
  },
  {
    "rank": 141,
    "name": "Ciprofloxacin (Eye/Ear)",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H",
    "brand": "Ciplox Eye/Ear / Ciproquin",
    "formation": "Fluoroquinolone",
    "uses": "Bacterial conjunctivitis, otitis externa",
    "adult": "1â€“2 drops every 4 hrs",
    "child": "Same as adult",
    "avoid": "Viral or fungal eye/ear infections"
  },
  {
    "rank": 142,
    "name": "Tinidazole",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H",
    "brand": "Tiniba / Fasigyn",
    "formation": "Nitroimidazole antiprotozoal",
    "uses": "Trichomoniasis, giardiasis, amoebiasis",
    "adult": "2 g single dose",
    "child": "50 mg/kg single dose",
    "avoid": "First trimester of pregnancy, blood dyscrasias"
  },
  {
    "rank": 143,
    "name": "Albendazole",
    "section": "Section 4: Anti-Infective",
    "category": "Antiparasitic",
    "schedule": "H",
    "brand": "Zentel / Noworm",
    "formation": "Benzimidazole anthelmintic",
    "uses": "Pinworm, hookworm, neurocysticercosis",
    "adult": "400 mg single dose or BID",
    "child": "200 mg (<2y) or 400 mg (>2y)",
    "avoid": "Pregnancy, severe liver disease"
  },
  {
    "rank": 144,
    "name": "Ivermectin",
    "section": "Section 4: Anti-Infective",
    "category": "Antiparasitic",
    "schedule": "H",
    "brand": "Stromectol / Ivercim",
    "formation": "Macrocyclic lactone",
    "uses": "Scabies, strongyloidiasis, onchocerciasis",
    "adult": "200 mcg/kg single dose",
    "child": "200 mcg/kg (Not recommended < 15 kg)",
    "avoid": "Pregnancy, disorders of the CNS"
  },
  {
    "rank": 145,
    "name": "Terbinafine HCl",
    "section": "Section 4: Anti-Infective",
    "category": "Antifungal",
    "schedule": "H",
    "brand": "Terbicip / Lamisil / Terbiforce",
    "formation": "Allylamine antifungal",
    "uses": "Onychomycosis, tinea capitis, tinea pedis",
    "adult": "250 mg OD for 6â€“12 weeks",
    "child": "62.5â€“250 mg OD (Weight-based)",
    "avoid": "Chronic or active liver disease"
  },
  {
    "rank": 146,
    "name": "Fluconazole",
    "section": "Section 4: Anti-Infective",
    "category": "Antifungal",
    "schedule": "OTC",
    "brand": "Forcan / Zocon / Diflucan",
    "formation": "Triazole antifungal",
    "uses": "Vaginal candidiasis, cryptococcal meningitis",
    "adult": "150 mg single dose or 100â€“400 mg daily",
    "child": "3â€“12 mg/kg/day",
    "avoid": "Concomitant QT-prolonging drugs"
  },
  {
    "rank": 147,
    "name": "Griseofulvin",
    "section": "Section 4: Anti-Infective",
    "category": "Antifungal",
    "schedule": "OTC",
    "brand": "Grifulvin / Grisovin / Fulvicin",
    "formation": "Penicillium-derived antifungal",
    "uses": "Dermatophyte infections of skin/hair/nails",
    "adult": "500 mg to 1 g daily",
    "child": "10â€“20 mg/kg/day",
    "avoid": "Porphyria, hepatocellular failure, pregnancy"
  },
  {
    "rank": 148,
    "name": "Ketoconazole (Topical)",
    "section": "Section 4: Anti-Infective",
    "category": "Antifungal",
    "schedule": "H",
    "brand": "Nizoral / Ketozol / Ketoskin",
    "formation": "Imidazole antifungal",
    "uses": "Dandruff (seborrheic dermatitis), tinea versicolor",
    "adult": "2% cream/shampoo PRN",
    "child": "Same as adult",
    "avoid": "Hypersensitivity"
  },
  {
    "rank": 149,
    "name": "Clotrimazole",
    "section": "Section 4: Anti-Infective",
    "category": "Antifungal",
    "schedule": "OTC",
    "brand": "Canesten / Candid / Clotrimazole",
    "formation": "Imidazole derivative",
    "uses": "Candidiasis, tinea corporis, tinea cruris",
    "adult": "1% cream/powder BID",
    "child": "Same as adult",
    "avoid": "Hypersensitivity"
  },
  {
    "rank": 150,
    "name": "Luliconazole",
    "section": "Section 4: Anti-Infective",
    "category": "Antifungal",
    "schedule": "H",
    "brand": "Lulifin / Lulican",
    "formation": "Imidazole-subclass antifungal",
    "uses": "Tinea pedis, tinea cruris, tinea corporis",
    "adult": "1% cream OD for 1â€“2 weeks",
    "child": "Not recommended (under 12 years)",
    "avoid": "Hypersensitivity"
  },
  {
    "rank": 151,
    "name": "Artesunate + Lumefantrine",
    "section": "Section 4: Anti-Infective",
    "category": "Antimalarial",
    "schedule": "H",
    "brand": "Riamet / Coartem",
    "formation": "Artemisinin derivative + fluorene",
    "uses": "Uncomplicated P. falciparum malaria",
    "adult": "80 mg/480 mg BID for 3 days",
    "child": "Weight-based dosing (Consult NCVBDC)",
    "avoid": "First trimester of pregnancy, severe malaria"
  },
  {
    "rank": 152,
    "name": "Chloroquine Phosphate",
    "section": "Section 4: Anti-Infective",
    "category": "Antimalarial",
    "schedule": "H",
    "brand": "Lariago / Resochin",
    "formation": "4-aminoquinoline derivative",
    "uses": "P. vivax malaria treatment and prophylaxis",
    "adult": "600 mg initial, then 300 mg at 6, 24, 48 hrs",
    "child": "10 mg/kg initial, then 5 mg/kg at 6, 24, 48 hrs",
    "avoid": "Psoriasis, retinal or visual field changes"
  },
  {
    "rank": 153,
    "name": "Primaquine",
    "section": "Section 4: Anti-Infective",
    "category": "Antimalarial",
    "schedule": "H1",
    "brand": "Malirid / Primaquine",
    "formation": "8-aminoquinoline derivative",
    "uses": "Radical cure of P. vivax and P. ovale malaria",
    "adult": "15 mg OD for 14 days",
    "child": "0.25â€“0.5 mg/kg/day for 14 days",
    "avoid": "G6PD deficiency, pregnancy"
  },
  {
    "rank": 154,
    "name": "Doxycycline HCl",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H1",
    "brand": "Doxrid / Doxy-1 / Vibramycin",
    "formation": "Tetracycline antibiotic",
    "uses": "Acne, malaria prophylaxis, rickettsial infections",
    "adult": "100 mg OD or BID",
    "child": "2.2â€“4.4 mg/kg/day (Avoid <8y)",
    "avoid": "Children under 8y (tooth discoloration), pregnancy"
  },
  {
    "rank": 155,
    "name": "Tenofovir Alafenamide",
    "section": "Section 4: Anti-Infective",
    "category": "Antiviral",
    "schedule": "H1",
    "brand": "Vemlidy",
    "formation": "Nucleotide reverse transcriptase inhibitor",
    "uses": "Chronic Hepatitis B, HIV-1 infection",
    "adult": "25 mg OD",
    "child": "Weight-based (approved >35 kg)",
    "avoid": "End-stage renal disease (not on dialysis)"
  },
  {
    "rank": 156,
    "name": "Abacavir + Lamivudine",
    "section": "Section 4: Anti-Infective",
    "category": "Antiviral",
    "schedule": "H1",
    "brand": "Epzicom / Kivexa / Abamune-L",
    "formation": "NRTI + NRTI combination",
    "uses": "Treatment of HIV-1 infection",
    "adult": "600 mg/300 mg OD",
    "child": "Weight-based titration",
    "avoid": "HLA-B*5701 positive patients (hypersensitivity)"
  },
  {
    "rank": 157,
    "name": "Dolutegravir",
    "section": "Section 4: Anti-Infective",
    "category": "Antiviral",
    "schedule": "H",
    "brand": "Tivicay / Dovato",
    "formation": "HIV integrase strand transfer inhibitor",
    "uses": "HIV-1 infection (in combination therapy)",
    "adult": "50 mg OD",
    "child": "5 mg to 50 mg OD (Weight-based)",
    "avoid": "Concurrent dofetilide use"
  },
  {
    "rank": 158,
    "name": "Sofosbuvir",
    "section": "Section 4: Anti-Infective",
    "category": "Antiviral",
    "schedule": "H",
    "brand": "Sovaldi / Hepcvir / Sofovir",
    "formation": "Nucleotide analog HCV NS5B polymerase inhibitor",
    "uses": "Chronic Hepatitis C (pangenotypic)",
    "adult": "400 mg OD",
    "child": "Weight-based (approved >3 years)",
    "avoid": "Concomitant use with amiodarone"
  },
  {
    "rank": 159,
    "name": "Acyclovir",
    "section": "Section 4: Anti-Infective",
    "category": "Antiviral",
    "schedule": "H",
    "brand": "Zovirax / Acivir / Herpex",
    "formation": "Synthetic purine nucleoside analog",
    "uses": "Herpes simplex, varicella-zoster (shingles)",
    "adult": "200â€“800 mg 5 times/day",
    "child": "20 mg/kg per dose QID",
    "avoid": "Renal impairment (dose reduction required)"
  },
  {
    "rank": 160,
    "name": "Vancomycin HCl",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H",
    "brand": "Vancocin / Vancomycin",
    "formation": "Tricyclic glycopeptide antibiotic",
    "uses": "MRSA, pseudomembranous colitis (Oral)",
    "adult": "500 mg to 1 g IV every 12 hrs",
    "child": "40 mg/kg/day in divided doses",
    "avoid": "Hypersensitivity, renal failure (titrate)"
  },
  {
    "rank": 161,
    "name": "Amikacin Sulfate",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H",
    "brand": "Amicin / Amikin",
    "formation": "Semisynthetic aminoglycoside",
    "uses": "Serious Gram-negative infections, MDR-TB",
    "adult": "15 mg/kg/day in divided doses",
    "child": "15â€“22.5 mg/kg/day",
    "avoid": "Myasthenia gravis, pregnancy"
  },
  {
    "rank": 162,
    "name": "Gentamicin Sulfate",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H",
    "brand": "Garamycin / Genticin",
    "formation": "Aminoglycoside complex",
    "uses": "Sepsis, complicated UTI, endocarditis adjunct",
    "adult": "3â€“5 mg/kg/day IV/IM",
    "child": "2.5 mg/kg per dose every 8 hrs",
    "avoid": "Renal failure (titrate levels), ototoxicity history"
  },
  {
    "rank": 163,
    "name": "Erythromycin Stearate",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H1",
    "brand": "Erythrocin / Erymed",
    "formation": "Macrolide antibiotic salt",
    "uses": "Respiratory/skin infections (penicillin-allergic)",
    "adult": "250â€“500 mg QID",
    "child": "30â€“50 mg/kg/day in divided doses",
    "avoid": "Concomitant terfenadine or astemizole"
  },
  {
    "rank": 164,
    "name": "Clarithromycin",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H",
    "brand": "Claribid / Biaxin / Clarimac",
    "formation": "Semisynthetic macrolide",
    "uses": "H. pylori eradication, RTI, mycobacterial infections",
    "adult": "250â€“500 mg BID",
    "child": "7.5 mg/kg BID (max 1 g/day)",
    "avoid": "Concomitant colchicine in renal impairment"
  },
  {
    "rank": 165,
    "name": "Roxithromycin",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H",
    "brand": "Rulide / Roxid / Surlid",
    "formation": "Semisynthetic macrolide antibiotic",
    "uses": "URTI, LRTI, skin and genital infections",
    "adult": "150 mg BID or 300 mg OD",
    "child": "5â€“8 mg/kg/day",
    "avoid": "Concomitant ergot alkaloid use"
  },
  {
    "rank": 166,
    "name": "Cephalexin",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H",
    "brand": "Sporidex / Keflex",
    "formation": "First-generation cephalosporin",
    "uses": "Mild UTI, skin and soft tissue infections",
    "adult": "250â€“500 mg QID",
    "child": "25â€“50 mg/kg/day in 4 divided doses",
    "avoid": "Severe penicillin allergy (cross-reactivity)"
  },
  {
    "rank": 167,
    "name": "Cefadroxil",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H",
    "brand": "Droxyl / Duricef",
    "formation": "First-generation cephalosporin",
    "uses": "Pharyngitis, tonsillitis, UTI",
    "adult": "500 mg to 1 g BID",
    "child": "30 mg/kg/day in divided doses",
    "avoid": "Renal failure (adjust dose)"
  },
  {
    "rank": 168,
    "name": "Colistin (Polymyxin E)",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H1",
    "brand": "Colistin / Polymyxin E",
    "formation": "Polymyxin subclass antibiotic",
    "uses": "Multi-drug resistant Gram-negative infections",
    "adult": "2.5â€“5 mg/kg/day in 2â€“4 divided doses",
    "child": "2.5â€“5 mg/kg/day",
    "avoid": "Myasthenia gravis, renal failure"
  },
  {
    "rank": 169,
    "name": "Fusidic Acid",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H",
    "brand": "Fucidin / Fusidate",
    "formation": "Steroidal antibiotic",
    "uses": "Impetigo, folliculitis, erythrasma",
    "adult": "2% cream TID",
    "child": "Same as adult",
    "avoid": "Extensive viral/fungal skin infections"
  },
  {
    "rank": 170,
    "name": "Mupirocin",
    "section": "Section 4: Anti-Infective",
    "category": "Antibiotics",
    "schedule": "H",
    "brand": "Bactroban / T-Bact",
    "formation": "Pseudomonic acid derivative",
    "uses": "Impetigo, eradication of nasal MRSA",
    "adult": "2% ointment TID",
    "child": "Same as adult",
    "avoid": "Large open wounds (polyethylene glycol risk)"
  },
  {
    "rank": 171,
    "name": "Rabeprazole Sodium",
    "section": "Section 5: GI & Pain",
    "category": "Gastrointestinal",
    "schedule": "H",
    "brand": "Razo / Rablet / Rabeloc",
    "formation": "PPI (substituted benzimidazole)",
    "uses": "Acid-peptic disorders, H. pylori eradication",
    "adult": "20 mg OD (30 mins before breakfast)",
    "child": "0.5â€“1 mg/kg/day",
    "avoid": "Hypersensitivity to benzimidazoles"
  },
  {
    "rank": 172,
    "name": "Esomeprazole Magnesium",
    "section": "Section 5: GI & Pain",
    "category": "Gastrointestinal",
    "schedule": "H",
    "brand": "Nexium / Raciper / Esomac",
    "formation": "S-isomer of omeprazole (PPI)",
    "uses": "Severe GERD, healing of erosive esophagitis",
    "adult": "20â€“40 mg OD",
    "child": "0.7â€“1 mg/kg/day",
    "avoid": "Concurrent use of clopidogrel (relative)"
  },
  {
    "rank": 173,
    "name": "Lansoprazole",
    "section": "Section 5: GI & Pain",
    "category": "Gastrointestinal",
    "schedule": "H",
    "brand": "Lanzol / Prevacid / Lancid",
    "formation": "Substituted benzimidazole (PPI)",
    "uses": "Duodenal ulcer, gastric ulcer, GERD",
    "adult": "15â€“30 mg OD",
    "child": "0.7â€“1.5 mg/kg/day",
    "avoid": "Severe hepatic impairment"
  },
  {
    "rank": 174,
    "name": "Ondansetron HCl",
    "section": "Section 5: GI & Pain",
    "category": "Gastrointestinal",
    "schedule": "H",
    "brand": "Emeset / Zofran / Vomistop",
    "formation": "Selective 5-HT3 receptor antagonist",
    "uses": "Nausea and vomiting (chemo/radio/post-op)",
    "adult": "4â€“8 mg TID or before chemo",
    "child": "0.15 mg/kg per dose",
    "avoid": "Congenital long QT syndrome, apomorphine use"
  },
  {
    "rank": 175,
    "name": "Metoclopramide HCl",
    "section": "Section 5: GI & Pain",
    "category": "Gastrointestinal",
    "schedule": "H",
    "brand": "Perinorm / Reglan / Metoclopramide",
    "formation": "Substituted benzamide (D2 antagonist)",
    "uses": "Nausea, gastroparesis, GERD prokinetic",
    "adult": "5â€“10 mg TID",
    "child": "0.1 mg/kg per dose (Avoid in < 1y)",
    "avoid": "Pheochromocytoma, GI hemorrhage"
  },
  {
    "rank": 176,
    "name": "Lactulose",
    "section": "Section 5: GI & Pain",
    "category": "Gastrointestinal",
    "schedule": "OTC",
    "brand": "Duphalac / Lactoloss",
    "formation": "Synthetic disaccharide (Osmotic laxative)",
    "uses": "Constipation, hepatic encephalopathy",
    "adult": "15â€“30 ml OD or BID",
    "child": "2.5â€“10 ml/day",
    "avoid": "Galactosemia, intestinal obstruction"
  },
  {
    "rank": 177,
    "name": "Bisacodyl",
    "section": "Section 5: GI & Pain",
    "category": "Gastrointestinal",
    "schedule": "OTC",
    "brand": "Dulcolax / Conlax",
    "formation": "Diphenylmethane stimulant laxative",
    "uses": "Acute constipation, bowel prep for surgery",
    "adult": "5â€“10 mg (Oral) at bedtime or 10 mg (Rectal)",
    "child": "5 mg at bedtime",
    "avoid": "Appendicitis, severe abdominal pain"
  },
  {
    "rank": 178,
    "name": "Polyethylene Glycol (PEG 3350)",
    "section": "Section 5: GI & Pain",
    "category": "Gastrointestinal",
    "schedule": "OTC",
    "brand": "Peglec / Forlax / Moviprep",
    "formation": "Osmotic polymer",
    "uses": "Occasional constipation, bowel cleansing",
    "adult": "17 g powder in 240 ml liquid daily",
    "child": "0.2â€“0.8 g/kg/day",
    "avoid": "GI perforation, toxic megacolon"
  },
  {
    "rank": 179,
    "name": "Liquid Paraffin",
    "section": "Section 5: GI & Pain",
    "category": "Gastrointestinal",
    "schedule": "H",
    "brand": "Cremaffin / Liquid Paraffin",
    "formation": "Mineral oil (Lubricant laxative)",
    "uses": "Short-term management of constipation",
    "adult": "10â€“30 ml at bedtime",
    "child": "5â€“10 ml at bedtime",
    "avoid": "Patients with difficulty swallowing (aspiration risk)"
  },
  {
    "rank": 180,
    "name": "Sucralfate",
    "section": "Section 5: GI & Pain",
    "category": "Gastrointestinal",
    "schedule": "OTC",
    "brand": "Sucrafil / Carafate / Sucral",
    "formation": "Aluminum hydroxide + sulfated sucrose",
    "uses": "Duodenal ulcer, stress ulcer prophylaxis",
    "adult": "1 g QID (1 hr before meals)",
    "child": "40â€“80 mg/kg/day in 4 divided doses",
    "avoid": "Chronic renal failure (aluminum toxicity risk)"
  },
  {
    "rank": 181,
    "name": "Megaldrate + Simethicone",
    "section": "Section 5: GI & Pain",
    "category": "Gastrointestinal",
    "schedule": "OTC",
    "brand": "Mucaine / Antacid Plus",
    "formation": "Antacid + anti-foaming agent",
    "uses": "Hyperacidity, bloating, flatulence",
    "adult": "5â€“10 ml after meals",
    "child": "Consult specialist",
    "avoid": "Severe renal impairment"
  },
  {
    "rank": 182,
    "name": "Aluminium + Magnesium Hydroxide",
    "section": "Section 5: GI & Pain",
    "category": "Gastrointestinal",
    "schedule": "H",
    "brand": "Digene / Gelusil / Maalox",
    "formation": "Mixed metal hydroxide antacid",
    "uses": "Acid indigestion, heartburn, sour stomach",
    "adult": "5â€“10 ml QID",
    "child": "0.5 ml/kg QID",
    "avoid": "Hypophosphatemia"
  },
  {
    "rank": 183,
    "name": "Mesalamine (5-ASA)",
    "section": "Section 5: GI & Pain",
    "category": "Gastrointestinal",
    "schedule": "H",
    "brand": "Mesacol / Asacol / Pentasa",
    "formation": "Salicylate derivative",
    "uses": "Ulcerative colitis, Crohnâ€™s disease",
    "adult": "800 mg TID or 2.4â€“4.8 g/day",
    "child": "30â€“50 mg/kg/day",
    "avoid": "Severe renal impairment, salicylate allergy"
  },
  {
    "rank": 184,
    "name": "Silymarin",
    "section": "Section 5: GI & Pain",
    "category": "Gastrointestinal",
    "schedule": "H",
    "brand": "Silybon / Legalon / Milk Thistle",
    "formation": "Flavonolignan complex (Milk thistle extract)",
    "uses": "Chronic inflammatory liver diseases, cirrhosis",
    "adult": "70â€“140 mg TID",
    "child": "Consult specialist",
    "avoid": "Hypersensitivity to Asteraceae plants"
  },
  {
    "rank": 185,
    "name": "L-Ornithine L-Aspartate",
    "section": "Section 5: GI & Pain",
    "category": "Gastrointestinal",
    "schedule": "H",
    "brand": "Hepa-Merz / Hepacare / LOLA",
    "formation": "Amino acid complex",
    "uses": "Hepatic encephalopathy, fatty liver",
    "adult": "3â€“6 g BID (Oral) or IV infusion",
    "child": "Not recommended",
    "avoid": "Severe renal impairment (CrCl < 3)"
  },
  {
    "rank": 186,
    "name": "Aceclofenac",
    "section": "Section 5: GI & Pain",
    "category": "Analgesics",
    "schedule": "H",
    "brand": "Zerodol / Hifenac / Aceclo",
    "formation": "Phenylacetic acid derivative (NSAID)",
    "uses": "Osteoarthritis, rheumatoid arthritis pain",
    "adult": "100 mg BID",
    "child": "Not recommended",
    "avoid": "Active peptic ulcer, third trimester pregnancy"
  },
  {
    "rank": 187,
    "name": "Ibuprofen",
    "section": "Section 5: GI & Pain",
    "category": "Analgesics",
    "schedule": "H",
    "brand": "Brufen / Advil / Ibugesic",
    "formation": "Propionic acid derivative (NSAID)",
    "uses": "Fever, mild pain, dysmenorrhea",
    "adult": "400 mg every 4â€“6 hrs",
    "child": "5â€“10 mg/kg/dose (max 40 mg/kg/day)",
    "avoid": "Aspirin triad, third trimester pregnancy"
  },
  {
    "rank": 188,
    "name": "Naproxen Sodium",
    "section": "Section 5: GI & Pain",
    "category": "Analgesics",
    "schedule": "H",
    "brand": "Naprosyn / Naprelan",
    "formation": "Propionic acid derivative (NSAID)",
    "uses": "RA, OA, acute gout, ankylosing spondylitis",
    "adult": "250â€“500 mg BID",
    "child": "10 mg/kg/day in 2 divided doses",
    "avoid": "Active GI bleed, severe heart failure"
  },
  {
    "rank": 189,
    "name": "Etoricoxib",
    "section": "Section 5: GI & Pain",
    "category": "Analgesics",
    "schedule": "H",
    "brand": "Arcoxia / Nucoxia",
    "formation": "Selective COX-2 inhibitor",
    "uses": "Gouty arthritis, dental pain, OA",
    "adult": "60â€“120 mg OD",
    "child": "Not recommended (under 16 years)",
    "avoid": "Uncontrolled hypertension (BP > 140/90), IHD"
  },
  {
    "rank": 190,
    "name": "Celecoxib",
    "section": "Section 5: GI & Pain",
    "category": "Analgesics",
    "schedule": "H",
    "brand": "Celebrex / Celact",
    "formation": "Selective COX-2 inhibitor (Sulfonamide)",
    "uses": "OA, RA, acute pain",
    "adult": "100â€“200 mg BID",
    "child": "50â€“100 mg BID (approved for >2y JRA)",
    "avoid": "Sulfa allergy, post-CABG pain"
  },
  {
    "rank": 191,
    "name": "Mefenamic Acid",
    "section": "Section 5: GI & Pain",
    "category": "Analgesics",
    "schedule": "H",
    "brand": "Meftal / Ponstan",
    "formation": "Anthranilic acid derivative",
    "uses": "Dysmenorrhea, mild-to-moderate pain",
    "adult": "250â€“500 mg TID",
    "child": "6.5 mg/kg per dose",
    "avoid": "Inflammatory bowel disease, GI ulcer"
  },
  {
    "rank": 192,
    "name": "Serratiopeptidase",
    "section": "Section 5: GI & Pain",
    "category": "Analgesics",
    "schedule": "H",
    "brand": "Serapeptase / Serraflam / Sermion",
    "formation": "Proteolytic enzyme",
    "uses": "Reducing inflammation and edema",
    "adult": "10 mg TID",
    "child": "0.5 mg/kg/day (Consult pediatric surgeon)",
    "avoid": "Bleeding disorders, pregnancy"
  },
  {
    "rank": 193,
    "name": "Chymotrypsin-Trypsin",
    "section": "Section 5: GI & Pain",
    "category": "Analgesics",
    "schedule": "H",
    "brand": "Chymoral / Wobenzym",
    "formation": "Proteolytic enzyme combination",
    "uses": "Trauma-related swelling, surgical wounds",
    "adult": "1â€“2 tablets TID",
    "child": "Consult specialist",
    "avoid": "Severe hepatic/renal disease, clotting issues"
  },
  {
    "rank": 194,
    "name": "Thiocolchicoside",
    "section": "Section 5: GI & Pain",
    "category": "Analgesics",
    "schedule": "H1",
    "brand": "Myoril / Muscoril",
    "formation": "Semisynthetic sulfur-derivative colchicoside",
    "uses": "Skeletal muscle spasm, low back pain",
    "adult": "4â€“8 mg BID",
    "child": "Not approved for pediatric use",
    "avoid": "Pregnancy, breastfeeding, history of seizures"
  },
  {
    "rank": 195,
    "name": "Tramadol HCl",
    "section": "Section 5: GI & Pain",
    "category": "Analgesics",
    "schedule": "X",
    "brand": "Tramazac / Tramacip / Ultram",
    "formation": "Synthetic opioid (Centrally acting)",
    "uses": "Moderate-to-severe acute or chronic pain",
    "adult": "50â€“100 mg every 4â€“6 hrs",
    "child": "1â€“2 mg/kg per dose (Avoid in < 12y)",
    "avoid": "Severe respiratory depression, acute alcoholism"
  },
  {
    "rank": 196,
    "name": "Morphine Sulfate",
    "section": "Section 5: GI & Pain",
    "category": "Opioids",
    "schedule": "X",
    "brand": "Morphine / MSContin / Roxanol",
    "formation": "Phenanthrene alkaloid (Opioid)",
    "uses": "Severe pain, palliative care, dyspnea in CHF",
    "adult": "10â€“30 mg every 4 hrs or 30â€“60 mg SR BID",
    "child": "0.1â€“0.2 mg/kg IV or 0.2â€“0.5 mg/kg Oral",
    "avoid": "Paralytic ileus, severe respiratory insufficiency"
  },
  {
    "rank": 197,
    "name": "Fentanyl Citrate",
    "section": "Section 5: GI & Pain",
    "category": "Opioids",
    "schedule": "H",
    "brand": "Duragesic / Fentanyl Patch",
    "formation": "Phenylpiperidine derivative (Opioid)",
    "uses": "Anesthesia, chronic severe pain (Patch)",
    "adult": "12.5â€“100 mcg/hr patch or 50â€“100 mcg IV",
    "child": "1â€“2 mcg/kg IV (Consult anesthesia)",
    "avoid": "Opioid-naive patients (for patch), acute pain"
  },
  {
    "rank": 198,
    "name": "Ketorolac Tromethamine",
    "section": "Section 5: GI & Pain",
    "category": "Analgesics",
    "schedule": "H",
    "brand": "Toradol / Ketanov / Ketrolac",
    "formation": "Pyrrolizine carboxylic acid derivative",
    "uses": "Short-term (max 5 days) severe pain",
    "adult": "10 mg every 4â€“6 hrs or 30 mg IV/IM",
    "child": "0.5â€“1 mg/kg IV (Restrict use)",
    "avoid": "Pre-operative use, renal impairment, GI bleed"
  },
  {
    "rank": 199,
    "name": "Nimesulide",
    "section": "Section 5: GI & Pain",
    "category": "Analgesics",
    "schedule": "H",
    "brand": "Nimulid / Nise",
    "formation": "Selective COX-2 inhibitor (Sulfonanilide)",
    "uses": "Acute pain, primary dysmenorrhea",
    "adult": "100 mg BID",
    "child": "Banned in India for children < 12 years",
    "avoid": "Liver disease, pregnancy, renal impairment"
  },
  {
    "rank": 200,
    "name": "Piroxicam",
    "section": "Section 5: GI & Pain",
    "category": "Analgesics",
    "schedule": "H",
    "brand": "Dolonex / Feldene",
    "formation": "Enolic acid derivative (Oxicam NSAID)",
    "uses": "RA, OA, musculoskeletal pain",
    "adult": "20 mg OD",
    "child": "0.2â€“0.3 mg/kg OD (Consult specialist)",
    "avoid": "GI ulcers, elderly patients (high GI risk)"
  },
  {
    "rank": 201,
    "name": "Gabapentin",
    "section": "Section 5: GI & Pain",
    "category": "CNS",
    "schedule": "H1",
    "brand": "Gabapin / Gabantin / Neurontin",
    "formation": "Cyclohexane derivative (GABA analog)",
    "uses": "Post-herpetic neuralgia, focal seizures",
    "adult": "300 mg initial, titrate to 900â€“1800 mg/day",
    "child": "10â€“30 mg/kg/day",
    "avoid": "Myasthenia gravis (caution), renal failure"
  },
  {
    "rank": 202,
    "name": "Methylcobalamin",
    "section": "Section 5: GI & Pain",
    "category": "Vitamins/Minerals",
    "schedule": "OTC",
    "brand": "Methylcobal / Mecobalamin / Neurobin",
    "formation": "Active form of Vitamin B12 (Organometallic)",
    "uses": "Peripheral neuropathy, B12 deficiency anemia",
    "adult": "500â€“1500 mcg OD",
    "child": "5â€“10 mcg/kg/day",
    "avoid": "Leberâ€™s optic atrophy"
  },
  {
    "rank": 203,
    "name": "Amitriptyline HCl",
    "section": "Section 5: GI & Pain",
    "category": "CNS",
    "schedule": "H",
    "brand": "Tryptomer / Elavil / Amitone",
    "formation": "Tricyclic antidepressant (Dibenzo-cycloheptene)",
    "uses": "Neuropathic pain, migraine prophy, depression",
    "adult": "10â€“75 mg OD (bedtime)",
    "child": "0.1 mg/kg/day (Restrict use)",
    "avoid": "Recent MI, glaucoma, concomitant MAOIs"
  },
  {
    "rank": 204,
    "name": "Duloxetine HCl",
    "section": "Section 5: GI & Pain",
    "category": "CNS",
    "schedule": "H",
    "brand": "Duvanta / Cymbalta / Duloxetine",
    "formation": "Serotonin-norepinephrine reuptake inhibitor",
    "uses": "Diabetic neuropathy, fibromyalgia, GAD",
    "adult": "30â€“60 mg OD",
    "child": "30 mg OD (approved for >7y GAD)",
    "avoid": "Chronic liver disease, severe renal failure"
  },
  {
    "rank": 205,
    "name": "Sumatriptan Succinate",
    "section": "Section 5: GI & Pain",
    "category": "CNS",
    "schedule": "H",
    "brand": "Suminat / Imitrex",
    "formation": "Selective 5-HT1 receptor agonist",
    "uses": "Acute treatment of migraine attacks",
    "adult": "50â€“100 mg single dose (max 200 mg/day)",
    "child": "Nasal spray only (Consult pediatric neuro)",
    "avoid": "Ischemic heart disease, Prinzmetal's angina"
  },
  {
    "rank": 206,
    "name": "Rimegepant",
    "section": "Section 5: GI & Pain",
    "category": "CNS",
    "schedule": "H",
    "brand": "Nurtec ODT",
    "formation": "CGRP receptor antagonist (Gepant)",
    "uses": "Acute and preventive treatment of migraine",
    "adult": "75 mg OD or every other day",
    "child": "Not recommended",
    "avoid": "Severe hepatic impairment"
  },
  {
    "rank": 207,
    "name": "Flunarizine",
    "section": "Section 5: GI & Pain",
    "category": "CNS",
    "schedule": "H",
    "brand": "Sibelium / Flunarin",
    "formation": "Difluorinated derivative of cinnarizine",
    "uses": "Prophylaxis of migraine, vertigo management",
    "adult": "5â€“10 mg OD (bedtime)",
    "child": "5 mg daily (Restrict use)",
    "avoid": "History of depression, Parkinsonâ€™s disease"
  },
  {
    "rank": 208,
    "name": "Escitalopram Oxalate",
    "section": "Section 5: GI & Pain",
    "category": "CNS",
    "schedule": "H",
    "brand": "Nexito / Cipralex / Escitalopram",
    "formation": "S-enantiomer of citalopram (SSRI)",
    "uses": "Generalized anxiety disorder, major depression",
    "adult": "10â€“20 mg OD",
    "child": "10 mg OD (approved >12y)",
    "avoid": "Concomitant QT-prolonging drugs, MAOIs"
  },
  {
    "rank": 209,
    "name": "Sertraline HCl",
    "section": "Section 5: GI & Pain",
    "category": "CNS",
    "schedule": "H",
    "brand": "Serta / Zoloft / Lustral",
    "formation": "Naphthylamine-derivative SSRI",
    "uses": "Panic disorder, OCD, PTSD",
    "adult": "50â€“200 mg OD",
    "child": "25â€“50 mg OD (OCD use)",
    "avoid": "Concomitant use of pimozide"
  },
  {
    "rank": 210,
    "name": "Fluoxetine HCl",
    "section": "Section 5: GI & Pain",
    "category": "CNS",
    "schedule": "H",
    "brand": "Fludac / Prozac / Fluoxetine",
    "formation": "Phenylpropylamine SSRI",
    "uses": "Bulimia nervosa, OCD, depression",
    "adult": "20â€“60 mg OD",
    "child": "10â€“20 mg OD (approved >8y)",
    "avoid": "Concomitant use with thioridazine"
  },
  {
    "rank": 211,
    "name": "Paroxetine HCl",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Paxidep / Paxil / Paroxetine",
    "formation": "Phenylpiperidine SSRI",
    "uses": "Social anxiety disorder, panic disorder",
    "adult": "20â€“50 mg OD (CR)",
    "child": "Not recommended",
    "avoid": "Pregnancy (Category D), MAOI use"
  },
  {
    "rank": 212,
    "name": "Venlafaxine HCl",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Venlor / Effexor / Veniz XR",
    "formation": "Phenethylamine derivative (SNRI)",
    "uses": "Major depressive disorder, panic disorder",
    "adult": "75â€“225 mg daily (ER)",
    "child": "Not recommended",
    "avoid": "High risk of suicidal ideation in young adults"
  },
  {
    "rank": 213,
    "name": "Desvenlafaxine",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Divaa / Pristiq / Desnax",
    "formation": "O-desmethyl metabolite of venlafaxine (SNRI)",
    "uses": "Major depressive disorder",
    "adult": "50â€“100 mg OD",
    "child": "Not recommended",
    "avoid": "Concomitant use with linezolid"
  },
  {
    "rank": 214,
    "name": "Imipramine",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Antideprin / Tofranil",
    "formation": "Dibenzazepine tricyclic antidepressant",
    "uses": "Depression, nocturnal enuresis in children",
    "adult": "75â€“150 mg/day",
    "child": "10â€“25 mg at bedtime (Enuresis)",
    "avoid": "Post-myocardial infarction, glaucoma"
  },
  {
    "rank": 215,
    "name": "Nortriptyline HCl",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Sensival / Pamelor / Nortriptyline",
    "formation": "Secondary amine tricyclic antidepressant",
    "uses": "Major depression, adjuvant for chronic pain",
    "adult": "25â€“100 mg daily",
    "child": "Not recommended",
    "avoid": "Concomitant MAOI use, severe cardiac disease"
  },
  {
    "rank": 216,
    "name": "Quetiapine Fumarate",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Qutipin / Seroquel / Quetiapine",
    "formation": "Dibenzothiazepine atypical antipsychotic",
    "uses": "Schizophrenia, bipolar mania, depression adjunct",
    "adult": "50â€“800 mg/day (titrate)",
    "child": "50â€“400 mg/day (Restrict use)",
    "avoid": "History of QT prolongation, dementia-related psychosis"
  },
  {
    "rank": 217,
    "name": "Risperidone",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Sizodon / Risperdal / Risperidone",
    "formation": "Benzisoxazole atypical antipsychotic",
    "uses": "Schizophrenia, irritability in autism",
    "adult": "2â€“6 mg daily",
    "child": "0.25â€“1 mg daily (Autism)",
    "avoid": "Elderly with dementia, cardiac disease"
  },
  {
    "rank": 218,
    "name": "Olanzapine",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Oleanz / Zyprexa / Olanzapine",
    "formation": "Thienobenzodiazepine atypical antipsychotic",
    "uses": "Schizophrenia, acute bipolar mania",
    "adult": "5â€“20 mg OD (bedtime)",
    "child": "2.5â€“10 mg OD (Restrict under 13y)",
    "avoid": "Severe metabolic syndrome, geriatric patients"
  },
  {
    "rank": 219,
    "name": "Haloperidol",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Serenace / Haldol / Haloperidol",
    "formation": "Butyrophenone derivative antipsychotic",
    "uses": "Acute psychosis, Tourette's syndrome, hiccups",
    "adult": "0.5â€“5 mg BID or TID",
    "child": "0.05â€“0.15 mg/kg/day",
    "avoid": "Parkinsonâ€™s disease, CNS depression"
  },
  {
    "rank": 220,
    "name": "Aripiprazole",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Arip MT / Abilify / Aripiprazole",
    "formation": "Quinolinone atypical antipsychotic",
    "uses": "Schizophrenia, bipolar I disorder, Touretteâ€™s",
    "adult": "10â€“30 mg OD",
    "child": "2â€“10 mg OD (Weight-based)",
    "avoid": "Dementia-related psychosis, severe liver disease"
  },
  {
    "rank": 221,
    "name": "Clozapine",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Sizopin / Clozaril / Leponex",
    "formation": "Dibenzodiazepine atypical antipsychotic",
    "uses": "Treatment-resistant schizophrenia",
    "adult": "12.5â€“450 mg/day (titrate slowly)",
    "child": "Not recommended",
    "avoid": "History of agranulocytosis, uncontrolled epilepsy"
  },
  {
    "rank": 222,
    "name": "Sodium Valproate",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Encorate / Depakote / Valprol",
    "formation": "Fatty acid derivative (Antiepileptic)",
    "uses": "Absence seizures, migraine prophylaxis, bipolar mania",
    "adult": "600â€“2000 mg/day in divided doses",
    "child": "20â€“30 mg/kg/day",
    "avoid": "Pregnancy (Category X for migraine), urea cycle disorders"
  },
  {
    "rank": 223,
    "name": "Carbamazepine",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Tegretol / Zen / Mazetol",
    "formation": "Dibenzazepine antiepileptic",
    "uses": "Trigeminal neuralgia, focal seizures",
    "adult": "200â€“800 mg/day in divided doses",
    "child": "10â€“20 mg/kg/day",
    "avoid": "Bone marrow depression, HLA-B*1502 positive"
  },
  {
    "rank": 224,
    "name": "Phenytoin Sodium",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Eptoin / Dilantin / Phenytek",
    "formation": "Hydantoin derivative (Antiepileptic)",
    "uses": "Generalized tonic-clonic seizures, status epilepticus",
    "adult": "300â€“400 mg daily",
    "child": "5â€“8 mg/kg/day",
    "avoid": "Sinus bradycardia, SA block, second/third-degree AV block"
  },
  {
    "rank": 225,
    "name": "Levetiracetam",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Keppra / Levipil / Levetiracetam",
    "formation": "Pyrrolidine derivative antiepileptic",
    "uses": "Focal and myoclonic seizures",
    "adult": "500â€“1500 mg BID",
    "child": "20â€“60 mg/kg/day",
    "avoid": "Suicidal behavior history, renal failure (titrate)"
  },
  {
    "rank": 226,
    "name": "Brivaracetam",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Briviact",
    "formation": "Selective SV2A ligand (Antiepileptic)",
    "uses": "Focal-onset seizures",
    "adult": "50â€“100 mg BID",
    "child": "Weight-based (approved >4 years)",
    "avoid": "End-stage renal disease"
  },
  {
    "rank": 227,
    "name": "Lamotrigine",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Lamictal / Lametec / Lamitor",
    "formation": "Phenyltriazine derivative antiepileptic",
    "uses": "Bipolar I maintenance, Lennox-Gastaut syndrome",
    "adult": "100â€“400 mg daily",
    "child": "1â€“5 mg/kg/day (with valproate) or higher alone",
    "avoid": "Severe skin rash (SJS/TEN risk), pregnancy"
  },
  {
    "rank": 228,
    "name": "Clobazam",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "X",
    "brand": "Frisium / Urban / Clobazam",
    "formation": "1,5-benzodiazepine antiepileptic",
    "uses": "Adjunct in LGS seizures, acute anxiety",
    "adult": "10â€“40 mg daily",
    "child": "5â€“20 mg/day (Weight-based)",
    "avoid": "Severe respiratory insufficiency, sleep apnea"
  },
  {
    "rank": 229,
    "name": "Alprazolam",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "X",
    "brand": "Alprax / Restyl / Xanax",
    "formation": "Triazolo-benzodiazepine (Anxiolytic)",
    "uses": "Anxiety, panic disorder",
    "adult": "0.25â€“1 mg TID",
    "child": "Not recommended",
    "avoid": "Concomitant use with opioids (fatal sedation risk)"
  },
  {
    "rank": 230,
    "name": "Clonazepam",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "X",
    "brand": "Clonaz / Rivotril / Klonopin",
    "formation": "Nitro-benzodiazepine derivative",
    "uses": "Panic disorder, petit mal seizures",
    "adult": "0.25â€“2 mg daily (divided or bedtime)",
    "child": "0.01â€“0.03 mg/kg/day",
    "avoid": "Severe liver disease, acute narrow-angle glaucoma"
  },
  {
    "rank": 231,
    "name": "Lorazepam",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "X",
    "brand": "Ativan / Calmpose / Lorazepam",
    "formation": "Benzodiazepine (Anxiolytic/Sedative)",
    "uses": "Acute anxiety, preoperative sedation, status epilepticus",
    "adult": "1â€“2 mg BID or TID",
    "child": "0.05 mg/kg per dose",
    "avoid": "Sleep apnea, severe respiratory insufficiency"
  },
  {
    "rank": 232,
    "name": "Diazepam",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "X",
    "brand": "Valium / Calmpose / Diazepam",
    "formation": "Benzodiazepine (1,4-substituted)",
    "uses": "Muscle spasms, seizures, alcohol withdrawal",
    "adult": "2â€“10 mg 2â€“4 times/day",
    "child": "0.1â€“0.5 mg/kg/day",
    "avoid": "Severe hepatic insufficiency, myasthenia gravis"
  },
  {
    "rank": 233,
    "name": "Midazolam HCl",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "X",
    "brand": "Dormicum / Versed / Midazolam",
    "formation": "Short-acting imidazole benzodiazepine",
    "uses": "Procedural sedation, induction of anesthesia",
    "adult": "1â€“5 mg IV/IM (titrate based on sedation)",
    "child": "0.1â€“0.5 mg/kg (Oral/IV)",
    "avoid": "Acute narrow-angle glaucoma, respiratory failure"
  },
  {
    "rank": 234,
    "name": "Zolpidem Tartrate",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "X",
    "brand": "Zolfresh / Ambien / Stilnox",
    "formation": "Imidazopyridine non-benzodiazepine hypnotic",
    "uses": "Short-term treatment of insomnia",
    "adult": "5â€“10 mg at bedtime",
    "child": "Not recommended",
    "avoid": "Obstructive sleep apnea, complex sleep behaviors"
  },
  {
    "rank": 235,
    "name": "Melatonin",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "OTC",
    "brand": "Meloset / Melalong",
    "formation": "Endogenous indole hormone analog",
    "uses": "Jet lag, delayed sleep phase syndrome",
    "adult": "3â€“10 mg (bedtime)",
    "child": "1â€“3 mg (Consult specialist)",
    "avoid": "Autoimmune disorders, concomitant anticoagulant use"
  },
  {
    "rank": 236,
    "name": "Donepezil HCl",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Donecept / Aricept / Alzil",
    "formation": "Piperidine-based acetylcholinesterase inhibitor",
    "uses": "Mild-to-severe Alzheimer's dementia",
    "adult": "5â€“10 mg OD (bedtime)",
    "child": "Not recommended",
    "avoid": "Severe cardiac arrhythmias, obstructive lung disease"
  },
  {
    "rank": 237,
    "name": "Memantine HCl",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Admenta / Namenda / Ebixa",
    "formation": "Adamantane-derivative NMDA antagonist",
    "uses": "Moderate-to-severe Alzheimer's disease",
    "adult": "5â€“20 mg OD",
    "child": "Not recommended",
    "avoid": "Severe renal impairment (CrCl < 5), seizures"
  },
  {
    "rank": 238,
    "name": "Levodopa + Carbidopa",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Syndopa / Sinemet / Tidomet",
    "formation": "Dopamine precursor + decarboxylase inhibitor",
    "uses": "Parkinsonâ€™s disease, restless legs syndrome",
    "adult": "100 mg/25 mg TID (titrate based on mobility)",
    "child": "Not recommended",
    "avoid": "Concomitant non-selective MAOIs, narrow-angle glaucoma"
  },
  {
    "rank": 239,
    "name": "Pramipexole",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Pramipex / Mirapex",
    "formation": "Non-ergot dopamine receptor agonist",
    "uses": "Parkinsonâ€™s disease, restless legs syndrome",
    "adult": "0.125â€“1.5 mg TID",
    "child": "Not recommended",
    "avoid": "Severe renal impairment, sudden sleep onset history"
  },
  {
    "rank": 240,
    "name": "Ropinirole",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Ropitor / Requip",
    "formation": "Non-ergoline dopamine agonist",
    "uses": "Idiopathic Parkinsonâ€™s disease",
    "adult": "0.25â€“4 mg TID",
    "child": "Not recommended",
    "avoid": "Severe hepatic impairment, neuropsychiatric symptoms"
  },
  {
    "rank": 241,
    "name": "Lithium Carbonate",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Licab / Eskalith / Lithosun",
    "formation": "Inorganic alkali metal salt",
    "uses": "Bipolar affective disorder, acute mania",
    "adult": "300 mg BID or TID (titrate to 0.6â€“1.2 mEq/L)",
    "child": "15â€“30 mg/kg/day (Restrict use <12y)",
    "avoid": "Severe renal disease, sodium depletion, dehydration"
  },
  {
    "rank": 242,
    "name": "Methylphenidate HCl",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "X",
    "brand": "Ritalin / Concerta / Inspiral",
    "formation": "Piperidine-derivative CNS stimulant",
    "uses": "ADHD, narcolepsy",
    "adult": "10â€“60 mg/day (divided or extended-release)",
    "child": "5 mg BID initial (approved >6y)",
    "avoid": "Severe anxiety, motor tics, glaucoma"
  },
  {
    "rank": 243,
    "name": "Modafinil",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Modalert / Provigil",
    "formation": "Benzhydryl sulfinyl acetamide (Wake-promoter)",
    "uses": "Narcolepsy, shift-work sleep disorder",
    "adult": "200 mg OD (morning)",
    "child": "Not recommended",
    "avoid": "Mitral valve prolapse, severe hypertension"
  },
  {
    "rank": 244,
    "name": "Donepezil + Memantine",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "CNS",
    "schedule": "H",
    "brand": "Donamem / Namzaric",
    "formation": "AChE inhibitor + NMDA antagonist",
    "uses": "Advanced Alzheimerâ€™s dementia",
    "adult": "10 mg/20 mg OD",
    "child": "Not recommended",
    "avoid": "Sick sinus syndrome, GI ulcer risk"
  },
  {
    "rank": 245,
    "name": "S-Adenosyl L-Methionine (SAMe)",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "Nutraceuticals",
    "schedule": "OTC",
    "brand": "Heptral / SAMe",
    "formation": "Naturally occurring cosubstrate",
    "uses": "Intrahepatic cholestasis, osteoarthritis",
    "adult": "400â€“800 mg daily",
    "child": "Consult specialist",
    "avoid": "Bipolar disorder (mania risk)"
  },
  {
    "rank": 246,
    "name": "Coenzyme Q10",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "Nutraceuticals",
    "schedule": "OTC",
    "brand": "CoQ10 / Ubiquinol",
    "formation": "Fat-soluble benzoquinone compound",
    "uses": "Heart health, adjunct in mitochondrial disorders",
    "adult": "100â€“300 mg daily",
    "child": "1â€“3 mg/kg/day (Mitochondrial use)",
    "avoid": "Concurrent use with warfarin (may reduce effect)"
  },
  {
    "rank": 247,
    "name": "Omega-3 Fatty Acids (EPA/DHA)",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "Nutraceuticals",
    "schedule": "OTC",
    "brand": "Maxepa / Omacor / Omega-3",
    "formation": "Polyunsaturated fatty acids (Ethyl esters)",
    "uses": "Severe hypertriglyceridemia, CV protection",
    "adult": "1â€“4 g daily",
    "child": "500â€“1000 mg/day",
    "avoid": "Fish/shellfish allergy"
  },
  {
    "rank": 248,
    "name": "Chondroitin + Glucosamine",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "Nutraceuticals",
    "schedule": "OTC",
    "brand": "Glucosamine / JointFlex / Chondrogard",
    "formation": "Glycosaminoglycan + amino sugar salt",
    "uses": "Symptomatic relief in Osteoarthritis",
    "adult": "1200 mg/1500 mg daily (divided)",
    "child": "Not recommended",
    "avoid": "Shellfish allergy, asthma flares"
  },
  {
    "rank": 249,
    "name": "Ashwagandha (Withania somnifera)",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "Nutraceuticals",
    "schedule": "OTC",
    "brand": "KSM-66 / Himalaya Ashwagandha",
    "formation": "Natural withanolide glycosides",
    "uses": "Stress management, immunomodulation, energy",
    "adult": "300â€“600 mg daily (Standardized extract)",
    "child": "Consult specialist (Herbal guidelines)",
    "avoid": "Pregnancy (abortifacient risk), autoimmune disease"
  },
  {
    "rank": 250,
    "name": "Bacopa Monnieri (Brahmi)",
    "section": "Section 6: Neuro-Psychiatry & CNS",
    "category": "Nutraceuticals",
    "schedule": "OTC",
    "brand": "Himalaya Brahmi / Bacopa",
    "formation": "Natural saponin complex (Bacosides)",
    "uses": "Cognitive enhancement, memory improvement",
    "adult": "300â€“450 mg daily",
    "child": "100â€“200 mg daily (Restrict <12y)",
    "avoid": "Bradycardia, GI obstruction"
  },
  {
    "rank": 251,
    "name": "Mometasone Furoate (Topical)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Dermatology",
    "schedule": "H",
    "brand": "Elocon / Momoz / Mometasone Cream",
    "formation": "Mid-potency fluorinated topical corticosteroid",
    "uses": "Atopic dermatitis, psoriasis, seborrheic dermatitis",
    "adult": "Apply thin layer to affected area OD",
    "child": "Avoid <2y; thin layer OD (2â€“12y, short term)",
    "avoid": "Rosacea, acne, perioral dermatitis, skin infections"
  },
  {
    "rank": 252,
    "name": "Clobetasol Propionate (Topical)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Dermatology",
    "schedule": "H",
    "brand": "Tenovate / Dermovate / Clobetasol",
    "formation": "Super-potent halogenated glucocorticoid",
    "uses": "Severe psoriasis, lichen planus, pemphigus vulgaris",
    "adult": "Apply thin layer BID (max 50 g/week, max 4 weeks)",
    "child": "Avoid <1y; restricted use <12y",
    "avoid": "Widespread plaque psoriasis, face/groin/axilla use"
  },
  {
    "rank": 253,
    "name": "Betamethasone + Clotrimazole (Topical)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Dermatology",
    "schedule": "H",
    "brand": "Candid-B / Clotrasone / Betacot",
    "formation": "Fluorinated corticosteroid + azole antifungal",
    "uses": "Dermatophytosis with inflammation, intertrigo, tinea with eczema",
    "adult": "Apply BID for 2â€“4 weeks",
    "child": "Avoid prolonged use; consult dermatologist",
    "avoid": "Viral skin lesions, acne, perioral dermatitis, rosacea"
  },
  {
    "rank": 254,
    "name": "Tretinoin (Topical)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Dermatology",
    "schedule": "H",
    "brand": "A-Ret / Airol / Retino-A",
    "formation": "All-trans retinoic acid (Vitamin A derivative)",
    "uses": "Acne vulgaris, photoaging, fine wrinkles, keratosis pilaris",
    "adult": "0.025â€“0.1% Apply OD (bedtime)",
    "child": "Not recommended <12y",
    "avoid": "Pregnancy, sunburned skin, eczema, rosacea"
  },
  {
    "rank": 255,
    "name": "Adapalene (Topical)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Dermatology",
    "schedule": "H",
    "brand": "Deriva / Differin / Adaferin",
    "formation": "Third-generation synthetic naphthoic acid retinoid",
    "uses": "Mild-to-moderate acne vulgaris, comedonal acne",
    "adult": "Apply thin layer OD (bedtime) to affected area",
    "child": "0.1% approved â‰¥12y",
    "avoid": "Pregnancy, sunburned or eczematous skin"
  },
  {
    "rank": 256,
    "name": "Azelaic Acid (Topical)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Dermatology",
    "schedule": "H",
    "brand": "Aziderm / Finacea / Azelaic cream",
    "formation": "Naturally occurring dicarboxylic acid (antibacterial + antikeratinizing)",
    "uses": "Acne vulgaris, rosacea, post-inflammatory hyperpigmentation",
    "adult": "15â€“20% Apply BID to clean skin",
    "child": "Avoid <12y",
    "avoid": "Known hypersensitivity to propylene glycol base"
  },
  {
    "rank": 257,
    "name": "Benzoyl Peroxide (Topical)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Dermatology",
    "schedule": "OTC",
    "brand": "Persol / Benzac AC / BP gel",
    "formation": "Organic peroxide (bactericidal oxidizing agent)",
    "uses": "Acne vulgaris (comedonal and inflammatory)",
    "adult": "2.5â€“10% Apply OD or BID",
    "child": "Approved â‰¥12y",
    "avoid": "Sensitive or broken skin, concurrent retinoid use (bleaches fabric)"
  },
  {
    "rank": 258,
    "name": "Salicylic Acid (Topical)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Dermatology",
    "schedule": "OTC",
    "brand": "Acne-Aid / Salicylic Lotion / Keralyt",
    "formation": "Beta-hydroxy acid (keratolytic agent)",
    "uses": "Acne, dandruff, calluses, psoriasis, verrucae",
    "adult": "2â€“6% Apply daily as directed",
    "child": "Avoid large surface area <2y",
    "avoid": "Aspirin sensitivity, mucous membranes, inflamed skin"
  },
  {
    "rank": 259,
    "name": "Hydroquinone + Tretinoin + Mometasone (Topical)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Dermatology",
    "schedule": "H",
    "brand": "Tri-Luma / Melafree / HM Triple",
    "formation": "Depigmenting agent + retinoid + corticosteroid triple combination",
    "uses": "Moderate-to-severe melasma (facial hyperpigmentation)",
    "adult": "Apply thin layer OD (bedtime) for max 8 weeks",
    "child": "Not recommended",
    "avoid": "Pregnancy, active inflammatory acne, hypersensitivity to any component"
  },
  {
    "rank": 260,
    "name": "Tacrolimus (Topical)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Dermatology",
    "schedule": "H",
    "brand": "Protopic / Tacroz / Tacromus Oint",
    "formation": "Macrolide calcineurin inhibitor (topical immunomodulator)",
    "uses": "Moderate-to-severe atopic dermatitis, vitiligo",
    "adult": "0.1% Apply BID (0.03% in elderly)",
    "child": "0.03% approved â‰¥2y",
    "avoid": "Netherton syndrome, active skin infections, immunocompromised state"
  },
  {
    "rank": 261,
    "name": "Pimecrolimus (Topical)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Dermatology",
    "schedule": "H",
    "brand": "Elidel / Pimecrolimus cream",
    "formation": "Calcineurin inhibitor (ascomycin macrolactam derivative)",
    "uses": "Mild-to-moderate atopic eczema (non-steroid alternative)",
    "adult": "1% Apply BID",
    "child": "1% approved â‰¥2y",
    "avoid": "Immunocompromised patients, pre-malignant skin conditions"
  },
  {
    "rank": 262,
    "name": "Isotretinoin (Oral)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Dermatology",
    "schedule": "H",
    "brand": "Isotroin / Acutret / Sotret",
    "formation": "13-cis-retinoic acid (oral systemic retinoid)",
    "uses": "Severe nodular/cystic acne vulgaris unresponsive to antibiotics",
    "adult": "0.5â€“1 mg/kg/day in 2 divided doses for 4â€“6 months",
    "child": "Not recommended <12y; extreme caution in adolescents",
    "avoid": "Pregnancy (Category X â€“ teratogenic), hyperlipidemia, hepatic disease"
  },
  {
    "rank": 263,
    "name": "Calcipotriol (Topical)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Dermatology",
    "schedule": "H",
    "brand": "Daivonex / Calpotrex / Dovonex",
    "formation": "Synthetic Vitamin D3 analog (inhibits keratinocyte proliferation)",
    "uses": "Mild-to-moderate plaque psoriasis",
    "adult": "Apply BID to affected areas (max 100 g/week)",
    "child": "Avoid <6y; consult dermatologist 6â€“18y",
    "avoid": "Hypercalcemia, widespread pustular psoriasis, severe renal/hepatic disease"
  },
  {
    "rank": 264,
    "name": "Minoxidil (Topical)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Dermatology",
    "schedule": "H",
    "brand": "Mintop / Tugain / Regaine",
    "formation": "Pyrimidine derivative (potassium channel opener â€“ vasodilator)",
    "uses": "Androgenetic alopecia (male and female pattern hair loss)",
    "adult": "2â€“5% Apply BID to dry scalp",
    "child": "Not recommended",
    "avoid": "Scalp inflammation or infection, concurrent oral minoxidil"
  },
  {
    "rank": 265,
    "name": "Dapsone",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Dermatology",
    "schedule": "H",
    "brand": "Dapsone / DDS / Maloprim (combination)",
    "formation": "Sulfone derivative (antibacterial and anti-inflammatory)",
    "uses": "Leprosy (multibacillary and paucibacillary), dermatitis herpetiformis",
    "adult": "50â€“100 mg OD (leprosy, for 6â€“12 months+)",
    "child": "1â€“2 mg/kg/day",
    "avoid": "G6PD deficiency, severe anemia, sulfonamide hypersensitivity"
  },
  {
    "rank": 266,
    "name": "Permethrin (Topical)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Dermatology",
    "schedule": "H",
    "brand": "Scaboma / Kwellada-P / Permethrin lotion",
    "formation": "Synthetic pyrethroid (neurotoxic to ectoparasites)",
    "uses": "Scabies (Sarcoptes scabiei), head lice infestation",
    "adult": "5% cream apply overnight and wash; 1% for lice",
    "child": "1% lotion (lice â‰¥2 months); 5% cream (scabies â‰¥2 months)",
    "avoid": "Hypersensitivity to chrysanthemums or pyrethrins"
  },
  {
    "rank": 267,
    "name": "Silver Sulfadiazine (Topical)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Dermatology",
    "schedule": "H",
    "brand": "Silverex / Silverskin / SSD Cream",
    "formation": "Silver salt of sulfonamide antibiotic",
    "uses": "Prophylaxis and treatment of infections in burns and skin grafts",
    "adult": "1% cream apply daily after cleansing",
    "child": "Avoid in neonates <2 months",
    "avoid": "Sulfonamide allergy, pregnancy near term, G6PD deficiency"
  },
  {
    "rank": 268,
    "name": "Clindamycin + Benzoyl Peroxide (Topical)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Dermatology",
    "schedule": "H",
    "brand": "Clindac BPO / Clindagel BPO / Acnesol-BP",
    "formation": "Lincosamide antibiotic + oxidizing bactericidal agent",
    "uses": "Moderate inflammatory acne, antibiotic-resistant acne vulgaris",
    "adult": "Apply OD to affected areas",
    "child": "Approved â‰¥12y",
    "avoid": "History of Clostridium difficile colitis, antibiotic-associated colitis"
  },
  {
    "rank": 269,
    "name": "Tazarotene (Topical)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Dermatology",
    "schedule": "H",
    "brand": "Tazorac / Tazret / Tazarotene gel",
    "formation": "Synthetic receptor-selective acetylenic retinoid",
    "uses": "Plaque psoriasis, acne vulgaris, fine wrinkles",
    "adult": "0.05â€“0.1% Apply OD (bedtime)",
    "child": "Not recommended <12y",
    "avoid": "Pregnancy, sunburned or eczematous skin, concurrent phototherapy"
  },
  {
    "rank": 270,
    "name": "Halobetasol Propionate (Topical)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Dermatology",
    "schedule": "H",
    "brand": "Ultravate / Haloderm / Halobetasol cream",
    "formation": "Super-high-potency halogenated glucocorticoid",
    "uses": "Severe dermatoses: recalcitrant psoriasis, lichen planus",
    "adult": "Apply thin film ODâ€“BID (max 2 weeks; max 50 g/week)",
    "child": "Not recommended <12y",
    "avoid": "Rosacea, perioral dermatitis, viral/fungal/bacterial skin infections"
  },
  {
    "rank": 271,
    "name": "Timolol Maleate (Eye Drops)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Ophthalmology",
    "schedule": "H",
    "brand": "Glucomol / Timoptic / Timoptol",
    "formation": "Non-selective beta-adrenergic blocker (ophthalmic)",
    "uses": "Elevated intraocular pressure (IOP), open-angle glaucoma",
    "adult": "0.25â€“0.5% one drop BID",
    "child": "0.25% (limited data; consult ophthalmologist)",
    "avoid": "Asthma, COPD, bradycardia, second/third-degree heart block"
  },
  {
    "rank": 272,
    "name": "Latanoprost (Eye Drops)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Ophthalmology",
    "schedule": "H",
    "brand": "Latoprost / Xalatan / Latanoprost eye drops",
    "formation": "Prostaglandin F2Î± analog (increases uveoscleral outflow)",
    "uses": "Open-angle glaucoma, ocular hypertension",
    "adult": "0.005% one drop OD (bedtime)",
    "child": "Safety not established; use with caution",
    "avoid": "Active ocular inflammation, aphakic eyes"
  },
  {
    "rank": 273,
    "name": "Brimonidine Tartrate (Eye Drops)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Ophthalmology",
    "schedule": "H",
    "brand": "Alphagan P / Brimosun / Brimo eye drops",
    "formation": "Selective alpha-2 adrenergic agonist (reduces aqueous production)",
    "uses": "Reduction of IOP in glaucoma and ocular hypertension",
    "adult": "0.1â€“0.2% one drop TID (every 8 hrs)",
    "child": "Avoid <2y; caution <6y (CNS depression risk)",
    "avoid": "Concurrent MAOI therapy, neonates, severe cardiovascular disease"
  },
  {
    "rank": 274,
    "name": "Bimatoprost (Eye Drops)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Ophthalmology",
    "schedule": "H",
    "brand": "Careprost / Lumigan / Bimat",
    "formation": "Prostamide (prostaglandin analog) â€“ increases trabecular and uveoscleral outflow",
    "uses": "Open-angle glaucoma, ocular hypertension, eyelash hypotrichosis",
    "adult": "0.03% one drop OD (bedtime)",
    "child": "Safety not established",
    "avoid": "Active intraocular inflammation, cystoid macular edema risk"
  },
  {
    "rank": 275,
    "name": "Dorzolamide + Timolol (Eye Drops)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Ophthalmology",
    "schedule": "H",
    "brand": "Cosopt / Orzol-T / Dorzo-T",
    "formation": "Carbonic anhydrase inhibitor + non-selective beta-blocker (ophthalmic)",
    "uses": "Glaucoma requiring more than one hypotensive agent",
    "adult": "2%/0.5% one drop BID",
    "child": "Safety not established",
    "avoid": "Asthma, COPD, sulfonamide hypersensitivity, severe cardiac disease"
  },
  {
    "rank": 276,
    "name": "Acetazolamide",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Ophthalmology",
    "schedule": "H",
    "brand": "Diamox / Glaumox / Acetazolamide",
    "formation": "Carbonic anhydrase inhibitor (sulfonamide derivative, systemic/IV)",
    "uses": "Acute angle-closure glaucoma, altitude sickness, epilepsy adjunct",
    "adult": "250â€“1000 mg daily in divided doses; 125â€“250 mg OD (altitude)",
    "child": "5â€“10 mg/kg every 6 hrs",
    "avoid": "Sulfonamide allergy, severe renal/hepatic disease, hyponatremia"
  },
  {
    "rank": 277,
    "name": "Moxifloxacin (Ophthalmic)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Ophthalmology",
    "schedule": "H",
    "brand": "Vigamox / Moxicip / Milflox",
    "formation": "Fourth-generation fluoroquinolone antibiotic (topical ophthalmic)",
    "uses": "Bacterial conjunctivitis, pre/post-operative ocular prophylaxis",
    "adult": "0.5% one drop TID for 7 days",
    "child": "Approved â‰¥1y (same dosing)",
    "avoid": "Hypersensitivity to fluoroquinolones"
  },
  {
    "rank": 278,
    "name": "Prednisolone Acetate (Ophthalmic)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Ophthalmology",
    "schedule": "H",
    "brand": "Pred Forte / Predforte / Ocumethyl",
    "formation": "Synthetic corticosteroid ophthalmic suspension",
    "uses": "Allergic and inflammatory ocular conditions, post-surgical inflammation",
    "adult": "1% one drop every 1â€“4 hrs initially, taper as inflammation resolves",
    "child": "Consult ophthalmologist",
    "avoid": "Herpes simplex keratitis, fungal/viral eye infections, glaucoma"
  },
  {
    "rank": 279,
    "name": "Nepafenac (Ophthalmic)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Ophthalmology",
    "schedule": "H",
    "brand": "Nevanac / Ilevro / Nepafenac eye drops",
    "formation": "NSAID prodrug (converted to amfenac in ocular tissues)",
    "uses": "Post-cataract surgery pain, inflammation, and macular edema prevention",
    "adult": "0.1% one drop TID (day before to 2 weeks post-surgery)",
    "child": "Approved â‰¥10y",
    "avoid": "Aspirin hypersensitivity, active ocular infection"
  },
  {
    "rank": 280,
    "name": "Olopatadine (Ophthalmic)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Ophthalmology",
    "schedule": "H",
    "brand": "Patanol / Pataday / Olopatadine eye drops",
    "formation": "Selective H1-receptor antagonist + mast cell stabilizer (ophthalmic)",
    "uses": "Seasonal and perennial allergic conjunctivitis",
    "adult": "0.1% one drop BID; 0.2%/0.7% OD formulations available",
    "child": "Approved â‰¥3y",
    "avoid": "Contact lens wear during instillation"
  },
  {
    "rank": 281,
    "name": "Cyclopentolate (Eye Drops)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Ophthalmology",
    "schedule": "H",
    "brand": "Cyclopentol / Cyclogyl / Cyclomydril",
    "formation": "Anticholinergic (muscarinic antagonist) ophthalmic cycloplegic",
    "uses": "Cycloplegia for refraction, mydriasis for diagnostic fundus examination",
    "adult": "1% one drop (repeat after 5â€“10 min if needed)",
    "child": "0.5% for infants; 1% for older children",
    "avoid": "Primary angle-closure glaucoma, narrow anterior chamber angle"
  },
  {
    "rank": 282,
    "name": "Tropicamide (Eye Drops)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Ophthalmology",
    "schedule": "H",
    "brand": "Tropicacyl / Mydracyl / Tropicamide drops",
    "formation": "Short-acting antimuscarinic mydriatic/cycloplegic",
    "uses": "Pupil dilation for fundus examination and refractive assessment",
    "adult": "0.5â€“1% one drop; repeat after 5 min",
    "child": "0.5% for children; consult specialist",
    "avoid": "Primary angle-closure glaucoma"
  },
  {
    "rank": 283,
    "name": "Ranibizumab (Intravitreal Injection)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Ophthalmology",
    "schedule": "H",
    "brand": "Accentrix / Lucentis / Razumab",
    "formation": "Recombinant humanized anti-VEGF Fab fragment",
    "uses": "Wet age-related macular degeneration, diabetic macular edema, RVO",
    "adult": "0.5 mg monthly intravitreal injection",
    "child": "Not recommended",
    "avoid": "Ocular/periocular infections, active intraocular inflammation"
  },
  {
    "rank": 284,
    "name": "Travoprost (Eye Drops)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Ophthalmology",
    "schedule": "H",
    "brand": "Travatan / Travoprost Z / TravAtan",
    "formation": "Synthetic prostaglandin F2Î± analog (selective FP receptor agonist)",
    "uses": "Open-angle glaucoma, elevated intraocular pressure",
    "adult": "0.004% one drop OD (evening)",
    "child": "Safety not established",
    "avoid": "Macular edema, uveitic glaucoma, contact lens wear during instillation"
  },
  {
    "rank": 285,
    "name": "Carboxymethylcellulose (Eye Drops)",
    "section": "Section 7: Dermatology & Ophthalmology",
    "category": "Ophthalmology",
    "schedule": "OTC",
    "brand": "Refresh Tears / Systane / Lubrex",
    "formation": "Polymer lubricant (viscous ophthalmic solution)",
    "uses": "Dry eye syndrome, ocular lubrication, computer vision syndrome",
    "adult": "0.5â€“1% one drop PRN (up to 6 times daily)",
    "child": "Safe for all ages as directed",
    "avoid": "Known hypersensitivity to preservatives (use preservative-free if sensitive)"
  },
  {
    "rank": 286,
    "name": "Imatinib Mesylate",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Gleevec / Veenat / Imatib",
    "formation": "BCR-ABL tyrosine kinase inhibitor (TKI)",
    "uses": "Chronic myeloid leukemia (CML), GIST, Ph+ ALL",
    "adult": "400â€“600 mg OD (CML-CP); 400 mg BID (blast phase)",
    "child": "260â€“340 mg/mÂ² OD",
    "avoid": "Severe hepatic impairment, concurrent strong CYP3A4 inducers"
  },
  {
    "rank": 287,
    "name": "Hydroxyurea",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Hydrea / Droxia / Hydroxyurea",
    "formation": "Ribonucleoside diphosphate reductase inhibitor (antimetabolite)",
    "uses": "CML, polycythemia vera, sickle cell disease (crisis reduction)",
    "adult": "15â€“35 mg/kg/day or 500â€“1000 mg daily",
    "child": "10â€“20 mg/kg OD (sickle cell disease)",
    "avoid": "Severe bone marrow suppression, pregnancy, breastfeeding"
  },
  {
    "rank": 288,
    "name": "Methotrexate",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H1",
    "brand": "Folitrax / Mexate / Methotrexate",
    "formation": "Dihydrofolate reductase inhibitor (antimetabolite + DMARD)",
    "uses": "Leukemia, lymphoma, rheumatoid arthritis, psoriasis, ectopic pregnancy",
    "adult": "7.5â€“25 mg/week (RA); high-dose IV (cancer protocols)",
    "child": "7.5â€“30 mg/mÂ²/week (consult hematology)",
    "avoid": "Pregnancy, severe renal/hepatic disease, pleural effusion, immunodeficiency"
  },
  {
    "rank": 289,
    "name": "Capecitabine",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Xeloda / Capecita / Xabine",
    "formation": "Oral fluoropyrimidine carbamate (prodrug of 5-FU)",
    "uses": "Metastatic colorectal cancer, breast cancer, gastric cancer",
    "adult": "1000â€“1250 mg/mÂ² BID for 14 days (21-day cycles)",
    "child": "Not recommended",
    "avoid": "DPD enzyme deficiency, severe renal impairment (CrCl <30)"
  },
  {
    "rank": 290,
    "name": "Tamoxifen Citrate",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Tamodex / Nolvadex / Tamoxifen",
    "formation": "Non-steroidal selective estrogen receptor modulator (SERM)",
    "uses": "Hormone receptor-positive breast cancer, breast cancer prevention",
    "adult": "20 mg OD for 5â€“10 years",
    "child": "Not recommended",
    "avoid": "History of DVT, pulmonary embolism, or stroke; anticoagulant use"
  },
  {
    "rank": 291,
    "name": "Anastrozole",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Arimidex / Anastrol / Anabrez",
    "formation": "Non-steroidal aromatase inhibitor (third-generation)",
    "uses": "Post-menopausal hormone receptor-positive breast cancer",
    "adult": "1 mg OD",
    "child": "Not recommended",
    "avoid": "Pre-menopausal women, osteoporosis (monitor BMD), pregnancy"
  },
  {
    "rank": 292,
    "name": "Erlotinib",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Tarceva / Erlonat / Erlotinib",
    "formation": "First-generation EGFR tyrosine kinase inhibitor",
    "uses": "EGFR-mutated NSCLC (exon 19 del / exon 21 L858R), pancreatic cancer",
    "adult": "150 mg OD (NSCLC); 100 mg OD (Pancreatic, with gemcitabine)",
    "child": "Not recommended",
    "avoid": "Interstitial lung disease, severe renal/hepatic impairment"
  },
  {
    "rank": 293,
    "name": "Gefitinib",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Iressa / Geftinat / Geftinib",
    "formation": "Selective EGFR-TKI (quinazoline derivative)",
    "uses": "EGFR-mutation positive NSCLC (first-line)",
    "adult": "250 mg OD",
    "child": "Not recommended",
    "avoid": "Interstitial lung disease, severe hepatic impairment"
  },
  {
    "rank": 294,
    "name": "Lenalidomide",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Revlimid / Lenalid / Lenalidomide",
    "formation": "Thalidomide analog â€“ immunomodulatory drug (IMiD)",
    "uses": "Multiple myeloma, myelodysplastic syndrome (del 5q), mantle cell lymphoma",
    "adult": "25 mg OD days 1â€“21 of 28-day cycle",
    "child": "Not recommended",
    "avoid": "Pregnancy (Category X â€“ highly teratogenic), DVT risk, severe renal failure"
  },
  {
    "rank": 295,
    "name": "Bortezomib",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Velcade / Bortecad / Bortenat",
    "formation": "Dipeptidyl boronic acid proteasome inhibitor",
    "uses": "Multiple myeloma, mantle cell lymphoma",
    "adult": "1.3 mg/mÂ² IV/SC (twice weekly Ã— 2 weeks in 21-day cycle)",
    "child": "Not established",
    "avoid": "Severe peripheral neuropathy, severe hepatic impairment"
  },
  {
    "rank": 296,
    "name": "Irinotecan HCl",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Campto / Irinotel / Irinotecan",
    "formation": "Topoisomerase I inhibitor (semisynthetic camptothecin)",
    "uses": "Metastatic colorectal cancer (FOLFIRI regimen), small cell lung cancer",
    "adult": "125 mg/mÂ² weekly Ã— 4 or 350 mg/mÂ² every 3 weeks",
    "child": "Protocol-based dosing under specialist guidance",
    "avoid": "Chronic inflammatory bowel disease, severe biliary obstruction, UGT1A1 deficiency"
  },
  {
    "rank": 297,
    "name": "Oxaliplatin",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Eloxatin / Oxalidem / Oxaliplatin",
    "formation": "Third-generation platinum complex (DNA cross-linking agent)",
    "uses": "Colorectal cancer (FOLFOX regimen), pancreatic cancer",
    "adult": "85 mg/mÂ² every 2 weeks or 130 mg/mÂ² every 3 weeks",
    "child": "Not recommended for routine use",
    "avoid": "Baseline peripheral sensory neuropathy, severe renal impairment"
  },
  {
    "rank": 298,
    "name": "Paclitaxel",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Taxol / Intaxel / Paclitaxel",
    "formation": "Taxane antimicrotubule agent (diterpene from Taxus brevifolia)",
    "uses": "Breast cancer, ovarian cancer, NSCLC, Kaposi's sarcoma",
    "adult": "135â€“175 mg/mÂ² IV every 3 weeks or 80 mg/mÂ²/week",
    "child": "Consult oncology (limited data)",
    "avoid": "Neutrophil count <1500 cells/mmÂ³, severe neuropathy, hypersensitivity to Cremophor EL"
  },
  {
    "rank": 299,
    "name": "Docetaxel",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Taxotere / Docefrez / Docepar",
    "formation": "Semi-synthetic taxane (antimitotic â€“ stabilizes microtubules)",
    "uses": "Breast cancer, prostate cancer, NSCLC, gastric cancer, HNSCC",
    "adult": "60â€“100 mg/mÂ² IV every 3 weeks",
    "child": "Not established",
    "avoid": "Neutrophil count <1500/mmÂ³, severe hepatic dysfunction"
  },
  {
    "rank": 300,
    "name": "Gemcitabine HCl",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Gemita / Gemtero / Gemcitabine",
    "formation": "Nucleoside analog (pyrimidine antimetabolite, pro-drug)",
    "uses": "Pancreatic cancer, NSCLC, breast cancer, ovarian cancer, bladder cancer",
    "adult": "1000â€“1250 mg/mÂ² IV over 30 min weekly",
    "child": "Not established",
    "avoid": "Concurrent radiation therapy (radiosensitization risk), severe renal failure"
  },
  {
    "rank": 301,
    "name": "Sorafenib",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Nexavar / Sorafenib / Sorafnat",
    "formation": "Multi-kinase inhibitor (Raf/VEGFR/PDGFR/c-KIT inhibitor)",
    "uses": "Hepatocellular carcinoma (HCC), renal cell carcinoma, differentiated thyroid cancer",
    "adult": "400 mg BID on empty stomach",
    "child": "Not recommended",
    "avoid": "Squamous cell lung cancer, severe hepatic impairment (Child-Pugh C)"
  },
  {
    "rank": 302,
    "name": "Sunitinib Malate",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Sutent / Sunitinib / Suni-50",
    "formation": "Multi-targeted receptor tyrosine kinase inhibitor (VEGFR/PDGFR/FLT3/c-KIT)",
    "uses": "Renal cell carcinoma, imatinib-resistant GIST, pNET",
    "adult": "50 mg OD (4 weeks on, 2 weeks off) or 37.5 mg OD continuous",
    "child": "Not recommended",
    "avoid": "Severe hepatic impairment, concurrent strong CYP3A4 inhibitors/inducers"
  },
  {
    "rank": 303,
    "name": "Bevacizumab (IV)",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Avastin / Bevatas / Bevacizumab",
    "formation": "Recombinant humanized anti-VEGF monoclonal antibody (IgG1)",
    "uses": "Metastatic colorectal cancer, NSCLC, glioblastoma, renal cell carcinoma",
    "adult": "5â€“15 mg/kg IV every 2â€“3 weeks (protocol-dependent)",
    "child": "Not established",
    "avoid": "Untreated brain metastases, uncontrolled hypertension, recent GI perforation, surgery within 28 days"
  },
  {
    "rank": 304,
    "name": "Rituximab",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Mabthera / Ristova / Rituximab",
    "formation": "Chimeric anti-CD20 monoclonal antibody (IgG1)",
    "uses": "Non-Hodgkin's lymphoma, CLL, RA, ANCA-associated vasculitis",
    "adult": "375 mg/mÂ² IV weekly Ã— 4 (NHL); 500â€“1000 mg IV (RA/vasculitis)",
    "child": "375 mg/mÂ² (mature B-cell NHL; specialist supervision)",
    "avoid": "Active severe infections, live virus vaccines, hepatitis B reactivation risk"
  },
  {
    "rank": 305,
    "name": "Trastuzumab",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Herceptin / Hertraz / Trastumab",
    "formation": "Recombinant humanized anti-HER2 monoclonal antibody (IgG1)",
    "uses": "HER2-positive early and metastatic breast cancer, HER2-positive gastric cancer",
    "adult": "8 mg/kg IV loading, then 6 mg/kg every 3 weeks",
    "child": "Not recommended",
    "avoid": "Severe cardiac dysfunction, baseline LVEF <50%, severe dyspnea"
  },
  {
    "rank": 306,
    "name": "Osimertinib",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Tagrisso / Osimertinib",
    "formation": "Third-generation EGFR-TKI (T790M-selective, irreversible)",
    "uses": "EGFR T790M mutation-positive NSCLC (1st and 2nd line); adjuvant use",
    "adult": "80 mg OD",
    "child": "Not recommended",
    "avoid": "QTc interval >470 ms, concurrent QT-prolonging drugs, severe hepatic impairment"
  },
  {
    "rank": 307,
    "name": "Pembrolizumab",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Keytruda / Pembrolizumab",
    "formation": "Anti-PD-1 humanized monoclonal antibody (immune checkpoint inhibitor)",
    "uses": "Melanoma, NSCLC, HNSCC, MSI-H solid tumors, classical Hodgkin lymphoma",
    "adult": "200 mg IV every 3 weeks or 400 mg every 6 weeks",
    "child": "2 mg/kg (â‰¥6y, max 200 mg) for classical Hodgkin lymphoma",
    "avoid": "Active autoimmune disease, organ transplant recipients, systemic immunosuppressants"
  },
  {
    "rank": 308,
    "name": "Nivolumab",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Opdivo / Nivolumab",
    "formation": "Human anti-PD-1 IgG4 monoclonal antibody",
    "uses": "Melanoma, NSCLC, RCC, urothelial carcinoma, HNSCC, ESCC",
    "adult": "240 mg IV every 2 weeks or 480 mg every 4 weeks",
    "child": "3 mg/kg IV every 2 weeks (specific malignancies; specialist guidance)",
    "avoid": "Active autoimmune disease, organ transplant, severe immune-mediated reactions"
  },
  {
    "rank": 309,
    "name": "Carboplatin",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Paraplatin / Kemocarb / Carbosynt",
    "formation": "Second-generation platinum complex (DNA cross-linking agent)",
    "uses": "Ovarian cancer, NSCLC, SCLC, head and neck cancer",
    "adult": "AUC 5â€“6 IV (Calvert formula) every 4 weeks",
    "child": "175â€“400 mg/mÂ² (protocol-based dosing)",
    "avoid": "Severe renal impairment, severe thrombocytopenia, hearing loss (ototoxicity risk)"
  },
  {
    "rank": 310,
    "name": "Cyclophosphamide",
    "section": "Section 8: Oncology & Immunology",
    "category": "Oncology",
    "schedule": "H",
    "brand": "Cycloxan / Endoxan / Cytoxan",
    "formation": "Nitrogen mustard alkylating agent (prodrug activated by CYP450)",
    "uses": "Breast cancer, lymphomas, leukemia, nephrotic syndrome, SLE",
    "adult": "50â€“100 mg/day (oral) or 500â€“1500 mg/mÂ² IV cyclical",
    "child": "1â€“5 mg/kg/day or protocol-based",
    "avoid": "Severe myelosuppression, urinary tract obstruction, active hemorrhagic cystitis"
  },
  {
    "rank": 311,
    "name": "Hydroxychloroquine Sulfate",
    "section": "Section 8: Oncology & Immunology",
    "category": "Immunology",
    "schedule": "H",
    "brand": "Hcqs / Plaquenil / Hydroxychloroquine",
    "formation": "4-aminoquinoline antimalarial and immunomodulatory agent",
    "uses": "Rheumatoid arthritis, SLE, Sjogren's syndrome, malaria prophylaxis",
    "adult": "200â€“400 mg/day (max 5 mg/kg/day ideal body weight)",
    "child": "3â€“5 mg/kg/day for juvenile RA",
    "avoid": "Pre-existing retinal disease, G6PD deficiency, QT prolongation history"
  },
  {
    "rank": 312,
    "name": "Sulfasalazine",
    "section": "Section 8: Oncology & Immunology",
    "category": "Immunology",
    "schedule": "H",
    "brand": "Saaz / Salazopyrin / Azulfidine",
    "formation": "Azo compound prodrug (5-ASA + sulfapyridine) â€“ DMARD",
    "uses": "Rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease",
    "adult": "500â€“1000 mg BIDâ€“TID (titrate to 2â€“3 g/day)",
    "child": "30â€“50 mg/kg/day in divided doses (JIA, UC)",
    "avoid": "Sulfonamide/salicylate hypersensitivity, G6PD deficiency, porphyria"
  },
  {
    "rank": 313,
    "name": "Leflunomide",
    "section": "Section 8: Oncology & Immunology",
    "category": "Immunology",
    "schedule": "H",
    "brand": "Arava / Lefno / Leflunomide",
    "formation": "Isoxazole immunosuppressant (DHODH inhibitor â€“ DMARD)",
    "uses": "Active rheumatoid arthritis, psoriatic arthritis",
    "adult": "100 mg OD loading Ã— 3 days, then 20 mg OD maintenance",
    "child": "Consult rheumatologist (limited evidence base)",
    "avoid": "Pregnancy (washout protocol required), severe hepatic impairment, immunodeficiency"
  },
  {
    "rank": 314,
    "name": "Mycophenolate Mofetil",
    "section": "Section 8: Oncology & Immunology",
    "category": "Immunology",
    "schedule": "H",
    "brand": "Cellcept / Mycophenol / Mofetil",
    "formation": "Prodrug of mycophenolic acid (IMPDH inhibitor)",
    "uses": "Prevention of organ transplant rejection, lupus nephritis, autoimmune diseases",
    "adult": "1â€“1.5 g BID",
    "child": "600 mg/mÂ² BID (renal transplant; â‰¥3 months)",
    "avoid": "Pregnancy (Category D), active serious GI disorders, live vaccines"
  },
  {
    "rank": 315,
    "name": "Tacrolimus (Systemic)",
    "section": "Section 8: Oncology & Immunology",
    "category": "Immunology",
    "schedule": "H",
    "brand": "Prograf / Tacromus / Pangraf",
    "formation": "Macrolide calcineurin inhibitor (FK506) â€“ systemic immunosuppressant",
    "uses": "Organ transplant rejection prevention, refractory nephrotic syndrome",
    "adult": "0.1â€“0.2 mg/kg/day in 2 divided doses (target trough 5â€“20 ng/mL)",
    "child": "0.15â€“0.3 mg/kg/day (higher clearance in pediatrics)",
    "avoid": "Concurrent ciclosporin, hypersensitivity to polyoxyl 60 hydrogenated castor oil"
  },
  {
    "rank": 316,
    "name": "Cyclosporine (Systemic)",
    "section": "Section 8: Oncology & Immunology",
    "category": "Immunology",
    "schedule": "H",
    "brand": "Sandimmun / Neoral / Panimun",
    "formation": "Cyclic undecapeptide calcineurin inhibitor",
    "uses": "Organ transplantation, psoriasis, RA, uveitis, nephrotic syndrome",
    "adult": "2.5â€“5 mg/kg/day in 2 divided doses (monitor renal function)",
    "child": "Weight-based dosing (similar to adult)",
    "avoid": "Uncontrolled hypertension, active infection, concurrent nephrotoxins"
  },
  {
    "rank": 317,
    "name": "Azathioprine",
    "section": "Section 8: Oncology & Immunology",
    "category": "Immunology",
    "schedule": "H",
    "brand": "Imuran / Azoran / Azathio",
    "formation": "Thiopurine immunosuppressant (6-mercaptopurine prodrug)",
    "uses": "RA, IBD, SLE, organ transplant rejection, autoimmune hepatitis",
    "adult": "1â€“3 mg/kg/day",
    "child": "1â€“2.5 mg/kg/day",
    "avoid": "TPMT enzyme deficiency, severe myelosuppression, pregnancy (relative)"
  },
  {
    "rank": 318,
    "name": "Tofacitinib",
    "section": "Section 8: Oncology & Immunology",
    "category": "Immunology",
    "schedule": "H",
    "brand": "Xeljanz / Tofacinat / Jakvinus",
    "formation": "Selective JAK1/JAK3 inhibitor (oral targeted DMARD)",
    "uses": "Rheumatoid arthritis, ulcerative colitis, psoriatic arthritis",
    "adult": "5 mg BID or 11 mg ER OD",
    "child": "Not approved for most indications",
    "avoid": "Active serious infection, malignancy history, thromboembolism risk"
  },
  {
    "rank": 319,
    "name": "Baricitinib",
    "section": "Section 8: Oncology & Immunology",
    "category": "Immunology",
    "schedule": "H",
    "brand": "Olumiant / Barinat / Baricitinib",
    "formation": "Selective JAK1/JAK2 inhibitor (oral small molecule)",
    "uses": "Moderate-to-severe RA, atopic dermatitis, severe COVID-19 (adjunct)",
    "adult": "2â€“4 mg OD",
    "child": "2 mg OD (atopic dermatitis â‰¥2y); not approved for RA",
    "avoid": "Active TB, severe infection, thrombosis history"
  },
  {
    "rank": 320,
    "name": "Upadacitinib",
    "section": "Section 8: Oncology & Immunology",
    "category": "Immunology",
    "schedule": "H",
    "brand": "Rinvoq / Upadacitinib",
    "formation": "Selective JAK1 inhibitor (oral DMARD)",
    "uses": "Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, atopic dermatitis",
    "adult": "15â€“30 mg OD (indication-dependent)",
    "child": "Not approved",
    "avoid": "Active serious infection, thromboembolism risk, malignancy"
  },
  {
    "rank": 321,
    "name": "Secukinumab",
    "section": "Section 8: Oncology & Immunology",
    "category": "Immunology",
    "schedule": "H",
    "brand": "Cosentyx / Secukinumab",
    "formation": "Fully human anti-IL-17A monoclonal antibody (IgG1/Îº)",
    "uses": "Plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, nr-axSpA",
    "adult": "300 mg SC (psoriasis) / 150 mg SC (PsA/AS) monthly after loading",
    "child": "75â€“150 mg SC (psoriasis â‰¥6y)",
    "avoid": "Active Crohn's disease, active serious infection, live vaccines"
  },
  {
    "rank": 322,
    "name": "Adalimumab",
    "section": "Section 8: Oncology & Immunology",
    "category": "Immunology",
    "schedule": "H",
    "brand": "Humira / Exemptia / Adalimumab",
    "formation": "Fully human anti-TNF-Î± monoclonal antibody",
    "uses": "RA, Crohn's disease, plaque psoriasis, ankylosing spondylitis, JIA",
    "adult": "40 mg SC every 2 weeks (RA/PsA); 80 then 40 mg biweekly (Crohn's)",
    "child": "24 mg/mÂ² (max 40 mg) SC every 2 weeks (JIA â‰¥2y)",
    "avoid": "Active TB/serious infections, demyelinating disease, CHF (NYHA III/IV)"
  },
  {
    "rank": 323,
    "name": "Etanercept",
    "section": "Section 8: Oncology & Immunology",
    "category": "Immunology",
    "schedule": "H",
    "brand": "Enbrel / Etacept / Etanercept",
    "formation": "Dimeric fusion protein (TNF receptor + IgG1 Fc â€“ soluble TNF decoy)",
    "uses": "RA, juvenile idiopathic arthritis, psoriatic arthritis, plaque psoriasis",
    "adult": "25 mg SC twice weekly or 50 mg once weekly",
    "child": "0.4â€“0.8 mg/kg (max 50 mg) SC weekly (JIA â‰¥2y)",
    "avoid": "Active serious infection, sepsis, demyelinating disease"
  },
  {
    "rank": 324,
    "name": "Infliximab",
    "section": "Section 8: Oncology & Immunology",
    "category": "Immunology",
    "schedule": "H",
    "brand": "Remicade / Infimab / Inflectra",
    "formation": "Chimeric anti-TNF-Î± monoclonal antibody (IgG1 â€“ 25% murine)",
    "uses": "RA, Crohn's disease, UC, psoriasis, ankylosing spondylitis",
    "adult": "3â€“10 mg/kg IV infusion at 0, 2, 6 weeks; then every 8 weeks",
    "child": "5 mg/kg IV (Crohn's, UC; â‰¥6y)",
    "avoid": "Active infection, CHF (NYHA III/IV), demyelinating disorders"
  },
  {
    "rank": 325,
    "name": "Abatacept",
    "section": "Section 8: Oncology & Immunology",
    "category": "Immunology",
    "schedule": "H",
    "brand": "Orencia / Abatacept",
    "formation": "Selective T-cell co-stimulation modulator (CTLA4-Ig fusion protein)",
    "uses": "Moderate-to-severe RA (inadequate response to MTX or TNF inhibitors)",
    "adult": "<60 kg: 500 mg; 60â€“100 kg: 750 mg; >100 kg: 1000 mg IV monthly",
    "child": "10 mg/kg IV (JIA â‰¥6y, max 1000 mg)",
    "avoid": "Active serious infection, COPD (worsens), live vaccines within 3 months"
  },
  {
    "rank": 326,
    "name": "Tiotropium Bromide",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Spiriva / Tiova / Tiotropium",
    "formation": "Long-acting muscarinic antagonist (LAMA) anticholinergic inhaler",
    "uses": "COPD maintenance, reduction of exacerbation frequency",
    "adult": "18 mcg OD (HandiHaler) or 5 mcg OD (Respimat)",
    "child": "Not recommended",
    "avoid": "Narrow-angle glaucoma, urinary retention, severe renal impairment"
  },
  {
    "rank": 327,
    "name": "Salmeterol + Fluticasone Propionate",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Seroflo / Advair / Foxair",
    "formation": "LABA (long-acting beta2-agonist) + ICS (inhaled corticosteroid)",
    "uses": "Asthma maintenance, symptomatic COPD",
    "adult": "50/100â€“500 mcg BID via inhaler",
    "child": "50/100 mcg BID (approved â‰¥4y)",
    "avoid": "Acute severe asthma attacks, LABA monotherapy in uncontrolled asthma"
  },
  {
    "rank": 328,
    "name": "Umeclidinium + Vilanterol",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Anoro Ellipta / Umeclidinium-Vilanterol",
    "formation": "LAMA + LABA dual bronchodilator (fixed-dose inhaler)",
    "uses": "COPD maintenance therapy (no ICS component)",
    "adult": "62.5/25 mcg OD via Ellipta inhaler",
    "child": "Not recommended",
    "avoid": "Narrow-angle glaucoma, urinary retention, asthma without ICS"
  },
  {
    "rank": 329,
    "name": "Indacaterol + Glycopyrronium",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Ultibro Breezhaler / QVA149",
    "formation": "LABA + LAMA fixed-dose combination bronchodilator",
    "uses": "COPD maintenance (GOLD grade 2â€“4)",
    "adult": "110/50 mcg OD via Breezhaler capsule",
    "child": "Not recommended",
    "avoid": "Severe heart disease, narrow-angle glaucoma, urinary retention"
  },
  {
    "rank": 330,
    "name": "Beclomethasone Dipropionate (Inhaled)",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Beclate / Becotide / Clenil",
    "formation": "Second-generation halogenated inhaled corticosteroid (MDI)",
    "uses": "Prophylaxis of asthma, inhaled maintenance anti-inflammatory therapy",
    "adult": "100â€“400 mcg BID via MDI",
    "child": "50â€“200 mcg BID (approved â‰¥5y)",
    "avoid": "Status asthmaticus, acute asthma attack, active pulmonary tuberculosis"
  },
  {
    "rank": 331,
    "name": "Ciclesonide (Inhaled)",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Alvesco / Omnaris / Ciclesonide inhaler",
    "formation": "Prodrug ICS (activated to des-ciclesonide in the airways)",
    "uses": "Asthma prophylaxis, mild-to-moderate COVID-19 early treatment (investigational)",
    "adult": "80â€“320 mcg ODâ€“BID via MDI",
    "child": "80 mcg BID (approved â‰¥6y)",
    "avoid": "Acute asthma attacks, active or latent pulmonary tuberculosis"
  },
  {
    "rank": 332,
    "name": "Theophylline",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Theo-Asthalin / Elixophyllin / Uniphyllin",
    "formation": "Methylxanthine bronchodilator (phosphodiesterase inhibitor)",
    "uses": "Asthma (add-on therapy), COPD, neonatal apnea of prematurity",
    "adult": "300â€“600 mg/day ER; target serum level 8â€“12 mcg/mL",
    "child": "5â€“10 mg/kg/day divided (neonatal apnea: 1â€“2 mg/kg BID)",
    "avoid": "Concurrent quinolone/macrolide antibiotics (toxicity risk), active peptic ulcer, seizure disorder"
  },
  {
    "rank": 333,
    "name": "Doxofylline",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Xanthium / Doxovent / Doxofyllin",
    "formation": "7-(1,3-dioxolan-2-ylmethyl)theophylline (methylxanthine with fewer side effects)",
    "uses": "Mild-to-moderate asthma, COPD (better GI and cardiac tolerability than theophylline)",
    "adult": "400 mg BID or TID",
    "child": "6â€“8 mg/kg BID",
    "avoid": "Acute MI, active peptic ulcer, severe hypotension"
  },
  {
    "rank": 334,
    "name": "Aminophylline",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Aminophylline Inj / Aminophylline",
    "formation": "Theophylline ethylenediamine complex (IV bronchodilator)",
    "uses": "Acute severe asthma, acute COPD exacerbation (IV use)",
    "adult": "5 mg/kg IV loading over 30 min, then 0.5â€“1 mg/kg/hr maintenance",
    "child": "5 mg/kg IV loading, then 0.7â€“1 mg/kg/hr",
    "avoid": "Concurrent oral theophylline therapy, severe cardiac arrhythmia"
  },
  {
    "rank": 335,
    "name": "Roflumilast",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Daxas / Libertas / Roflumilast",
    "formation": "Selective PDE4 inhibitor (oral anti-inflammatory for COPD)",
    "uses": "COPD (GOLD D) with chronic bronchitis and frequent exacerbations",
    "adult": "500 mcg OD (with food to reduce GI effects)",
    "child": "Not recommended",
    "avoid": "Severe hepatic impairment (Child-Pugh B/C), depression/suicidal history"
  },
  {
    "rank": 336,
    "name": "N-Acetylcysteine (NAC)",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Fluimucil / Mucomyst / Acetylcysteine",
    "formation": "Cysteine derivative (glutathione precursor and mucolytic)",
    "uses": "COPD mucolytic, paracetamol overdose antidote, contrast nephropathy prevention",
    "adult": "600 mg ODâ€“BID (mucolytic); 150 mg/kg IV (paracetamol overdose antidote)",
    "child": "100 mg BID (mucolytic); weight-based IV protocol (overdose antidote)",
    "avoid": "Active bronchospasm (may worsen asthma), known hypersensitivity"
  },
  {
    "rank": 337,
    "name": "Ambroxol HCl",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Ambrodil / Mucosolvan / Ambrox",
    "formation": "Active metabolite of bromhexine (mucokinetic secretolytic agent)",
    "uses": "Acute and chronic bronchopulmonary diseases with viscous mucus hypersecretion",
    "adult": "30 mg TID or 75 mg SR OD",
    "child": "1.2â€“1.6 mg/kg/day in 2â€“3 divided doses",
    "avoid": "Rare hereditary galactose intolerance (formulation-specific)"
  },
  {
    "rank": 338,
    "name": "Bromhexine HCl",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Bisolvon / Bisolvin / Bromhexine",
    "formation": "Synthetic derivative of vasicine (mucolytic expectorant)",
    "uses": "Productive cough with viscous mucus, chronic bronchitis, bronchiectasis",
    "adult": "8â€“16 mg TID",
    "child": "4 mg TID (6â€“12y); 2 mg TID (<6y)",
    "avoid": "Active peptic ulcer, hereditary fructose intolerance"
  },
  {
    "rank": 339,
    "name": "Levosalbutamol (Levalbuterol)",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Levolin / Asthavent-L / Levalbuterol",
    "formation": "R-enantiomer of salbutamol (selective beta2-agonist with less cardiac stimulation)",
    "uses": "Bronchospasm in asthma and COPD (fewer cardiac side effects than racemic salbutamol)",
    "adult": "45â€“90 mcg (0.63â€“1.25 mg) via nebulizer TIDâ€“QID PRN",
    "child": "0.31â€“0.63 mg nebulized TID",
    "avoid": "Cardiac arrhythmias, tachycardia, severe hypertension"
  },
  {
    "rank": 340,
    "name": "Guaifenesin",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Respiratory",
    "schedule": "OTC",
    "brand": "Mucinex / Grilinctus-SF / Robitussin",
    "formation": "Glycerol guaiacolate (expectorant â€“ reduces mucus viscosity)",
    "uses": "Productive cough, chest congestion in upper and lower respiratory tract infections",
    "adult": "200â€“400 mg every 4 hrs (max 2400 mg/day)",
    "child": "50â€“100 mg every 4 hrs (2â€“12y)",
    "avoid": "Persistent or chronic cough without diagnosis, cough with haemoptysis"
  },
  {
    "rank": 341,
    "name": "Xylometazoline HCl",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "ENT",
    "schedule": "OTC",
    "brand": "Otrivin / Nasivion / Xylomist",
    "formation": "Imidazoline alpha-adrenergic agonist (topical nasal decongestant)",
    "uses": "Nasal congestion due to rhinitis, sinusitis, common cold",
    "adult": "0.1% spray: 2â€“3 drops/sprays each nostril TID (max 5 days)",
    "child": "0.05% (2â€“12y); 0.025% (<2y, under medical guidance)",
    "avoid": "Atrophic rhinitis, concurrent MAOI use, >5 days use (rebound congestion)"
  },
  {
    "rank": 342,
    "name": "Oxymetazoline HCl",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "ENT",
    "schedule": "OTC",
    "brand": "Nasivion / Afrin / Nasifit",
    "formation": "Imidazoline sympathomimetic amine (long-acting nasal decongestant)",
    "uses": "Nasal and sinus congestion, allergic rhinitis, sinusitis",
    "adult": "0.05% two sprays per nostril BID (12-hr; max 3 days)",
    "child": "0.025% (2â€“5y); 0.05% (â‰¥6y)",
    "avoid": "Atrophic rhinitis, hypertension, MAOI use (14-day washout required)"
  },
  {
    "rank": 343,
    "name": "Budesonide (Nasal Spray)",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "ENT",
    "schedule": "H",
    "brand": "Rhinocort / Rhinobudez / Budesonide Nasal",
    "formation": "Non-halogenated topical glucocorticoid (nasal formulation)",
    "uses": "Seasonal and perennial allergic rhinitis, nasal polyps",
    "adult": "64â€“256 mcg (2â€“4 sprays) ODâ€“BID per nostril",
    "child": "32â€“64 mcg (1â€“2 sprays) OD (â‰¥6y)",
    "avoid": "Nasal septum perforation, active epistaxis, untreated nasal infections"
  },
  {
    "rank": 344,
    "name": "Fluticasone Propionate (Nasal Spray)",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "ENT",
    "schedule": "H",
    "brand": "Flixonase / Nasoflo / Flutinose",
    "formation": "Synthetic trifluorinated corticosteroid (nasal spray)",
    "uses": "Seasonal and perennial allergic rhinitis, chronic sinusitis",
    "adult": "100 mcg (2 sprays) per nostril OD (or 50 mcg each nostril BID)",
    "child": "50 mcg (1 spray) per nostril OD (â‰¥4y)",
    "avoid": "Recent nasal surgery, nasal septum deviation/perforation"
  },
  {
    "rank": 345,
    "name": "Azelastine HCl (Nasal Spray)",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "ENT",
    "schedule": "H",
    "brand": "Astelin / Azep / Azelastin nasal",
    "formation": "Phthalazinone H1-receptor antagonist (topical nasal antihistamine)",
    "uses": "Seasonal and perennial allergic rhinitis, vasomotor rhinitis",
    "adult": "1â€“2 sprays per nostril BID",
    "child": "1 spray per nostril BID (5â€“11y); 2 sprays (â‰¥12y)",
    "avoid": "Hypersensitivity to azelastine, avoid driving after intranasal use (drowsiness)"
  },
  {
    "rank": 346,
    "name": "Ipratropium Bromide (Nasal Spray)",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "ENT",
    "schedule": "H",
    "brand": "Ipravent Nasal / Atrovent Nasal",
    "formation": "Quaternary ammonium anticholinergic (nasal anticholinergic)",
    "uses": "Rhinorrhea in perennial rhinitis, post-infectious rhinitis",
    "adult": "0.03% two sprays per nostril BIDâ€“TID",
    "child": "0.03% (â‰¥5y); same dosing",
    "avoid": "Narrow-angle glaucoma, urinary retention, soy/peanut allergy (CFC-free)"
  },
  {
    "rank": 347,
    "name": "Cetirizine HCl",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Antiallergic",
    "schedule": "H",
    "brand": "Cetzine / Zyrtec / Alerid",
    "formation": "Racemic piperazine carboxylate H1-antihistamine (second-generation)",
    "uses": "Perennial and seasonal allergic rhinitis, chronic idiopathic urticaria",
    "adult": "10 mg OD",
    "child": "5 mg OD (6â€“11y); 2.5 mg OD (2â€“5y)",
    "avoid": "End-stage renal disease (CrCl <10 mL/min), concurrent CNS depressants"
  },
  {
    "rank": 348,
    "name": "Fexofenadine HCl",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Antiallergic",
    "schedule": "H",
    "brand": "Allegra / Fexova / Telfast",
    "formation": "Carboxylate active metabolite of terfenadine (H1-antihistamine)",
    "uses": "Seasonal allergic rhinitis, chronic idiopathic urticaria",
    "adult": "120â€“180 mg OD",
    "child": "30 mg BID (2â€“11y); 60 mg BID (â‰¥12y)",
    "avoid": "Severe renal impairment (dose reduction needed), concurrent antacids (Al/Mg)"
  },
  {
    "rank": 349,
    "name": "Loratadine",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Antiallergic",
    "schedule": "OTC",
    "brand": "Lorfast / Clarityn / Loratadine",
    "formation": "Piperidine-type long-acting non-sedating antihistamine (H1-blocker)",
    "uses": "Allergic rhinitis, urticaria",
    "adult": "10 mg OD",
    "child": "5 mg OD (2â€“12y, <30 kg); 10 mg OD (>30 kg)",
    "avoid": "Severe hepatic impairment (dose adjustment or avoid)"
  },
  {
    "rank": 350,
    "name": "Desloratadine",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Antiallergic",
    "schedule": "H",
    "brand": "Neoclarityn / Deslor / Desloratadine",
    "formation": "Active metabolite of loratadine (non-sedating H1-antagonist)",
    "uses": "Seasonal and perennial allergic rhinitis, chronic idiopathic urticaria",
    "adult": "5 mg OD",
    "child": "1.25 mg OD (1â€“5y); 2.5 mg OD (6â€“11y)",
    "avoid": "Severe renal impairment, galactose intolerance"
  },
  {
    "rank": 351,
    "name": "Chlorpheniramine Maleate",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Antiallergic",
    "schedule": "OTC",
    "brand": "Piriton / Allercet / Chlor-Trimeton",
    "formation": "Propylamine-type first-generation H1-antihistamine",
    "uses": "Allergic rhinitis, urticaria, common cold, anaphylaxis (adjunct)",
    "adult": "4 mg every 4â€“6 hrs (max 24 mg/day)",
    "child": "0.1 mg/kg/dose every 6 hrs (â‰¥2y)",
    "avoid": "Narrow-angle glaucoma, urinary retention, concurrent CNS depressants"
  },
  {
    "rank": 352,
    "name": "Montelukast",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Antiallergic",
    "schedule": "H",
    "brand": "Montair / Singulair / Montek",
    "formation": "Cysteinyl leukotriene receptor (CysLT1) antagonist",
    "uses": "Seasonal allergic rhinitis, mild persistent asthma prophylaxis",
    "adult": "10 mg OD (bedtime)",
    "child": "4 mg (2â€“5y); 5 mg (6â€“14y); 10 mg (â‰¥15y)",
    "avoid": "Acute asthma attacks, neuropsychiatric adverse events (monitor closely)"
  },
  {
    "rank": 353,
    "name": "Ketotifen",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Antiallergic",
    "schedule": "H",
    "brand": "Zaditen / Ketotifen / Kelast",
    "formation": "Benzocycloheptathiophene (mast cell stabilizer + H1-receptor antagonist)",
    "uses": "Prophylaxis of asthma, allergic rhinitis, atopic dermatitis",
    "adult": "1â€“2 mg BID",
    "child": "0.5â€“1 mg BID (â‰¥3y)",
    "avoid": "Concurrent oral hypoglycemic drugs (thrombocytopenia risk), drowsiness warning"
  },
  {
    "rank": 354,
    "name": "Rupatadine",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Antiallergic",
    "schedule": "H",
    "brand": "Rupanex / Rupatadine / Pafinur",
    "formation": "Dual H1 and PAF (platelet-activating factor) receptor antagonist",
    "uses": "Seasonal and perennial allergic rhinitis, chronic urticaria",
    "adult": "10 mg OD",
    "child": "2.5â€“5 mg OD (â‰¥2y)",
    "avoid": "Severe hepatic/renal impairment, concurrent CYP3A4 inhibitors"
  },
  {
    "rank": 355,
    "name": "Bilastine",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Antiallergic",
    "schedule": "H",
    "brand": "Bilistin / Bilaxten / Bilastine",
    "formation": "Piperidine non-sedating H1-antihistamine (benzimidazole derivative)",
    "uses": "Allergic rhinoconjunctivitis, chronic urticaria",
    "adult": "20 mg OD (on empty stomach)",
    "child": "10 mg OD (4â€“11y, weight >20 kg); 20 mg (â‰¥12y)",
    "avoid": "Severe renal impairment (reduce dose), concurrent P-gp inhibitors"
  },
  {
    "rank": 356,
    "name": "Omalizumab",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Antiallergic",
    "schedule": "H",
    "brand": "Xolair / Omab / Omalizumab",
    "formation": "Recombinant humanized anti-IgE monoclonal antibody",
    "uses": "Moderate-to-severe allergic asthma (uncontrolled), chronic urticaria",
    "adult": "150â€“375 mg SC every 2â€“4 weeks (dose based on serum IgE level and weight)",
    "child": "â‰¥6y (asthma): 75â€“375 mg SC every 2â€“4 weeks",
    "avoid": "Acute asthma exacerbation, anaphylaxis history (observe post-injection)"
  },
  {
    "rank": 357,
    "name": "Pirfenidone",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Esbriet / Pirfenidone / Pirespa",
    "formation": "Pyridinone antifibrotic agent (TGF-Î², TNF-Î±, and PDGF inhibitor)",
    "uses": "Idiopathic pulmonary fibrosis (IPF) â€“ slows disease progression",
    "adult": "267 mg TID (wk 1â€“2), 534 mg TID (wk 3â€“4), 801 mg TID (wk â‰¥5)",
    "child": "Not recommended",
    "avoid": "Severe hepatic impairment, concurrent fluvoxamine, photosensitivity (sunscreen essential)"
  },
  {
    "rank": 358,
    "name": "Nintedanib Esylate",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Ofev / Nintedanib / Vargatef",
    "formation": "Triple kinase inhibitor (VEGFR, FGFR, PDGFR) â€“ antifibrotic",
    "uses": "Idiopathic pulmonary fibrosis (IPF), systemic sclerosis-ILD, other fibrosing ILDs",
    "adult": "150 mg BID (with food)",
    "child": "Not recommended",
    "avoid": "Severe hepatic impairment (Child-Pugh B/C), concurrent anticoagulants (bleeding risk)"
  },
  {
    "rank": 359,
    "name": "Erdosteine",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Erdotin / Erdos / Orcerin",
    "formation": "Thiol derivative mucolytic agent (indirect mucokinetic)",
    "uses": "Chronic obstructive pulmonary disease, chronic bronchitis",
    "adult": "300 mg BIDâ€“TID",
    "child": "Consult specialist (limited data)",
    "avoid": "Cystinuria, homocystinuria, active peptic ulcer"
  },
  {
    "rank": 360,
    "name": "Carbocisteine",
    "section": "Section 9: Respiratory, Allergy & ENT",
    "category": "Respiratory",
    "schedule": "H",
    "brand": "Solmux / Mucodyne / Carbocisteine",
    "formation": "S-carboxymethylcysteine (mucoregulatory agent â€“ modifies mucus glycoproteins)",
    "uses": "Respiratory tract hypersecretion, COPD, chronic bronchitis",
    "adult": "750 mg TID initially, reduce to 500 mg TID",
    "child": "62.5â€“125 mg TID (2â€“12y)",
    "avoid": "Active peptic ulceration, first trimester of pregnancy"
  },
  {
    "rank": 361,
    "name": "Tamsulosin HCl",
    "section": "Section 10: Specialty & Emerging",
    "category": "Urology",
    "schedule": "H",
    "brand": "Urimax / Flomax / Tamsulosin",
    "formation": "Selective alpha1A/1D-adrenergic receptor blocker (uroselective)",
    "uses": "Benign prostatic hyperplasia (BPH), ureteral calculi expulsion (medical expulsion therapy)",
    "adult": "0.4 mg OD (30 min after breakfast)",
    "child": "Not recommended",
    "avoid": "Orthostatic hypotension, concurrent PDE5 inhibitors, sulfa drug allergy"
  },
  {
    "rank": 362,
    "name": "Alfuzosin HCl",
    "section": "Section 10: Specialty & Emerging",
    "category": "Urology",
    "schedule": "H",
    "brand": "Xatral / Alfoo / Alfuzosin",
    "formation": "Quinazolinamine selective alpha1-adrenergic receptor blocker",
    "uses": "Symptomatic BPH, ureteral stone passage",
    "adult": "2.5 mg TID or 10 mg XR OD (after dinner)",
    "child": "Not recommended",
    "avoid": "Severe hepatic impairment, orthostatic hypotension, QT prolongation"
  },
  {
    "rank": 363,
    "name": "Solifenacin Succinate",
    "section": "Section 10: Specialty & Emerging",
    "category": "Urology",
    "schedule": "H",
    "brand": "Vesicare / Soliflow / Urifit",
    "formation": "Selective M3 muscarinic receptor antagonist",
    "uses": "Overactive bladder (urgency urinary incontinence, frequency)",
    "adult": "5â€“10 mg OD",
    "child": "Not recommended",
    "avoid": "Urinary retention, narrow-angle glaucoma, severe GI motility disorder"
  },
  {
    "rank": 364,
    "name": "Oxybutynin Chloride",
    "section": "Section 10: Specialty & Emerging",
    "category": "Urology",
    "schedule": "H",
    "brand": "Ditropan / Oxytrol / Cyspas",
    "formation": "Tertiary amine anticholinergic + smooth muscle relaxant",
    "uses": "Overactive bladder, neurogenic bladder, nocturnal enuresis",
    "adult": "5 mg BIDâ€“TID or 5â€“15 mg/day (ER)",
    "child": "0.2 mg/kg BIDâ€“TID (â‰¥5y)",
    "avoid": "Urinary retention, GI obstruction, myasthenia gravis, uncontrolled glaucoma"
  },
  {
    "rank": 365,
    "name": "Mirabegron",
    "section": "Section 10: Specialty & Emerging",
    "category": "Urology",
    "schedule": "H",
    "brand": "Betmiga / Myrbetriq / Mirabegron",
    "formation": "Beta-3 adrenergic receptor agonist (non-antimuscarinic OAB agent)",
    "uses": "Overactive bladder (urgency, incontinence) â€“ alternative when antimuscarinics are not tolerated",
    "adult": "25â€“50 mg OD",
    "child": "Not approved for adults <18y",
    "avoid": "Severe uncontrolled hypertension (SBP â‰¥180 mmHg), severe renal impairment (25 mg only)"
  },
  {
    "rank": 366,
    "name": "Tolterodine Tartrate",
    "section": "Section 10: Specialty & Emerging",
    "category": "Urology",
    "schedule": "H",
    "brand": "Detrol / Tolterol / Tolterodine",
    "formation": "Muscarinic receptor antagonist (bladder-selective profile)",
    "uses": "Overactive bladder (OAB) with urge incontinence",
    "adult": "2 mg BID or 4 mg ER OD",
    "child": "Not recommended",
    "avoid": "Urinary retention, gastric retention, narrow-angle glaucoma"
  },
  {
    "rank": 367,
    "name": "Tadalafil",
    "section": "Section 10: Specialty & Emerging",
    "category": "Urology",
    "schedule": "H",
    "brand": "Megalis / Cialis / Forzest",
    "formation": "Long-acting phosphodiesterase-5 (PDE5) inhibitor",
    "uses": "Erectile dysfunction, BPH symptoms, pulmonary arterial hypertension",
    "adult": "10â€“20 mg PRN (ED); 5 mg OD (BPH/daily ED); 40 mg OD (PAH)",
    "child": "Not recommended",
    "avoid": "Concurrent nitrate use, severe hypotension, LVOT obstruction, severe renal/hepatic disease"
  },
  {
    "rank": 368,
    "name": "Dutasteride + Tamsulosin",
    "section": "Section 10: Specialty & Emerging",
    "category": "Urology",
    "schedule": "H",
    "brand": "Duodart / Combodart / Dynapress",
    "formation": "Dual 5-alpha-reductase inhibitor + uroselective alpha1-blocker combination",
    "uses": "Moderate-to-severe symptomatic BPH requiring combination therapy",
    "adult": "Dutasteride 0.5 mg + Tamsulosin 0.4 mg OD",
    "child": "Not recommended",
    "avoid": "Women (especially pregnant), severe hepatic impairment, severe orthostatic hypotension"
  },
  {
    "rank": 369,
    "name": "Phenazopyridine HCl",
    "section": "Section 10: Specialty & Emerging",
    "category": "Urology",
    "schedule": "H",
    "brand": "Pyridium / Uristat / Phenazopyridine",
    "formation": "Azo dye (urinary tract analgesic â€“ not an antibiotic)",
    "uses": "Symptomatic relief of burning, urgency, and pain in UTI (adjunct to antibiotic)",
    "adult": "200 mg TID after meals (max 2 days)",
    "child": "4 mg/kg TID (â‰¥6y)",
    "avoid": "Hepatic impairment, renal failure (orange/red urine discoloration â€“ inform patient)"
  },
  {
    "rank": 370,
    "name": "Bethanechol Chloride",
    "section": "Section 10: Specialty & Emerging",
    "category": "Urology",
    "schedule": "H",
    "brand": "Myotonine / Urecholine / Bethacol",
    "formation": "Synthetic carbamate choline ester (direct muscarinic cholinergic agonist)",
    "uses": "Neurogenic bladder, postoperative urinary retention, GERD adjunct",
    "adult": "10â€“50 mg TIDâ€“QID",
    "child": "0.3â€“0.6 mg/kg/day in 3â€“4 divided doses",
    "avoid": "Asthma, bradycardia, hypotension, GI/bladder obstruction, peptic ulcer"
  },
  {
    "rank": 371,
    "name": "Alendronate Sodium",
    "section": "Section 10: Specialty & Emerging",
    "category": "Rheumatology",
    "schedule": "H",
    "brand": "Osteofos / Fosamax / Alendromax",
    "formation": "Aminobisphosphonate (nitrogen-containing â€“ osteoclast inhibitor)",
    "uses": "Osteoporosis, glucocorticoid-induced osteoporosis, Paget's disease of bone",
    "adult": "10 mg OD or 70 mg once weekly (fasting, plain water, upright 30 min)",
    "child": "Not recommended",
    "avoid": "Hypocalcemia, esophageal abnormalities, inability to sit or stand upright for 30 min"
  },
  {
    "rank": 372,
    "name": "Zoledronic Acid",
    "section": "Section 10: Specialty & Emerging",
    "category": "Rheumatology",
    "schedule": "H",
    "brand": "Zometa / Aclasta / Zoledronate",
    "formation": "Imidazole bisphosphonate (intravenous â€“ most potent bisphosphonate)",
    "uses": "Osteoporosis, hypercalcemia of malignancy, Paget's disease, bone metastases",
    "adult": "4 mg IV once (oncology) or 5 mg IV once yearly (osteoporosis)",
    "child": "0.025â€“0.05 mg/kg IV (osteogenesis imperfecta; specialist supervised)",
    "avoid": "Severe renal impairment (CrCl <35 mL/min), hypocalcemia, osteonecrosis of jaw risk"
  },
  {
    "rank": 373,
    "name": "Teriparatide",
    "section": "Section 10: Specialty & Emerging",
    "category": "Rheumatology",
    "schedule": "H",
    "brand": "Forsteo / Osteoace / Teribone",
    "formation": "Recombinant human PTH 1â€“34 (anabolic bone-forming agent)",
    "uses": "Severe osteoporosis at high fracture risk, glucocorticoid-induced osteoporosis",
    "adult": "20 mcg SC OD (maximum 2 years lifetime use)",
    "child": "Not recommended",
    "avoid": "Prior radiation to skeleton, Paget's disease, bone malignancy, hypercalcemia"
  },
  {
    "rank": 374,
    "name": "Denosumab",
    "section": "Section 10: Specialty & Emerging",
    "category": "Rheumatology",
    "schedule": "H",
    "brand": "Prolia / Xgeva / Denosumab",
    "formation": "Human anti-RANKL monoclonal antibody (bone resorption inhibitor)",
    "uses": "Postmenopausal osteoporosis, bone metastases (solid tumors), GCTB",
    "adult": "60 mg SC every 6 months (Prolia); 120 mg SC every 4 weeks (Xgeva)",
    "child": "Consult specialist for Xgeva; Prolia not for pediatrics",
    "avoid": "Hypocalcemia, osteonecrosis of jaw risk (dental check prior to treatment)"
  },
  {
    "rank": 375,
    "name": "Colchicine",
    "section": "Section 10: Specialty & Emerging",
    "category": "Rheumatology",
    "schedule": "H",
    "brand": "Colchicine / Colmibe / Zycolchine",
    "formation": "Alkaloid from Colchicum autumnale (anti-tubulin, anti-inflammatory)",
    "uses": "Acute gout attack, FMF (Familial Mediterranean Fever) prophylaxis, pericarditis",
    "adult": "1â€“1.2 mg stat, then 0.5â€“0.6 mg every 1â€“2 hrs (acute gout, max 6 mg/course)",
    "child": "0.3â€“1.8 mg/day (FMF â‰¥5y)",
    "avoid": "Severe renal/hepatic impairment, concurrent strong CYP3A4 inhibitors (clarithromycin etc.)"
  },
  {
    "rank": 376,
    "name": "Allopurinol",
    "section": "Section 10: Specialty & Emerging",
    "category": "Rheumatology",
    "schedule": "H",
    "brand": "Zyloric / Lopurin / Allopurinol",
    "formation": "Hypoxanthine analog (xanthine oxidase inhibitor â€“ urate-lowering agent)",
    "uses": "Chronic gout and hyperuricemia, tumor lysis syndrome prevention",
    "adult": "100â€“300 mg OD (after meals; titrate to serum urate <6 mg/dL)",
    "child": "100â€“300 mg/day (tumor lysis syndrome)",
    "avoid": "Allopurinol hypersensitivity syndrome, azathioprine/6-MP without dose reduction"
  },
  {
    "rank": 377,
    "name": "Febuxostat",
    "section": "Section 10: Specialty & Emerging",
    "category": "Rheumatology",
    "schedule": "H",
    "brand": "Febustat / Zurig / Fequin",
    "formation": "Non-purine selective xanthine oxidase inhibitor",
    "uses": "Hyperuricemia in gout (when allopurinol is contraindicated or not tolerated)",
    "adult": "40â€“80 mg OD",
    "child": "Not recommended",
    "avoid": "Cardiovascular disease (higher CV risk vs allopurinol), concurrent azathioprine/6-MP"
  },
  {
    "rank": 378,
    "name": "Indomethacin",
    "section": "Section 10: Specialty & Emerging",
    "category": "Rheumatology",
    "schedule": "H",
    "brand": "Indocap / Indocin / Indomethacin",
    "formation": "Indole acetic acid derivative (potent non-selective NSAID/COX inhibitor)",
    "uses": "Acute gout attack, ankylosing spondylitis, pericarditis, PDA closure (neonatal)",
    "adult": "25â€“50 mg TID or 75â€“100 mg SR OD",
    "child": "0.5â€“1 mg/kg BIDâ€“QID (PDA closure or JIA; specialist use)",
    "avoid": "Active GI ulceration, severe renal impairment, aspirin hypersensitivity, cerebrovascular disease"
  },
  {
    "rank": 379,
    "name": "Benzbromarone",
    "section": "Section 10: Specialty & Emerging",
    "category": "Rheumatology",
    "schedule": "H",
    "brand": "Normalurate / Urinorm / Benzbromarone",
    "formation": "Benzofuranyl ketone uricosuric agent (URAT1 inhibitor)",
    "uses": "Hyperuricemia and gout (renal under-excretion type), when xanthine oxidase inhibitors fail",
    "adult": "50â€“200 mg OD (with food)",
    "child": "Not recommended",
    "avoid": "Uric acid nephrolithiasis, severe renal impairment, hepatotoxicity risk (monitor LFT)"
  },
  {
    "rank": 380,
    "name": "Strontium Ranelate",
    "section": "Section 10: Specialty & Emerging",
    "category": "Rheumatology",
    "schedule": "H",
    "brand": "Protelos / Osseor / Strontium Ranelate",
    "formation": "Strontium salt of ranelic acid (dual-action bone agent â€“ inhibits resorption and stimulates formation)",
    "uses": "Postmenopausal osteoporosis at high fracture risk (when bisphosphonates are contraindicated)",
    "adult": "2 g/day sachet in water at bedtime (>2 hrs after food and calcium)",
    "child": "Not recommended",
    "avoid": "Ischemic heart disease, peripheral arterial disease, uncontrolled hypertension, DVT history"
  },
  {
    "rank": 381,
    "name": "Folic Acid",
    "section": "Section 10: Specialty & Emerging",
    "category": "Vitamins/Minerals",
    "schedule": "OTC",
    "brand": "Folvite / Folinine / Folirich",
    "formation": "Vitamin B9 (pteroylmonoglutamic acid â€“ essential for one-carbon metabolism)",
    "uses": "Megaloblastic anemia, neural tube defect prevention in pregnancy, methotrexate-induced deficiency",
    "adult": "5 mg OD (anemia treatment); 0.4â€“5 mg/day (pre-conception and pregnancy)",
    "child": "50â€“200 mcg OD (deficiency); 5 mg OD (megaloblastic anemia)",
    "avoid": "Undiagnosed Vitamin B12 deficiency (may mask macrocytosis, unmask subacute combined degeneration)"
  },
  {
    "rank": 382,
    "name": "Pyridoxine HCl (Vitamin B6)",
    "section": "Section 10: Specialty & Emerging",
    "category": "Vitamins/Minerals",
    "schedule": "OTC",
    "brand": "Becadex / B6 / Pyridoxine",
    "formation": "Water-soluble B-vitamin (coenzyme for aminotransferases and decarboxylases)",
    "uses": "Vitamin B6 deficiency, hyperemesis gravidarum, INH-induced peripheral neuropathy prophylaxis",
    "adult": "10â€“50 mg daily (deficiency); 25 mg TID (morning sickness)",
    "child": "5â€“25 mg/day",
    "avoid": "High-dose >200 mg/day prolonged use (sensory neuropathy risk)"
  },
  {
    "rank": 383,
    "name": "Cyanocobalamin (Vitamin B12)",
    "section": "Section 10: Specialty & Emerging",
    "category": "Vitamins/Minerals",
    "schedule": "H",
    "brand": "Neurobion / Cobadex / Cyanocobalamin",
    "formation": "Cyano form of cobalamin (synthetic Vitamin B12)",
    "uses": "Pernicious anemia, strict vegetarian B12 deficiency, peripheral neuropathy",
    "adult": "1000 mcg IM/SC monthly (pernicious anemia); 25â€“250 mcg oral daily (prophylaxis)",
    "child": "0.5â€“1 mcg/day (infant); 1â€“2 mcg/day (child)",
    "avoid": "Leber's hereditary optic neuropathy (can cause acute optic atrophy)"
  },
  {
    "rank": 384,
    "name": "Thiamine HCl (Vitamin B1)",
    "section": "Section 10: Specialty & Emerging",
    "category": "Vitamins/Minerals",
    "schedule": "H",
    "brand": "Bevitex / Beplex / Thiamine inj",
    "formation": "Water-soluble vitamin (cocarboxylase precursor â€“ essential for carbohydrate metabolism)",
    "uses": "Wernicke's encephalopathy, beriberi, alcoholic neuropathy",
    "adult": "100â€“500 mg IV/IM (Wernicke's emergency); 10â€“25 mg OD oral (deficiency)",
    "child": "10â€“50 mg OD (deficiency)",
    "avoid": "Known hypersensitivity (rare anaphylaxis with parenteral use â€“ always have resuscitation available)"
  },
  {
    "rank": 385,
    "name": "Ascorbic Acid (Vitamin C)",
    "section": "Section 10: Specialty & Emerging",
    "category": "Vitamins/Minerals",
    "schedule": "OTC",
    "brand": "Limcee / Cevit / Ester-C",
    "formation": "L-ascorbic acid (reducing agent, antioxidant, collagen synthesis cofactor)",
    "uses": "Scurvy prevention and treatment, immune support, enhanced iron absorption",
    "adult": "70â€“500 mg/day (preventive); 1â€“2 g/day (therapeutic scurvy)",
    "child": "30â€“45 mg/day (RDA); 100â€“400 mg/day (therapeutic)",
    "avoid": "High-dose >2 g/day chronically (oxalate kidney stones risk), G6PD deficiency"
  },
  {
    "rank": 386,
    "name": "Biotin (Vitamin B7)",
    "section": "Section 10: Specialty & Emerging",
    "category": "Vitamins/Minerals",
    "schedule": "OTC",
    "brand": "Biotax / Biotimax / Bioten",
    "formation": "Water-soluble sulfur-containing vitamin (coenzyme for carboxylases)",
    "uses": "Biotin deficiency, brittle nails and hair loss, biotinidase deficiency",
    "adult": "2.5â€“5 mg OD (hair/nail); 5â€“10 mg OD (deficiency)",
    "child": "5â€“20 mcg/kg/day (biotinidase deficiency)",
    "avoid": "Interferes with thyroid immunoassays (stop biotin 48 hrs before TSH testing)"
  },
  {
    "rank": 387,
    "name": "Zinc Sulfate",
    "section": "Section 10: Specialty & Emerging",
    "category": "Vitamins/Minerals",
    "schedule": "OTC",
    "brand": "Zincovit / Zinconia / Zinc",
    "formation": "Inorganic zinc salt (essential trace element for enzyme function and immunity)",
    "uses": "Zinc deficiency, diarrhea (WHO ORS protocol), wound healing support",
    "adult": "220 mg (50 mg elemental zinc) ODâ€“TID",
    "child": "10â€“20 mg elemental zinc OD (diarrhea WHO protocol)",
    "avoid": "Concurrent high-dose copper/iron (competitive absorption), IV zinc without dilution"
  },
  {
    "rank": 388,
    "name": "Magnesium Hydroxide",
    "section": "Section 10: Specialty & Emerging",
    "category": "Vitamins/Minerals",
    "schedule": "OTC",
    "brand": "Milk of Magnesia / Gelusil / MOM",
    "formation": "Inorganic magnesium salt (antacid and osmotic laxative)",
    "uses": "Constipation (osmotic laxative), mild heartburn and hyperacidity (antacid), hypomagnesemia",
    "adult": "30â€“60 mL OD (laxative); 5â€“15 mL QID (antacid)",
    "child": "0.5 mL/kg ODâ€“BID (laxative)",
    "avoid": "Renal failure (hypermagnesemia risk), intestinal obstruction, appendicitis"
  },
  {
    "rank": 389,
    "name": "Potassium Chloride (Oral)",
    "section": "Section 10: Specialty & Emerging",
    "category": "Vitamins/Minerals",
    "schedule": "H",
    "brand": "Slow K / KCl / Potrate",
    "formation": "Inorganic potassium salt (electrolyte replenisher)",
    "uses": "Hypokalemia (mild-to-moderate), diuretic-induced potassium depletion prevention",
    "adult": "40â€“100 mEq/day in divided doses (with food and adequate water)",
    "child": "2â€“4 mEq/kg/day (supplementation)",
    "avoid": "Hyperkalemia, renal failure, concurrent potassium-sparing diuretics"
  },
  {
    "rank": 390,
    "name": "Ferric Carboxymaltose (IV)",
    "section": "Section 10: Specialty & Emerging",
    "category": "Vitamins/Minerals",
    "schedule": "H",
    "brand": "Ferinject / FCM Inj / Jectofer",
    "formation": "Non-dextran iron(III) complex (IV iron preparation)",
    "uses": "Iron deficiency anemia when oral iron is insufficient, intolerable, or ineffective",
    "adult": "500â€“1000 mg IV per dose (based on hemoglobin and body weight)",
    "child": "750 mg/dose (>50 kg); 15 mg/kg (<50 kg)",
    "avoid": "Iron overload, anemia not due to iron deficiency, hypersensitivity to parenteral iron"
  },
  {
    "rank": 391,
    "name": "Rifaximin",
    "section": "Section 10: Specialty & Emerging",
    "category": "Gastrointestinal",
    "schedule": "H",
    "brand": "Xifaxan / Rcifax / Rifaximin",
    "formation": "Rifamycin-derived minimally-absorbed oral broad-spectrum antibiotic",
    "uses": "Traveler's diarrhea, hepatic encephalopathy (prophylaxis/reduction), IBS-D",
    "adult": "200 mg TID Ã— 3 days (traveler's diarrhea); 550 mg BID (hepatic encephalopathy)",
    "child": "12 mg/kg/day (â‰¥12y for traveler's diarrhea)",
    "avoid": "Active intestinal obstruction, systemic infection requiring absorbable antibiotic"
  },
  {
    "rank": 392,
    "name": "Domperidone",
    "section": "Section 10: Specialty & Emerging",
    "category": "Gastrointestinal",
    "schedule": "H",
    "brand": "Domstal / Vomistop / Motilium",
    "formation": "Peripheral dopamine D2-receptor antagonist (prokinetic antiemetic)",
    "uses": "Nausea, vomiting, gastroparesis, functional dyspepsia",
    "adult": "10 mg TID (before meals, short-term use only; max 30 mg/day)",
    "child": "0.25 mg/kg TID (avoid in <12 kg or <1y)",
    "avoid": "Cardiac arrhythmia (QT prolongation risk), severe hepatic impairment, pheochromocytoma"
  },
  {
    "rank": 393,
    "name": "Drotaverine HCl",
    "section": "Section 10: Specialty & Emerging",
    "category": "Gastrointestinal",
    "schedule": "H",
    "brand": "No-Spa / Drotin / Spasmofen",
    "formation": "Isoquinoline derivative (selective smooth muscle PDE4 inhibitor â€“ spasmolytic)",
    "uses": "Renal, biliary and gastrointestinal smooth muscle colic, spasm, dysmenorrhea",
    "adult": "40â€“80 mg TID",
    "child": "20 mg BIDâ€“TID (â‰¥6y)",
    "avoid": "Heart failure, severe hepatic/renal failure, hypotension"
  },
  {
    "rank": 394,
    "name": "Hyoscine Butylbromide",
    "section": "Section 10: Specialty & Emerging",
    "category": "Gastrointestinal",
    "schedule": "H",
    "brand": "Buscopan / Hyoscine / Spancopal",
    "formation": "Quaternary ammonium anticholinergic (does not cross blood-brain barrier)",
    "uses": "Abdominal spasm, irritable bowel syndrome, renal colic, biliary colic",
    "adult": "20 mg TIDâ€“QID (oral) or 20 mg IV (acute spasm)",
    "child": "0.5â€“1 mg/kg/dose TID (â‰¥6y)",
    "avoid": "Myasthenia gravis, narrow-angle glaucoma, obstructive GI disease, tachyarrhythmia"
  },
  {
    "rank": 395,
    "name": "Mosapride Citrate",
    "section": "Section 10: Specialty & Emerging",
    "category": "Gastrointestinal",
    "schedule": "H",
    "brand": "Mosaride / Mosarex / Gastropride",
    "formation": "Substituted benzamide â€“ selective serotonin 5-HT4 receptor agonist (prokinetic)",
    "uses": "Gastroparesis, GERD (acid regurgitation), functional dyspepsia",
    "adult": "5 mg TID (30 min before meals)",
    "child": "Consult specialist",
    "avoid": "Severe hepatic disease, GI obstruction or hemorrhage"
  },
  {
    "rank": 396,
    "name": "Topiramate",
    "section": "Section 10: Specialty & Emerging",
    "category": "CNS",
    "schedule": "H",
    "brand": "Topamax / Topamac / Topirol",
    "formation": "Sulfamate-substituted monosaccharide (multiple antiepileptic mechanisms)",
    "uses": "Epilepsy (focal and generalized), migraine prophylaxis, weight management adjunct",
    "adult": "25â€“400 mg/day in 2 divided doses (titrate slowly over 6â€“8 weeks)",
    "child": "5â€“9 mg/kg/day in 2 divided doses (epilepsy â‰¥2y)",
    "avoid": "Metabolic acidosis, kidney stones (risk increased), acute myopia/glaucoma"
  },
  {
    "rank": 397,
    "name": "Oxcarbazepine",
    "section": "Section 10: Specialty & Emerging",
    "category": "CNS",
    "schedule": "H",
    "brand": "Trileptal / Oxrate / Oxcarb",
    "formation": "Dibenzazepine ketone (active keto-analog of carbamazepine â€“ Na+ channel blocker)",
    "uses": "Focal (partial) seizures, generalized tonic-clonic seizures",
    "adult": "300â€“1200 mg BID",
    "child": "8â€“10 mg/kg/day in 2 divided doses (â‰¥2y)",
    "avoid": "Hyponatremia (significant risk), carbamazepine hypersensitivity (cross-reactivity in ~25%)"
  },
  {
    "rank": 398,
    "name": "Lacosamide",
    "section": "Section 10: Specialty & Emerging",
    "category": "CNS",
    "schedule": "H",
    "brand": "Vimpat / Lacosam / Lacoset",
    "formation": "Functionalized amino acid â€“ selective slow inactivation enhancer of sodium channels",
    "uses": "Focal-onset (partial) seizures, adjunct in generalized tonic-clonic seizures",
    "adult": "50 mg BID initial; titrate to 100â€“400 mg BID (target)",
    "child": "2 mg/kg/day BID initial (â‰¥4y; weight-based titration)",
    "avoid": "Second/third-degree AV block, severe cardiac conduction abnormalities"
  },
  {
    "rank": 399,
    "name": "Clomipramine HCl",
    "section": "Section 10: Specialty & Emerging",
    "category": "CNS",
    "schedule": "H",
    "brand": "Anafranil / Clonil / Clomipramine",
    "formation": "Chloro-substituted imipramine (TCA with potent serotonin reuptake inhibition)",
    "uses": "Obsessive-compulsive disorder (OCD), depression, panic disorder, cataplexy",
    "adult": "25â€“250 mg/day (divided or single nocturnal dose; titrate over weeks)",
    "child": "25â€“200 mg/day (OCD â‰¥10y; titrate carefully)",
    "avoid": "Acute MI, closed-angle glaucoma, urinary retention, concurrent MAOI use (14-day washout)"
  },
  {
    "rank": 400,
    "name": "Mirtazapine",
    "section": "Section 10: Specialty & Emerging",
    "category": "CNS",
    "schedule": "H",
    "brand": "Mirtaz / Remeron / Mirteron",
    "formation": "Tetracyclic antidepressant (NaSSA â€“ noradrenergic and specific serotonergic antidepressant)",
    "uses": "Major depressive disorder, anxiety, appetite stimulation, insomnia adjunct",
    "adult": "15â€“45 mg OD (bedtime; higher doses are less sedating)",
    "child": "Not recommended",
    "avoid": "Concurrent MAOI use (14-day washout), narrow-angle glaucoma, agranulocytosis history"
  }
];

// â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
//  SCHEDULE META
// â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
const SCHED_META = {
  "OTC": { label:"OTC",     desc:"No Rx Required",       cls:"sch-OTC" },
  "C":   { label:"Sch. C",  desc:"Biological Product",   cls:"sch-C"   },
  "H":   { label:"Sch. H",  desc:"Prescription Only",    cls:"sch-H"   },
  "H1":  { label:"Sch. H1", desc:"Red Box Rx",           cls:"sch-H1"  },
  "X":   { label:"Sch. X",  desc:"Strict Control",       cls:"sch-X"   },
};

const SECTION_CLS = {
  "Section 1: Foundational Molecules":        "sec-1",
  "Section 2: Cardiovascular":                "sec-2",
  "Section 3: Metabolic & Endocrine":         "sec-3",
  "Section 4: Anti-Infective":                "sec-4",
  "Section 5: GI & Pain":                     "sec-5",
  "Section 6: Neuro-Psychiatry & CNS":        "sec-6",
  "Section 7: Dermatology & Ophthalmology":   "sec-7",
  "Section 8: Oncology & Immunology":         "sec-8",
  "Section 9: Respiratory, Allergy & ENT":    "sec-9",
  "Section 10: Specialty & Emerging":         "sec-10",
};

// â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
//  STATE
// â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
let state = { category:"All", section:"All", schedule:"All", search:"", sort:"rank", liver:false, ped:false };

// â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
//  FILTER
// â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
function filterData(){
  let d = saltsData.filter(s=>{
    const q = state.search.toLowerCase();
    const matchSearch = !q || s.name.toLowerCase().includes(q)
      || s.brand.toLowerCase().includes(q)
      || s.uses.toLowerCase().includes(q)
      || s.formation.toLowerCase().includes(q)
      || s.category.toLowerCase().includes(q);
    const matchCat  = state.category==="All" || s.category===state.category;
    const matchSec  = state.section ==="All" || s.section ===state.section;
    const matchSch  = state.schedule==="All" || s.schedule===state.schedule;
    let ok = true;
    if(state.liver){
      const av=s.avoid.toLowerCase();
      if(av.includes("liver")||av.includes("hepatic")) ok=false;
    }
    if(state.ped){
      const bad=["not recommended","avoid","contraindicated","safety not established","not indicated","not approved"];
      if(bad.some(w=>s.child.toLowerCase().includes(w))) ok=false;
    }
    return matchSearch&&matchCat&&matchSec&&matchSch&&ok;
  });
  if(state.sort==="rank")  d.sort((a,b)=>a.rank-b.rank);
  if(state.sort==="alpha") d.sort((a,b)=>a.name.localeCompare(b.name));
  return d;
}

// â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
//  RENDER CARDS
// â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
function renderGrid(){
  const data = filterData();
  document.getElementById("count-badge").textContent = data.length+" salts";
  const grid = document.getElementById("saltGrid");
  const empty= document.getElementById("emptyState");
  if(!data.length){ grid.classList.add("hidden"); empty.classList.remove("hidden"); return; }
  grid.classList.remove("hidden"); empty.classList.add("hidden");

  grid.innerHTML = data.map(s=>{
    const sm = SCHED_META[s.schedule]||SCHED_META["H"];
    const sc = SECTION_CLS[s.section]||"sec-1";
    return `
    <div class="bg-white rounded-2xl border border-slate-200 card-hover flex flex-col overflow-hidden shadow-sm">
      <!-- Card header -->
      <div class="px-4 pt-4 pb-3 border-b border-slate-100">
        <div class="flex items-start justify-between gap-2 mb-2">
          <span class="text-slate-400 text-xs font-bold bg-slate-100 px-2 py-0.5 rounded">#${s.rank}</span>
          <div class="flex flex-wrap gap-1 justify-end">
            <span class="${sm.cls} text-[10px] font-bold px-2 py-0.5 rounded-full" title="${sm.desc}">${sm.label}</span>
            <span class="${sc} text-[10px] font-semibold px-2 py-0.5 rounded-full">${s.section.replace("Section ","S")}</span>
            <span class="bg-teal-50 text-teal-700 text-[10px] font-semibold px-2 py-0.5 rounded-full uppercase tracking-wide">${s.category}</span>
          </div>
        </div>
        <h3 class="text-base font-bold text-slate-800 leading-tight">${s.name}</h3>
        <p class="text-[11px] text-slate-500 italic mt-0.5 leading-snug">${s.formation}</p>
        <div class="flex items-start gap-1 mt-1.5">
          <span class="text-[10px] font-bold text-amber-600 whitespace-nowrap mt-0.5">ğŸ· Brand:</span>
          <span class="text-[11px] text-amber-700 font-medium leading-snug">${s.brand}</span>
        </div>
      </div>

      <!-- Card body -->
      <div class="px-4 py-3 flex flex-col gap-2.5 flex-grow">
        <div>
          <span class="text-[10px] font-bold text-slate-400 uppercase block mb-0.5">Indications</span>
          <p class="text-xs text-slate-700 leading-snug">${s.uses}</p>
        </div>
        <div class="grid grid-cols-2 gap-2">
          <div class="bg-slate-50 rounded-lg p-2 border border-slate-100">
            <span class="text-[9px] font-bold text-slate-400 uppercase block">Adult Dose</span>
            <p class="text-[11px] text-slate-700 font-medium leading-snug mt-0.5">${s.adult}</p>
          </div>
          <div class="bg-slate-50 rounded-lg p-2 border border-slate-100">
            <span class="text-[9px] font-bold text-slate-400 uppercase block">Child Dose</span>
            <p class="text-[11px] text-slate-700 font-medium leading-snug mt-0.5">${s.child}</p>
          </div>
        </div>
        <div class="bg-rose-50 rounded-lg p-2 border border-rose-100">
          <span class="text-[9px] font-bold text-rose-400 uppercase block mb-0.5">â›” Avoid In</span>
          <p class="text-[11px] text-rose-700 font-medium leading-snug">${s.avoid}</p>
        </div>
      </div>
    </div>`;
  }).join("");
}

// â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
//  RENDER FILTER PILLS
// â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
function pill(label, active, onclick, extraCls=""){
  return `<button onclick="${onclick}" class="px-2.5 py-1 rounded-full text-xs font-medium transition border
    ${active ? "bg-teal-600 text-white border-teal-600 shadow" : "bg-slate-100 text-slate-600 border-slate-200 hover:bg-slate-200"}
    ${extraCls}">${label}</button>`;
}

function renderPills(){
  // Categories
  const cats = ["All", ...new Set(saltsData.map(s=>s.category))].sort((a,b)=>a==="All"?-1:a.localeCompare(b));
  document.getElementById("category-pills").innerHTML =
    cats.map(c=>pill(c, state.category===c, `setFilter('category','${c}')`)).join("");

  // Sections
  const secs = ["All", ...new Set(saltsData.map(s=>s.section))];
  document.getElementById("section-pills").innerHTML =
    secs.map(s=>pill(s.replace("Section ","S"), state.section===s, `setFilter('section','${s}')`)).join("");

  // Schedules
  const schs = ["All","OTC","C","H","H1","X"];
  document.getElementById("schedule-pills").innerHTML =
    schs.map(s=>{
      const meta = s==="All"?{label:"All",cls:""}:SCHED_META[s];
      const activeCls = state.schedule===s ? "bg-teal-600 text-white border-teal-600 shadow" : "bg-slate-100 text-slate-600 border-slate-200 hover:bg-slate-200";
      return `<button onclick="setFilter('schedule','${s}')"
        class="px-2.5 py-1 rounded-full text-xs font-medium transition border ${activeCls}">${meta.label}</button>`;
    }).join("");
}

window.setFilter = (key, val) => { state[key]=val; renderPills(); renderGrid(); };

window.resetFilters = () => {
  state = { category:"All", section:"All", schedule:"All", search:"", sort:state.sort, liver:false, ped:false };
  document.getElementById("searchInput").value = "";
  document.getElementById("btn-liver").classList.remove("bg-rose-100","ring-2","ring-rose-400");
  document.getElementById("btn-pediatric").classList.remove("bg-blue-100","ring-2","ring-blue-400");
  renderPills(); renderGrid();
};

// â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
//  EVENTS
// â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
document.getElementById("searchInput").addEventListener("input", e=>{
  state.search = e.target.value; renderGrid();
});
document.getElementById("sortSelect").addEventListener("change", e=>{
  state.sort = e.target.value; renderGrid();
});
document.getElementById("btn-liver").addEventListener("click", function(){
  state.liver = !state.liver;
  this.classList.toggle("bg-rose-100"); this.classList.toggle("ring-2"); this.classList.toggle("ring-rose-400");
  renderGrid();
});
document.getElementById("btn-pediatric").addEventListener("click", function(){
  state.ped = !state.ped;
  this.classList.toggle("bg-blue-100"); this.classList.toggle("ring-2"); this.classList.toggle("ring-blue-400");
  renderGrid();
});

// â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
//  CHART
// â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
function initChart(){
  const counts = {};
  saltsData.forEach(s=>{ counts[s.category]=(counts[s.category]||0)+1; });
  const sorted = Object.entries(counts).sort((a,b)=>b[1]-a[1]);
  const labels = sorted.map(e=>e[0]);
  const data   = sorted.map(e=>e[1]);
  const palette = [
    "#0D9488","#2DD4BF","#3B82F6","#8B5CF6","#EC4899",
    "#F59E0B","#10B981","#EF4444","#6366F1","#F97316",
    "#06B6D4","#84CC16","#A855F7","#14B8A6","#FBBF24"
  ];
  new Chart(document.getElementById("categoryChart").getContext("2d"),{
    type:"doughnut",
    data:{ labels, datasets:[{ data, backgroundColor:palette, borderWidth:0, hoverOffset:6 }] },
    options:{
      responsive:true, maintainAspectRatio:false,
      plugins:{
        legend:{ position:"bottom", labels:{ boxWidth:10, font:{size:10}, padding:8 } },
        tooltip:{ callbacks:{ label: ctx=>`${ctx.label}: ${ctx.raw} salts` } }
      }
    }
  });
}

// â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
//  INIT
// â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
document.addEventListener("DOMContentLoaded", ()=>{
  renderPills();
  renderGrid();
  initChart();
});
</script>
</body>
</html>